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1Abstract
Malaria is a major global threat caused by the protozoan parasites of the 
genus Plasmodium, leading to more than 400,000 deaths in 2015 alone. These 
parasites possess a specialised collection of three unusual apical secretory 
organelles called rhoptries, micronemes and dense granules that are required for the 
infection of new host cells. The rhoptries are the most prominent of the apical 
organelles and are an essential component of the parasite invasion machinery.
Studies on the Rhoptry Associated Protein (RAP) complex (consisting of RAP1, 
RAP2 and/or RAP3) of the rhoptry proteome have highlighted the potential of these 
members as asexual antimalarial vaccine candidates. However, studies in P. 
falciparum have shown that RAP1 is not essential in vitro, as genetic disruption of 
RAP1 had no consequential effect on the blood stage development and host cell 
invasion.  Conversely, attempts to delete the RAP2 gene in the rodent malaria line, 
P. berghei, which is grown in vivo, have been unsuccessful, indicating that the RAP 
complex may indeed be important to the parasite. Thus, this study aimed to resolve 
the contribution of the RAP complex to the survival of these parasites and to shed 
light on it potential function. Also since proteolytic maturation and correct 
trafficking of the RAP complex to the rhoptry is mandatory for its secretion and 
effector function, this study also investigated the significance of proteolytic 
processing in the targeting of the RAP complex to the rhoptry to help further 
understand the process of host cell invasion by the malaria parasite. 
Characterisation of RAP1 in P. falciparum revealed that RAP1 is not only 
expressed in the late schizont stage (consistent with having a role in the later part 
of the parasite lifecycle), it is also carried into the newly formed ring, where it 
persists in a membrane-associated form for up to 15 hrs post-invasion. Proteolytic 
maturation of P. falciparum RAP1 and its trafficking to the rhoptries could be 
affected by conditionally regulating the expression of a schizont-specific protease 
Dipeptidyl aminopeptidase 3, DPAP3, a protease hypothesised to proteolytically 
process RAP1. DPAP3 knockdown also affected the trafficking of other rhoptry 
proteins like RhopH3 and RON4, along with the microneme protein AMA1. 
Knockdown of DPAP3 also led to a delay in schizont development, resulting in a 
2delayed egress phenotype and a slower growth phenotype in the following cycle of 
parasite replication, indicating that DPAP3 may serve as a general maturase of 
these apical secreted proteins.
Attempts to knockout RAP1 in the rodent malaria strain P. berghei were 
unsuccessful, indicating that like RAP2, RAP1 is also essential in vivo.  However, 
conditional knockdown of RAP1 and RAP2 expression did not affect rhoptry 
formation, parasite replication or erythrocyte invasion, although depletion of RAP1 
inhibited the trafficking of RAP2 to the rhoptries, a phenotype previously observed 
in the P. falciparum RAP1 knockout line. Moreover, both RAP1 and RAP2
knockdown lines displayed an abnormal PVM morphology and a delayed growth 
phenotype, affecting the transition from ring to trophozoite stage. Thus the RAPs 
could potentially be involved in maintaining the integrity of the PVM or transport 
of nutrients/wastes across the PVM, and hence when the RAP complex is absent, it 
leads to fragmented and a discontinuous PVM and stalling of parasite growth. 
Combined, these data provide compelling evidence that RAPs are not involved in 
erythrocyte invasion, but instead play an important post-invasion role. Hence, this 
demands a reformation of the existing notion of RAPs as possible vaccine 
candidates to being potential anti-malarial drug targets.
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1.1 Global burden of malaria 
Malaria remains one of the most prevalent and devastating diseases afflicting 
humans worldwide. About 3.2 billion people, almost half of the world’s population, 
are at a risk of infection, of which an estimated 300–500 million people contract 
malaria each year and in 2015, malaria caused an estimated 438 000 deaths 
worldwide [1]. The disease is caused by protozoan parasite belonging to the genus 
Plasmodium, part of a large monophyletic assemblage of parasitic organisms within 
the phylum Apicomplexa [2]. There are five major species that can infect humans: 
Plasmodium falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, the latter 
of which is zoonotic and whose usual host is the Kra monkey [3]. P. falciparum is 
considered the deadliest of the species that infect humans because of the high level 
of mortality associated with infection, but P. vivax is associated with larger number 
of infections and considerable morbidity.
1.2 Disease symptoms and pathology 
All the clinical symptoms associated with malaria are caused by the blood stage 
parasites, and may result in a wide array of symptoms, ranging from very mild 
conditions to severe disease and even death. Patients with uncomplicated malaria 
present with high fever often accompanied by nausea, vomiting, headache, body 
ache, diarrhoea and general malaise. In severe cases, the clinical manifestations 
include cerebral malaria (CM), with nervous system complications, abnormal 
behaviour, seizures, fits and other neuralgic abnormalities [4]. In CM, parasite 
sequestration in the brain microvasculature coupled with an onslaught of an acute 
inflammatory response resulting in blockage of blood vessels, and even coma [4].
CM is often fatal causing death in 40% of the cases [5]. Parasites may also sequester 
in other organs like kidney, resulting in organ failure [6], or in the placenta [7],
giving rise to low birth weight babies. Other clinical manifestations of severe 
malaria include anaemia, hemoglobinuria, acute respiratory disease syndrome, 
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metabolic acidosis, abnormalities in blood coagulation, low blood pressure and 
hypoglycemia. Pregnant woman and children below the age of 5 are especially 
susceptible to primary infection and repeated malaria episodes possibly due to 
suppressed immunity.
1.3 The malaria parasite and its life cycle 
Plasmodium parasites have a complex life cycle that involves a female Anopheles 
mosquito vector, where sexual reproduction occurs, and a vertebrate host where 
asexual reproduction takes place (Fig 1.1). Infection of the human host is initiated 
when the parasite in the form of sporozoite is introduced into the human body 
through the bite of an infected mosquito (Fig 1.1A). The sporozoites are carried to 
the liver by the circulatory system where they infect the hepatocytes, then grow and 
multiply, resulting in the production of hundreds of merozoites (Fig 1.1B). These 
are released in the blood stream following the rupture of the infected hepatocytes.  
A proportion of liver stage parasites from P. vivax and P. ovale, undergo a dormant 
period lasting several weeks to months or even years after the primary infection 
and these forms termed hypnozoites are responsible for relapses.
The merozoites released into the blood then infect red blood cells (RBCs), upon 
which the parasite becomes encased into a vacuolar chamber called the 
parasitophorous vacuole (PV) lined by the parasitophorous vacuole membrane 
(PVM) (Fig 1.1C, Fig 1.2). Inside the RBC, the parasite enters a trophic phase in 
which the parasite grows and enlarges. On account of its morphology, the early 
form is referred to as “ring form” (Fig 1.2). This is followed by the trophozoite 
stage during which active metabolism including ingestion of host cytoplasm and 
proteolysis of haemoglobin into amino acids occurs. Multiple rounds of nuclear 
division without cytokinesis results in the formation of a schizont containing 
between 16-32 individual daughter merozoites. Merozoites bud from the mature 
schizont and following rupture of the infected RBC are released into the serum. 
Invasion of a new RBC reinitiates another round of the blood stage replicative cycle 
(Fig 1.2). In addition, a percentage of the asexual replicative forms in the RBC 
Chapter 1
19
become committed to forming the sexual forms known as macro or 
microgametocytes. Ingestion of gametocytes by the mosquito (Fig 1.1D) triggers 
their egress from the RBC and differentiation into gametes, initiating the mosquito
cycle of the parasite (Fig 1.1E). Fusion of the macro and the microgametes results 
in the formation of the zygote. The zygote develops into a motile ookinete, which 
traverses the mosquito mid gut layer and develops into oocysts. The oocysts 
undergo multiple rounds of asexual reproduction, leading to the formation of 
thousands of sporozoites. Rupture of the mature oocyst releases the sporozoites
Fig 1.1: Schematic representation of the Plasmodium life cycle
Infection with the Plasmodium parasites includes transmission between a mosquito 
vector and a vertebrate host, where the asexual replication cycles occur in the liver 
(exo-erythrocytic cycle) and the erythrocytes (erythrocytic cycle). Some asexual 
blood-stage parasites commit to forming sexual stage gametocytes, which are then 
transmitted to the feeding mosquito during a blood meal. This marks the beginning 
of the mosquito cycle where sexual reproduction of the parasite occurs. Adapted 
from Michalakis Y and Renaud F, 2009 [8].
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Fig 1.2: The Plasmodium erythrocytic cycle
An illustration of the different growth stages of the intra-erythrocytic cycle of the 
Plasmodium falciparum life cycle along with their respective Giemsa-stained 
images taken under a light microscope (100X magnification). The intra-
erythrocytic growth cycle of P. falciparum typically takes 48 hrs to complete, 
whereas that of rodent malaria species takes 24 hrs.
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into the mosquito hemocoel. The sporozoites then migrate to and invade the 
salivary gland, ready to infect the next vertebrate host when the female mosquito 
takes another blood meal.
1.4 Malaria control strategies 
In theory, any intervention that aims to achieve a complete blockage at any point 
in the parasite life cycle should effectively disrupt transmission and facilitate 
eradication efforts. This task of malaria control and eradication becomes 
particularly problematic in light of the fact that both the vector and the parasites are 
extremely adaptable. Because of the large number of people affected, the severity 
of disease symptoms and its consequences, several international public and private 
organisations like the Bill and Melinda Gates foundation, Medicines for Malaria 
Venture and the Global Fund to Fight Aids, Tuberculosis and Malaria are funding 
research that will lead to the long-term goal of global malaria eradication. The 
framework of malaria control strategies requires an integrate approach that seeks 
to prevent infections and to promptly treat infected people with effective anti-
malarials [9].
1.4.1 Prevention of malaria infection 
Strategies to prevent infection from malaria include effective vector control, the 
administration of prophylactic drugs and vaccine development.
1.4.1.1 Vector control 
As malaria is a vector-borne disease, vector control measures that reduce contacts 
between the mosquitoes and humans is an indispensable component of malaria 
prevention. This includes mosquito eradication by controlling mosquito breeding 
and killing adult mosquito to prevent mosquito bites. Up until the 1970s, the 
insecticide dichlorodiphenyltrichloroethane (DDT) was one of the most successful 
and widely used vector control measures employed to control the spread of malaria. 
However, because of mosquito resistance, health-associated risks along with its 
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potential environmental impact and accumulation in the food chain, DDT has been 
banned. Thus today, alternate measures are implemented, which at present includes 
the use of bed nets, preferably treated with insecticides, removing areas of water 
where mosquitoes breed, undertaking indoor residual spraying  and monitoring 
mosquito populations for their sensitivity to the respective insecticides used [10].
1.4.1.2 Prophylactic drugs 
Particular anti-malaria drugs can be used to prevent malaria infections. This 
includes doxycycline, mefloquine and the combination of proguanil hydrochloride 
and atovaquone. However, use of prophylactic drug is seldom a practical option for 
people living in malaria endemic areas, and is mainly restricted for short time 
travelers visiting malaria endemic regions.
1.4.1.3 Malaria vaccines  
A key tool that will be required to help eliminate and to eradicate malaria is an 
effective malaria vaccine. To date, more than thirty P. falciparum malaria vaccine 
candidates have been evaluated at either advanced preclinical or clinical stages 
[11]. This includes vaccines that target the pre-erythrocytic stages, with vaccines 
based on the circumsporozoite protein (CSP) making up the largest number. Other 
vaccine candidates include those that target the erythrocytic stages (which aim to 
induce immunity towards the blood stages of infection and/or to prevent 
pathogenesis associated with the disease by preventing parasite cytoadherence to 
the microvasculature and placenta) as well as transmission-blocking vaccines that 
target the sexual stages of the parasite [12-17].
The most advanced malaria vaccine in development, and the only one to have 
completed Phase 3 testing is the pre-erythrocytic stage hybrid recombinant protein 
vaccine RTS, S/AS01. It comprises the hybrid recombinant fusion protein RTS, 
which includes  regions of the P. falciparum CSP known to induce humoral (R 
region) and cellular immune (T region) responses, covalently bound to the hepatitis 
B surface antigen (S) co-administered with the adjuvant S/AS01. However, RTS,
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S/AS01 showed only a modest protection against P. falciparum challenge and no 
protection against P. vivax malaria  [18, 19] .
Malaria vaccine development has been severely hindered by the complexity of the 
parasite and  its lifecycle [20, 21], extensive antigenic variation [22], and a poor 
understanding of the interaction between P. falciparum and the human immune 
system [23]. In addition, as an intracellular parasite, the parasite is only exposed to 
the immune system for a very short window between parasite egress and invasion. 
Moreover, even during invasion, the essential parasite proteins and ligands are 
exposed only when released from the parasite. Also, the infected host erythrocyte 
does not express major histocompatibility complex molecules on its surface, which 
are required for antigen presentation to the immune system. Thus, the parasite 
successfully replicates undetected from the circulating antibodies. Furthermore, the 
parasite is capable of rapid mutation and many of the P. falciparum proteins are 
highly polymorphic and exhibit redundant functions, which presents significant 
challenges for vaccine design.
Thus, owing to the complex nature of the parasite life cycle, its high antigenic 
variability and host Major Histocompatibility Complex - MHC restriction, there is 
pressing need for the development of a multistage, multivalent malarial vaccine, 
incorporating key antigens and/or epitopes from multiple stages, especially the two 
invasive forms of the parasite in the human host , the sporozoite and the merozoite 
stage of the parasite lifecycle, resulting in the induction of both humoral and 
cellular immunity.
1.4.2 Treatment of malaria infection 
The primary objective of treatment of malaria infection is to ensure an immediate 
and complete elimination of the Plasmodium parasite from the blood of an infected 
patient, thus preventing progression of uncomplicated malaria to severe disease and 
death. This would also reduce the infectious reservoir, thereby reducing 
transmission of the infection to others. Despite the wide availability of antimalarial 
treatments, a major obstacle to the control of malaria is the emergence of drug-
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resistant parasite strains. The widespread and irrational use of the available 
treatment options that were previously cheap and effective has resulted in the 
appearance and spread of drug-resistant parasites. Thus, World Health Organisation
(WHO) recommends the use of the present frontline drug artemisinin in 
combination therapy (ACTs) with other conventional anti-malarials like 
amiodiaquine, mefloquine, piperaquine, rather than monotherapy [1].  Despite this 
approach, there has been recent reports on the failure of ACTs on the Thai-
Cambodian border [24], suggesting the emergence of local artemisinin resistance. 
1.4.3 Addressing malaria control and eradication from a biomedical research 
perspective 
As malaria parasites continue to display multi-drug resistance to even the last-line 
of anti-malarials available, it is now obvious that new strategies are desperately 
required to combat malaria. Previous attempts at malaria eradication have taught us 
significant lessons, including the importance of a sustained and robust research 
foundation for addressing malaria elimination. From a biomedical research 
perspective, it is essential to have an in-depth understanding of malaria parasite 
biology and to identify the points in the life cycle where the parasite could be most 
vulnerable to drugs or vaccines. One of the processes that is central to parasite 
survival is the ability of the parasite to invade its host cells and persist within its 
new host environment. Therefore understanding the mechanisms by which the 
parasites achieves this could possibly aid in identifying new molecular pathways 
that can be targeted via drugs or vaccines to  ultimately prevent parasite growth or 
reduce the severity of disease pathogenesis. Recognising this, one of the Malaria 
Eradication Research Agenda (malERA) research priorities is to gain a thorough 
understanding of the basic biology of the parasite through the use of gene 
technologies that enable dissection of gene function [25]. Such knowledge would 
facilitate the identification, development, evaluation and ultimately validation of 
new intervention strategies to address the challenges of the ambitious goals of 
elimination and eventual eradication of malaria.
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1.5 Invasion and establishment of Plasmodium parasites within the 
host red blood cells 
As Plasmodium parasites cannot grow or multiply extracellularly, their survival and 
transmission depends on the ability of the invasive form at each life cycle stage 
(sporozoite, merozoite and ookinete) to specifically recognize, invade and to 
transverse their respective host cell (hepatocyte, RBC and mosquito mid gut 
epithelial cell). Each of these invasive ‘zoite’ forms contain a set of apical 
organelles that include the micronemes, rhoptries and dense granules, which play a 
crucial role in host cell invasion by the parasites [26]. These apical organelles are 
not only found in Plasmodium, they are the defining characteristics of the phylum 
Apicomplexa to which Plasmodium belongs. Much of the knowledge regarding 
invasion has been gained from not only studying Plasmodium sporozoites and 
merozoites, but also from studies on the invading tachyzoite form of the 
Apicomplexan parasite, Toxoplasma gondii. [27]. A schematic of a Plasmodium 
merozoite and its apical organelles is shown in Fig 1.3. 
Preparation for parasite invasion into a new host RBC begins at the end of the cell 
cycle prior to merozoite egress from the current host RBC in which the parasite 
resides (Fig 1.4A). Invasion of RBCs by the Plasmodium merozoite is a complex 
multi-step process that involves the sequential release of contents from the apical 
organelles [28].  The contents of the apical organelles not only enable the merozoite 
to selectively attach to and invade host cells, but allows the parasite to subsequently 
establish itself in the new host cell and remodel the host cell to aid its survival and 
replication. The initial interaction between the merozoite and the host RBC results 
from a random collision of the two, which involves a reversible interaction between 
the host cell and the parasite coat proteins. The Merozoite Surface Proteins (MSPs) 
are implicated in this initial low affinity attachment between the host cell surface 
and the parasite [29, 30]. This recognition and primary attachment ensures binding 
of the parasite to the correct target host RBC (Fig 1.4B) [30, 31].
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Fig 1.3: The apical invasion machinery of Plasmodium parasites
A Plasmodium falciparum merozoite showing the presence of apical structures, 
which is the defining feature of -zoites from the phylum Apicomplexa. These 
include rhoptries, micronemes and dense granules. Other organellar structures 
includes the apical polar ring, mitochondrion, apicoplast, nucleus and endoplasmic 
reticulum.
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After the initial reversible attachment, the parasite reorients itself to juxtapose its 
apical end with the RBC membrane (Fig 1.4C). It is speculated that by opposing 
the most pointed apical end of the parasite against the RBC membrane, also assures 
minimum energy cost of membrane distortion required for parasite internalisation
and invasion [32]. In P. falciparum, two gene families encode important proteins 
that then function in irreversible parasite adhesion to the host, and this includes the 
erythrocyte binding-like antigens (EBAs) and reticulocyte binding-like homolog 
proteins (PfRhs). P. falciparum encodes four EBAs; EBA-140, EBA-175, EBA-
181 and EBL-1, which show a sialic acid-dependant binding to the glycophorin 
receptors on the host RBC, and five PfRhs including  PfRh1, PfRh2a, PfRh2b, 
PfRh4 and PfRh5, which vary in their dependency for sialic acid binding (reviewed 
in [33-35]), while Rh3 is a pseudogene [36]. For example EBA-175 was the first 
parasite protein identified to bind to glycophorin A on the erythrocyte surface to 
mediate a sialic acid dependant invasion of the host erythrocyte [37]. Recently 
basigin was identified as the erythrocyte receptor that bind to Rh5 during invasion 
in a sialic acid independent manner, and this interaction between the parasite ligand 
and host receptor is essential to merozoite invasion [38]. Accordingly, Rh5 is 
refractory to genetic ablation, making it a good vaccine candidate [39]. These 
parasite ligands are implicated in mediating parasite commitment to invasion and 
triggering subsequent events leading to parasite entry into the host. 
As the parasite invades the RBC, it becomes enveloped by the host plasma 
membrane. The parasite first forms a strong grasp on the RBC membrane by 
establishing a series of protein – protein interactions that bridge the parasite and the 
host membranes. This in effect creates a ring-like structure around the parasite 
apex, giving rise to the formation of a tight junction (Fig 1.4D) [40]. The secreted 
micronemal protein apical membrane antigen-1 (AMA1) spans the parasite 
membrane and forms the bridge between the parasite and the RBC membrane by 
binding to a domain on the rhoptry neck protein RON2 secreted into the host 
erythrocyte [41], and triggering the actin- myosin motor dependant internalisation 
of the invading parasite. The tight junction passes along the length of the parasite 
during internalisation, sealing behind the rear end of the parasite after invasion is 
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completed such that parasite is now encased within a parasitophorous vacuole (PV) 
in its new host cell [42] (Fig 1.2). Rhoptry secretion is concomitant with parasite 
entry into the host RBC (Fig 1.4E), and is implicated to aid in the formation of the 
PV in which the parasite resides throughout the intra-erythrocytic stage of its 
lifecycle [43]. The invasion process is now completed. Immediately following this, 
the dense granules contents are secreted into the PV. Some of the dense granule 
proteins are exported into the host RBC and have been shown to induce a series of
host cell modifications to make the host cell a more suitable habitat for the growth 
and replication of the parasite [44].
1.6 The rhoptry contents and their role in invasion 
Although the stages of erythrocyte invasion are beginning to be unraveled, most of 
the research has focused on the initial attachment phase, as parasite antigens 
involved in these processes present obvious targets for strategies to block invasion. 
However, the events that occur downstream of tight junction formation, including 
formation of the PVM and the initial establishment of the parasite in its new host 
environment are less well studied. While the proteins secreted from micronemes 
are implicated to play roles in the early stages of invasion (parasite reorientation 
and tight junction formation) and those from the dense granules in host cell 
modification, the rhoptries proteins have been implicated to play a diverse role in a 
merozoite adhesion [39], establishment of the PVM [45] as well as formation of 
new permeation pathways in the erythrocyte membrane for nutrient uptake to 
facilitate  parasite survival in the host [46]. Thus, a deeper insight into the rhoptry 
organelle, its contents, their timing of secretion and trafficking to their ultimate 
destination may help to address how rhoptry proteins contribute to the entry into 
and securement of survival of the invading parasite within the new host RBC.
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1.6.1 The rhoptry structure and proteome 
Rhoptries in mature Plasmodium schizonts are twin, membrane-bound, pear shaped 
and ducted organelles, approximately 650 nm long and 300 nm in diameter at the 
base [47]. Electron microscopic (EM) studies show that the rhoptry comprises two 
distinct compartments, the rhoptry bulb and the rhoptry neck. In transmission EM 
micrographs, the bulb appears as a granular region, whereas the neck has a more 
electron-lucent appearance [47]. The same observation has been reported in the 
related Apicomplexan parasite, T. gondii [48, 49]. The rhoptry neck is elongated 
and ends just beneath the plasma membrane at the apical prominence of the forming 
merozoite. 
The availability of the genome sequences from Plasmodium, Toxoplasma and more 
recently Eimeria spp. has greatly accelerated studies on the rhoptry proteome [50-
52]. To date, more than 30 rhoptry proteins have been identified and characterised 
in Plasmodium (detailed in Table 1.1 and 1.2) [53-55]. Dissection of the rhoptry 
proteome has nevertheless, posed a challenging task because these organelles are 
extremely fragile, making it difficult to isolate the organelle and perform 
subsequent analysis. Attempts to purify the rhoptries from the rodent species 
Plasmodium yoelii have been made, which has added a further 27 potential rhoptry 
proteins of unknown functions to the rhoptry proteome [56].
Interestingly, the rhoptry proteome is sorted and sub-compartmentalised to either 
the bulb or the neck region of the organelle [43, 57]. The proteins that localise to 
the rhoptry neck are called RONs (Rhoptry Neck Proteins), while the proteins 
localizing to the bulb are known as ROPs (Rhoptry Bulb Proteins; Fig 1.5) [58].
Surprisingly, no internal membranes seem to separate these compartments within 
the rhoptry and thus the mechanism by which the rhoptry proteome is restricted to 
either rhoptry compartment remains elusive [47]. In contrast to other organelles 
such as the apicoplast [59, 60], the rhoptry appears to lack proteins that are part of 
any known biochemical pathway. In fact, most rhoptry proteins show little or no 
homology to any proteins of known function, and even the rhoptry proteomes of 
Chapter 1
31
Plasmodium and Toxoplasma show relatively limited overlap. In contrast, there is
conservation of some of the microneme proteins across the Apicomplexa [61]. As 
the majority of the Plasmodium rhoptry proteins are expressed late in the 
erythrocytic cycle, this indicates they may play a potential role both during and post 
host erythrocyte invasion. 
1.6.1.1 The rhoptry neck proteome 
Although the proteomes of Plasmodium and Toxoplasma display minimal overlap, 
there is some degree of conservation of rhoptry neck proteins across the 
apicomplexan species for which genomes are available. Plasmodium rhoptry 
proteins that localise to the neck include the well-characterised reticulocyte 
binding-like (RBL) family and the RON complex as well as poorly characterised 
proteins such as Apical Sushi Protein (ASP) and Pf34 (Fig 1.5) (Table 1.1). These 
proteins are secreted during invasion, responding to the initial triggering signal 
likely from the discharge of the micronemes.  The neck proteins are implicated to 
be mainly involved in host cell adhesion and tight junction formation before and 
during invasion. 
1.6.1.1.1 The RBL family 
The Plasmodium RBL family comprising of Rh1, Rh2a, Rh2b, Rh4 and Rh5 are 
large (>200 kDa) Type I integral membrane proteins. RBL proteins are adhesins 
and are implicated in host cell attachment by interacting with host cell receptors 
(Table 1.1). PfRh1 binds to erythrocyte in a sialic acid dependant manner and this 
binding is sensitive to neuramidase treatment of the host cell, while in contrast 
binding of PfRh4 to the erythrocyte is neuramidase resistant [62]. PfRh2a and 2b 
binding to the erythrocyte occurs via a sialic acid-independent mechanism [63].
Knockout studies of PfRh’s have led to researchers to conclude that differential 
expression of RBLs allows P. falciparum to invade via alternative invasion 
pathways,  thereby providing the merozoite with a mechanism to screen numerous 
potential host cells before committing to invade a susceptible host erythrocyte [64,
65]. It also serves as a mechanism for the malaria parasite to circumvent the host
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Fig 1.5: The role of rhoptry proteins during and after erythrocyte invasion.
RONs predominantly function during initial attachment and tight junction (TJ) 
formation, whilst the ROPs, which are secreted after TJ formation are mainly 
implicated post invasion in PVM formation and establishment of the parasite in the 
new host environment.
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Immune response [66]. However, the interaction between Rh5 and its recently 
identified erythrocyte receptor basigin is essential to merozoite invasion [38].
Accordingly, Rh5 is refractory to genetic ablation, making it a promising vaccine 
candidate [32].
1.6.1.1.2 The RON complex 
Plasmodium RONs have orthologues in Toxoplasma, indicating these proteins play 
a conserved role throughout the Apicomplexa. The importance of RONs came to 
light in studies on Toxoplasma, where a complex comprising RON2, RON4 and 
RON5 was shown to act as a parasite-specific receptor that is inserted into the host 
cell plasma membrane during invasion for the microneme protein AMA1 to form 
the tight junction during invasion (Fig 1.5) (Table 1.1) [67, 68]. RON2 spans the 
RBC membrane, with its C- terminal domain exposed to the surface of the host 
membrane [69], while RON4 interacts with the host cytoskeleton in the host cytosol 
[41, 45, 70]. The RON complex then binds to the hydrophobic binding pocket of 
AMA1 exposed on the parasite plasma membrane, forming the TJ complex. Thus 
the TJ complex provides a bridge between the parasite and the host cortical 
cytoskeleton, serving as an anchor point for the actin myosin motor to pull the 
parasite into the nascent PV during invasion [41]. Since then, several studies have 
established that a similar interaction also occurs between AMA1 and RON2 in 
Plasmodium [67, 69, 71-75]. The presence of the same complex in the sporozoites 
re-enforces the suggestion that these proteins are required by the invasive forms to 
invade their respective host cells and is in agreement with the notion that these 
proteins allow invasion of a range of host cells by the Apicomplexan parasites [76].
1.6.1.2 Rhoptry bulb proteome 
In contrast to the RONs, Plasmodium Rhoptry Bulb Proteins (ROPs) are not 
conserved among the Apicomplexa and are thus unique to Plasmodium. This 
indicates that the Apicomplexan ROPs are highly adapted to function in their 
respective specific intracellular niche to ensure parasite virulence and survival. 
Like the neck proteins, the ROPs are released during invasion, however they have 
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been observed to migrate to one of three general locations: the lumen of the nascent 
PV, the PVM or to the host cell [45, 46]. The timing of secretion of the ROPs post-
TJ formation indicates a functional role of the ROPs downstream of invasion rather 
than invasion per se (Table 1.2). However, most of the Plasmodium ROPs still
require detailed characterisation before a functional role in the infected erythrocyte 
can be designated. In T. gondii, ROPs have been implicated in diverse roles such
as rhoptry biogenesis, PVM formation and remodeling the host cell (Fig 1.5) [77,
78]. Many of the TgROPs are kinases and after injection into the host cell upon 
invasion, some ROPs have been shown to translocate to the nucleus to interfere 
with the host signal transduction pathway (reviewed in [78, 79]) and to modulate 
and subvert the host immune response [80-84]. Hence TgROPs support virulence 
and survival of the parasite in the new host environment. 
In contrast, very little is known about the function of the Plasmodium ROPs and 
the lack of conservation to T. gondii ROPs also means that insight into Plasmodium 
ROP function cannot be gleaned from studies in T. gondii. No Plasmodium ROPs 
with predicted kinase activity have been reported as of yet. To date Plasmodium 
ROPs have been implicated to play roles in erythrocyte invasion, PV formation, 
establishment of permeability pathways in the erythrocyte for the acquisition of 
nutrients from the host serum and host cell modification [46, 85-87], although there 
is still limited functional data to support some of these conclusions. Thus, further 
experimental evidence to validate the function of ROPs would be extremely 
beneficial and would help to unravel why many of these proteins have become 
indispensable for the Plasmodium parasite to survive within its specific cellular 
niche.
Immunoprecipitation experiments on rhoptry extracts have led to the identification 
of two ROP complexes; the low molecular weight (LMW) or Rhoptry Associated 
Protein (RAP) complex and the high molecular weight (HMW) RhopH complex, 
both of which have been characterised to some extent. Other ROPs include 
Rhoptry-Associated Membrane Antigen (RAMA) and those listed in Table 1.2 [86,
88-93].
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1.6.1.2.1 Rhoptry Associated Membrane Antigen (RAMA) 
RAMA is reported as being one of the first rhoptry proteins expressed, appearing 
15-20 hrs after invasion during the late ring/early trophozoite phases of the
parasite’s life-cycle, which is even before the rhoptry is actually formed (at ~40 
hrs) [94] . RAMA is predominantly hydrophilic and is primarily translated as a 
protein of molecular mass of 170 kDa (p170). RAMA is proteolytically processed
within the nascent and mature rhoptries to produce a 60 kDa form (p60), derived 
from the C-terminus of the precursor protein [93]. RAMA binds to the membrane 
with the aid of a C-terminal consensus glycosylphosphatidylinositol (GPI) 
attachment site and associates with lipid rafts [92]. Thus p170/PfRAMA has been 
suggested to be involved in the biogenesis of rhoptry organelles, whereas 
p60/RAMA appears to participate in RBC invasion [93]. p60/RAMA also contains 
a potential protective epitope and is associated with high antibody responses in 
humans [86], making RAMA a potential vaccine candidate.
1.6.1.2.2 The High Molecular Weight Complex (HMW) 
The HMW complex or the RhopH complex [88, 89] is conserved among the 
Plasmodium spp., and comprises of RhopH1 (155 kDa), RhopH2 (140 kDa), and 
RhopH3 (110 kDa) [95 , 96]. Whilst RhopH2 and RhopH3 are encoded by single 
genes in all Plasmodium spp., RhopH1 is encoded by 5 paralogous genes, termed 
clag 2, 3.1, 3.2, 8 and 9 in P. falciparum and only by two genes, clagX and clag9, 
in the rodent malaria species P. berghei [97]. Members of the RhopH complex are 
transferred to the host cytosol and plasma membrane after parasite internalisation, 
where they are implicated to function post invasion (Fig 1.5) [46, 98-101]. For 
example, RhopH1/Clag3 localises to the RBC membrane and is involved in altering 
the permeability of host cell membrane to a varied range of solutes to potentially 
aid in parasite nutrient acquisition [46]. Accordingly, clag3 mutants exhibit a 
significant growth defect as well as an invasion phenotype in vitro [102]. Another 
study has revealed P. falciparum RhopH1/Clag9 aids in the cytoadherence of 
infected RBCs to the microvasculature, thereby preventing clearance through the 
spleen [98], although it should be noted that the length of time these parasites were 
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in culture could have contributed to the loss of cytoadherence through the loss of 
the end of chromosome 9, which is essential for erythrocyte cytoadhesion under 
flow conditions. The function of RhopH1/Clag8 and RhopH1/Clag2 in P. 
falciparum is unknown. The P. berghei clag9 and clagX (an orthologue of the P. 
falciparum Clags 2, 3.1, 3.2 and 8) genes are refractory to gene deletion [103],
which advocates for an essential role of these proteins  in vivo (Table 1.3).
1.6.1.2.3 The Low Molecular Weight Complex (LMW) 
The low molecular weight complex of Plasmodium rhoptries consist of three, non-
covalently associated proteins that include Rhoptry Associated Protein 1 (RAP1), 
and RAP2 or RAP3. The members of the LMW/RAP family are conserved among 
the Plasmodium species and are highly abundant proteins. RAP1 protein is 
translated as a 782 residue polypeptide with an apparent molecular mass of 86 kDa 
as determined by sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-
PAGE) [104, 105]. RAP1 maturation involves multiple processing steps. The full 
length RAP1 is processed to an 82 kDa molecule (p82) in a process which can be 
blocked by Brefeldin A or low temperature incubation, in agreement with the 
presence of the protein within compartments of the classical secretory pathway 
[105]. This protein is further processed seemingly in nascent rhoptries to a 67 kDa 
molecule (p67) with an occasional p70 intermediate (Fig 1.6B) [106, 107]. RAP2 
and RAP3, on the other hand, are not processed and mature RAP2 and RAP3 have 
an apparent MW of 42 kDa and 37 kDa respectively as determined by SDS-PAGE 
[108].
In P. falciparum,  the RAP gene family has undergone  gene duplication such that 
RAP2 and RAP3 are paralogs - RAP3 shares 68% similarity and 44% identity with  
RAP2 [91]. RAP1 p82 and p67 binds  to RAP2 p42 and RAP3 p37 in a mutually 
exclusive fashion to form hetero-oligomeric RAP1/RAP2 or RAP1/RAP3 
complexes (Fig 1.6A) [107]. In contrast, P. berghei harbours only a single RAP2/3
gene, and thus forms a single hetero-oligomeric complex comprising RAP1 with 
either RAP2 or RAP3 [91, 109].
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In terms of the function of the RAP complex, we still know very little [110-112].
While the processed RAP1 proteins p82 and p67 are observed in complexes with 
RAP2 and RAP3 in schizont stages and free merozoites [110] only complexes 
comprising RAP1 p82, RAP2 and RAP3 (but not RAP1 p67) are detected after 
invasion in ring-stage parasites. This has led to the suggestion that RAP1 p67 has 
a role in RBC invasion [110]. The importance of RAPs was further augmented 
following the evaluation of the protective potential of the antibodies against the 
rhoptry proteins. Recombinant RAP1 (rRAP1) and RAP2 (rRAP2) were shown to 
generate immune responses in rabbits and mice against the native antigens. Human 
antibodies in the sera from people living in malaria endemic areas also recognized 
the rRAP1 and rRAP2 [113]. Monoclonal antibodies directed against PfRAP-1 and 
PfRAP-2 have also been shown to inhibit erythrocyte invasion in vitro [112, 114,
115]. Immunizations of Saimiri sciureus and S. boliviensis monkeys with the 
PfRAP1 and PfRAP2 complex demonstrated partial protection against P. 
falciparum [116-118]. In addition, individuals naturally exposed to P. falciparum
develop antibodies against PfRAP1 [113, 119-121] and antibodies against the 23-
294 aa RAP1 fragment were associated with low parasite burden in Tanzanian 
children [122]. The 23-294aa fragment of RAP1 has been reported to include both 
B and T cell epitopes [123], with the N terminal fragment being the main target for 
antibody reactivities [114, 124]. These immunogenic and functional 
characterisation studies of the RAP complex, the minimal sequence diversity of 
RAP1 [120, 125, 126] and RAP2 [127] together with the importance of RAP1 and 
RAP2 for binding of P. falciparum parasites to RBCs [128], highlighted the 
potential of these members of the RAP family as asexual antimalarial vaccine 
candidates. However, contrary to the existing expectations, vaccines directed 
against RAP1 failed to render complete protection against a challenge infection 
(reviewed in [53]). This lack of protection is consistent with the present knowledge 
regarding the sequence of events during invasion in which the ROPs are secreted 
into the PV/PVM after the  tight junction has formed [45]. The immunogenicity of 
RAP1 could thus be explained in the light of abortive invasion events, whereby the 
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attached merozoite releases its rhoptry contents without committing to invasion, 
leading to the recognition of the rhoptry bulb proteins by the host immune system.
To gain a better understanding regarding the function of the RAPs, loss of function 
studies have been performed in P. falciparum, in the cloned parasite line D10 Here 
the single wild type copy of RAP1 was targeted for disruption by single site 
homologous recombination, resulting in a pseudodiploid producing a truncated 
RAP1 gene predicted to encode only 344 amino acids of the total 782 amino acids 
of the wild type RAP1 protein. Disruption of RAP1, led to expression of a severely 
truncated form of the protein by Western blot analysis, which showed the presence 
of an ~ 40kDa protein band as opposed to full length 83kDa wild type RAP1 
protein. The truncated RAP1, showed a punctate rhoptry localisation by IFA, 
suggesting that the N-terminal 344 amino acids of RAP1 are sufficient for 
trafficking to the rhoptries. However, the RAP1 knockout line did not show any 
defect in in vitro growth or RBC invasion by sialic acid dependant or independent 
pathways. These have revealed that the RAP complex is not essential for the blood 
stage development and RBC invasion [91, 129]. However, as the gene was not 
entirely deleted, the resulting truncated form of the protein, may still be partially 
functional.
Although there was no in vitro phenotype in the RAP1 knockout line, RAP2 
targeting to the rhoptry was perturbed in these parasites. The ability to disrupt RAP3
in P. falciparum stems from RAP2 being able to complement its function, although 
this remains to be formally proven [91]. In P. berghei, which only has a single 
RAP2/3 gene, attempts to knock out the RAP2/3 gene using targeted gene disruption 
technology have been unsuccessful [130], suggesting the RAP complex plays a 
critical role in an in vivo setting (Table 1.3). 
1.6.2 Trafficking of rhoptry cargo and rhoptry biogenesis 
Although the rhoptries are the most prominent of organelles characterizing the 
Apicomplexa, we still know very little about how these large membrane-bound, 
club shaped structures actually form during each erythrocytic cycle, how the 
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rhoptry cargo traffics to these structure and the mechanism that underlines the 
segregation of the rhoptry proteome within the neck or the bulb region of the 
rhoptry to ensure timely secretion during invasion. Rhoptry biogenesis occurs by 
the docking and fusion of Golgi-derived vesicles delivering protein cargo into the 
rhoptry lumen [47], although the nature of the signal(s) that initiate this process is 
unknown. It is now known that rhoptry proteins traffic through the classical 
secretory pathway via the endoplasmic reticulum and the Golgi owing to the 
presence of an N-terminal classical hydrophobic signal sequence [93, 131]. As P. 
falciparum possesses a stripped down version of a higher eukaryotic secretory 
pathway, it is intriguing how the parasite directs proteins specifically to the 
rhoptries (and to either the neck/bulb region of the organelle) and not to any of the 
other apical secretory organelle within the parasite. 
In Plasmodium, only a limited number of studies focussing on rhoptry protein 
trafficking have been done. The proteins on which the most extensive work have 
been done are the members of the RAP complex, which implicates that the targeting 
of the RAP complex to the rhoptry occurs via the N-terminus of RAP1, although 
the mechanism is not understood [129, 131]. RAP1 has a hydrophobic N terminal 
sequence that acts as a signal sequence, with a signal peptide processing site at 
position 22 [132]. RAP1 is synthesized as a polypeptide of 782 amino acids. By 
expressing RAP1-GFP chimeras in P. falciparum, it was revealed that the N-
terminal amino acids 22-55 are necessary and sufficient for optimal targeting to the 
rhoptries. RAP1 also appeared to possess distinct signals within amino acids 344-
782 (Bulb retention domain) for localisation to the rhoptry bulb and amino acid 
344-44 for subsequent transfer to the PV after invasion [131]. The C terminus of 
RAP1 was also shown to be important for the interaction of RAP1 with the other
members of the RAP complex [132]. Thus, truncation of RAP1, in which this C-
terminal region has been removed, results in trafficking of RAP1 to the rhoptry 
neck and retention of RAP2 in the endoplasmic reticulum (ER) [129]. It may be 
possible that RAP3 is also mis-localised in the parasites with a truncated RAP1 
[129 88], however in the absence of specific antisera to RAP3, it is not possible to 
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prove this unequivocally. Disruption of the RAP3 gene resulted in the loss of the 
corresponding protein in the RAP complex [91].
Interestingly, Fluorescence Resonance Energy Transfer (FRET) and immune 
precipitation (IP) experiments have revealed that the RAP complex (and possibly 
the RhopH complex) interacts with RAMA in the Golgi. In vitro pull-down assays 
mapped amino acids 22-152 at the N terminus of RAP1 as the RAMA binding 
domain [131]. Unpublished studies have shown that RAMA temporarily 
accumulates within the ER and Golgi compartments in lipid rafts, prior to the 
appearance of rhoptries (unpublished information from Prof Coppel). These data 
suggest that RAMA may be responsible for generating rhoptry-destined cargo at 
the Golgi that is ultimately delivered to the rhoptries. However, the presence of 
RAMA in vesicles has not been established yet. RAMA is conserved in 
Plasmodium spp. and refractory to gene deletion thus is likely to be an essential 
parasite protein [92, 93]. These findings led Richard et al [131] to propose that 
RAMA, a GPI anchored protein, recruits RAP1, 2 and 3 into a complex within a 
lipid raft at the Golgi exit face to generate a rhoptry destined aggregate thus  serving 
as an escorter for the RAP complex (Fig 1.7). Lipid rafts are specialised domains 
in the membrane that aid in compartmentalisation of cellular processes and which 
serve as organising centres influencing protein trafficking [133] . Because of their 
unusual lipid composition and detergent resistance, they are also known as 
Detergent Resistant Microdomains (DRM) [134]. DRM clustering, coupled with
protein oligomerisation, has been shown to be essential for polarised trafficking of 
GPI anchored proteins. With RAMA and RAP1 being associated with DRMs, it is 
tempting to speculate that this mechanism is involved in differential sorting of 
proteins within the Golgi thus leading to the formation of rhoptry destined cargo,  
within the Golgi exit face that ultimately bud of as rhoptry destined cargo vesicles 
[131]. However, since the C-terminus of RAMA is embedded within the lipid 
bilayer [92], it necessitates the presence of a transmembrane (TM) escoter protein 
which can interact with RAMA and the rhoptry cargo on one side, and cytosolic 
machinery on the other, ensuring the trafficking of the protein complexes to the 
nascent rhoptries (Fig 1.7). 
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A candidate protein that is transcribed around the same time as RAMA and can 
potentially act as this TM escorter is the Plasmodium ortholog of the T. gondii 
sortilin-like receptor (TgSORTLR). In T. gondii, TgSORTLR was seen to interact 
with both the rhoptry cargo and the components of the cytosolic sorting 
machinery, aiding in subcellular localisation and rhoptry biogenesis [135]. Further, 
studies in T. gondii also showed the role of a conserved Apicomplexan dynamin-
like protein GTPase, DrpB, in the generation of secretory pathway vesicles 
necessary for rhoptry biogenesis [136] and implicate adaptor protein 1 complex in 
the trafficking of rhoptry-destined vesicles to the organelle [137]. Recently, a 
conserved Apicomplexan protein termed Armadillo Repeats-Only (ARO) protein 
has been reported to localise to the cytosolic face of T. gondii rhoptries and has 
been implicated in vesicle fusion to the rhoptries [138]. Thus, it is clear that 
components of the eukaryotic “classical” vesicle-mediated pathway is functional 
and essential in the protein trafficking of rhoptry proteins of the closely related 
apicomplexan species, Toxoplasma. Of interest, there is a DrpB and ARO ortholog 
in Plasmodium spp., which hints that the same mechanism could be involved in 
protein trafficking and rhoptry organelle biogenesis in Plasmodium (Fig 1.7)  [21,
136, 137, 139].
1.6.2.1 Proteolytic processing in rhoptry protein trafficking  
In addition to the presence of a signal sequence, some P. falciparum and T. gondii
rhoptry proteins consist of an additional prodomain that is processed en route or 
upon entry into the rhoptries [74, 140-143]. RAMA is synthesized with an 
unusually large N-terminal pro-peptide comprising of more than 50% of the protein 
[93]. Mapping of the N-terminus of mature RAMA (p60), has predicted cleavage 
of the protein between residues 477L and 478Q, while RAP1 pro-peptide cleavage 
has been mapped upstream of aa124 involving the removal of ~40 amino acids after 
the signal sequence [110]. Proteolytic maturation of proproteins is often a regular 
feature for protein targeting to eukaryotic organelles;  indeed  in T. gondii the 
prodomain plays a vital role in mediating protein trafficking and assembly. For 
example, for the T. gondii rhoptry protein ROP1, the prodomain plays a crucial role 
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in  targeting the protein to the rhoptries before invasion [140]. The pro-domain can 
also potentially aid in maintaining some of these rhoptry proteins as zymogens until 
activated for subsequent effector function. 
Additionally, processing of rhoptry proteins may also assist in protein folding and 
maturation, which may potentially enable the RAP complex (and possibly the 
RhopH complex) to be released from RAMA to allow the appropriate delivery 
within the rhoptry. En route or upon arrival at the rhoptry, the RAMA-RAP 
complex is speculated to be dissociated by proteolytic cleavage [93, 110, 131]. The 
presence of putative cleavage site (D/E)SFL(Q/E)  in the N-terminus of RAP1 and 
RAMA suggests that a single rhoptry-resident protease is responsible for their 
processing  [131]. RAMA orthologues from other Plasmodium spp. also harbour 
this (D/E)SFL(Q/E) sequence and/or closely related sequences repeated eight times 
within the pro-peptide region of RAMA (Fig 1.8A, B) The identity of the protease 
responsible for cleavage and the biological purpose of this putative processing 
event are unknown: whilst it may be required for the dissociation of trafficking 
complexes once they have arrived at the rhoptry, it may also promote correct 
assembly and/or activation of the rhoptry proteins for their effector function. 
Interestingly, attempts to purify the RAMA-RAP complex from mature parasite 
schizonts yielded only a small amount of RAP1 co-precipitating with RAMA or 
vice versa [107, 111, 131, 144, 145]. This suggests that the RAMA-RAP interaction 
is transient and that after complexes are packed into transport vesicles, they are 
disassembled potentially by proteolytic processing upon arrival at their destination 
(Fig 1.7).
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Fig 1.6: The RAP complex of the malaria parasite.
A. P. falciparum comprises of three RAP proteins, RAP1, 2 and 3. RAP2 and 3 
are paralogues in P. falciparum and thus RAP1 binds to RAP2 or to RAP3 to 
form heterodimers. The rodent strain P. berghei comprises of only two RAP 
proteins which form RAP1/2(3) heterocomplexes.
B. Schematic representation of the proteolytic maturation of RAP1.
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Fig 1.7: Model depicting protein sorting to the rhoptries in Plasmodium.
Proteins destined for rhoptries are co-translationally inserted into ER and trafficked 
to Golgi within COPII coated vesicles. At the Golgi exit face, RAMA aggregates 
with other rhoptry cargo within lipid rafts, which finally bud off and traffic within 
Clathrin Coated Vesicles (CCV). The sortilin-like receptor could act as a potential 
rhoptry escorter, facilitating interaction between the rhoptry cargo and the adapter 
proteins (AP) (and the cytosolic trafficking machinery). The CCVs fuse into the 
nascent rhoptry, releasing the cargo. Proteolytic processing of the rhoptry cargo
possibly facilitates their release from the trafficking complex. The armadillo 
repeats-only (ARO) protein is targeted to the rhoptry membrane and may be crucial 
in membrane fusion. Pf34, a GPI anchored rhoptry neck protein could play a similar 
role to RAMA. DrpB is also implicated in rhoptry biogenesis, however, its 
localisation and function in rhoptry biogenesis and trafficking is yet to be elucidated 
(adapted from [164]).
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Fig 1.8: Schematic of the putative cleavage sites within RAMA & RAP1. 
A. Amino acid alignment of putative protease cleavage sites within RAMA and 
RAP1 generated using KALIGN [131].
B. Schematic showing putative cleavage sites within RAMA and RAP1, where 
black shaded areas represent the signal sequence; orange shaded areas represent 
the pro-peptide, yellow shaded area represents the GPI anchor, and brown 
shaded areas represent the mature protein. Putative cleavage sites are indicated 
with black arrows. The p60 RAMA [165] and p67 RAP1cleavage site [110] are 
indicated by red arrows. RAP1 and RAMA binding sites are indicated (adapted 
from [131]).
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1.7 Project hypothesis and aims 
The ability of the malaria parasites to invade and remodel their target host cell is 
vital for their survival and ability to cause disease. The rhoptries are the most 
prominent apical organelles and are an essential component of the Apicomplexan 
invasion machinery. To date, very little is known regarding how rhoptries are 
formed and how proteins specifically traffic to these structures after trafficking 
through the secretory pathway. Moreover, the signals that regulate the precise 
spatial segregation of proteins to either the rhoptry neck or the bulb region have yet 
to be revealed. The correct localisation of rhoptry proteins ensures correct timing 
of protein secretion and hence function during the invasion process. Furthermore, 
whilst we have some insight into the role of RONs in host cell invasion and studies 
in T. gondii have revealed ROPs play crucial roles in subverting host cell function,
knowledge about the functional role of Plasmodium ROPs is relatively scant. This 
is attributed to the fact that the ROPs are not conserved between Apicomplexans, 
because these parasites reside in different types of host cells. Moreover, up until 
recently, there has been lack of molecular tools to investigate the function of 
essential malaria genes such as the ROPs. 
This project aims to exploit the latest advances in molecular malaria research, to 
generate novel transgenic malaria parasite lines so that the expression of essential 
ROPs, in particular, members of the RAP complex, can be regulated to dissect gene 
function. Dissecting the function of these essential ROPs would unravel the 
mystery as to why these proteins have become indispensable for parasite survival. 
Moreover, as rhoptries are present at multiple stages in the Plasmodium life cycle 
of all malaria species, this research could lead to re-assessment of ROPs as potential 
vaccine candidates or drug targets.
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Hypothesis: This study is based on the hypothesis that the Plasmodium rhoptry 
body proteins (ROPs) are essential post-invasion for the establishment of the 
parasite in its new intracellular environment.
To investigate this hypothesis, the following aims will be pursued:
AIM 1: Characterisation of RAP1 and establishing its importance to parasite 
survival;
AIM 2: To establish the function of members of the RAP complex through the use 
of gene regulation technologies;
AIM 3: To determine the role of ROP proteolytic processing in rhoptry trafficking.
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2.1 MATERIALS 
The following companies supplied reagents and equipment used in this work: 
 Abcam, Cambridge, MA, USA 
 Agilent Technologies, Forest Hill, Victoria, Australia 
 Ajax Chemicals, Sydney, NSW, Australia 
 Ambion, Austin, TX, USA 
 Amersham Biosciences, Piscataway, NJ, USA 
 Amresco, Solo, OH, USA 
 Applied Biosystems, Foster City, CA, USA 
 Astral Scientific, Gymea, NSW, Australia 
 Australian Science Supply, Glen Waverley, Victoria, Australia 
 Axygen Scientific, Union City, CA, USA 
 BD Biosciences, North Ryde, NSW, Australia 
 Becton Dickinson Labware, Franklin Lakes, NJ, USA 
 Berthold Technologies, Bundoora, Victoria, Australia 
 BioBest, Wentworthville, NSW, Australia 
 BioCore Pty. Ltd, Alexandria, NSW, Australia 
 Biocorp, Quebec, Montreal, Canada 
 Bioline, Alexandria, NSW, Australia
 Bio-Rad, Regents Park, NSW, Australia
 Cell Signaling Technologies Inc., Danvers, MA, USA
 Dako LSAB, Cambellfield, Victoria, Australia
 Eppendorf, Hamburg, Germany
 Fluka BioChemika, Castle Hill, NSW, Australia
 Gilson, Guelph, ON, Canada
 Greiner Bio-one GmbH, Frickenhausen, Germany
 Hospira, Melbourne, Victoria, Australia
 Integrated Sciences, Willoughby, NSW, Australia
 Interpath, West Heidelberg, Victoria, Australia
 Invitrogen, Mount Waverley, Victoria, Australia
 Leica Microsystems GmbH, Wetzlar, Germany
 Life Research Pty. Ltd., Scoresby, Victoria, Australia
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 Life Technologies, Rockville, MD, USA
 MatTek Corporation, MA, USA
 Merck Millipore, Kilsyth, Victoria, Australia
 Merck/Calbiochem, San Diego, CA, USA
 Millennium Science Pty. Ltd., Mulgrave, Victoria, Australia
 Millipore, Billerica, MA, USA
 Nalgen Nunc International, Roskilde, MA, USA
 Olympus, Tokyo, Japan
 Pacific Lab Products, Blackburn, Victoria, Australia
 Perkin Elmer, Glen Waverly, Victoria, Australia
 Pfizer, Perth, Australia 
 Promega, Annandale, NSW, Australia 
 Proscience, Nunawading, Victoria, Australia 
 RnDSystems, Minneapolis, MN, USA 
 Sigma-Aldrich, Castle Hill, NSW, Australia 
 Stratagene GmbH, Heidelberg, Germany 
 Thermo Fisher, Scoresby, Victoria, Australia 
 Thermoline Scientific, Smithfield, NSW, Australia 
 Victorian Bio Bank, Melbourne, Victoria, Australia 
 Whatman, Middlesex, United Kingdom
2.2 METHODS 
2.2.1 Ethics statement 
All experiments involving rodents were performed adhering to the Australian 
Government recommendations and the National Health and Medical Research 
Council Australian code of practice for the care and use of animals for scientific 
purposes. The protocols were approved by the Animal Welfare Committee at 
Deakin University (Approval No.: AWC A97/2010, A98/2010 and G37/2014).
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2.2.2 Software and databases 
Primer design was performed with Primer3 (http://frodo.wi.mit.edu/) and 
OligoCalc (Kibbe, 2007). Plasmodium gene sequences were retrieved from the 
Plasmodium genome Resource database (PlasmoDB) (Aurrecoechea et al., 2009). 
Flow cytometry analysis was performed with FlowJoTM software. Image analysis 
and data processing was done using Adobe® Illustrator, Adobe® Photoshop, ImageJ 
(US National Institute of Health, Bethesda), GraphPad Prism version 6.0c 
(GraphPad Software, Inc.), Microsoft® Excel and Microsoft® Powerpoint. 
Statistical analysis was done using GraphPad Prism version 6.0c (GraphPad 
Software, Inc.). In silico sequence alignments and restriction enzyme digests were 
performed using SerialCloner version 2.5 (Serialbasics). The bibliography was 
managed with EndNote (Thomson Reuters). 
2.2.3 Oligonucleotide Primers 
All oligonucleotides used in this project were obtained from Sigma Aldrich or 
Geneworks and are listed in Table 2.1.
2.2.4 DNA applications 
2.2.4.1 Plasmid preparation (Miniprep/Midiprep) 
Plasmid DNA was prepared from 2 ml (miniprep) and 15 ml (midiprep) of bacterial 
FXOWXUH$PUHVFR/%EURWKFRQWDLQLQJȝJml ampicillin) that had been grown 
overnight with shaking at 200 rpm at 37°C. Plasmid DNA was isolated using the 
PureLink™ Quick Plasmid Miniprep Kit/HiPure Plasmid Midiprep Kit 
(Invitrogen), following the protocol outlined by the manufacturer. DNA was eluted
LQDILQDOYROXPHRIȝO10 mM Tris, 1 mM EDTA (TE) buffer for miniprep and 
ȝOIRUPLGLSUHS.
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2.2.4.2 Precipitation of DNA 
To concentrate purified DNA, 1/10 reaction volume of 3 M sodium acetate (pH 
5.2) and 2.5 times the reaction volume of 100% (v/v) ethanol were added to the 
DNA. These samples were precipitated overnight at -20°C. DNA was recovered by 
centrifugation at 17000g for 10 minutes and the supernatant was discarded. The 
'1$SHOOHWZDVKHGLQȝOYYHWKDQRODQGDIWHUFHQWULIXJDWion, the DNA 
pellet was resuspended in TE buffer (Invitrogen).
2.2.4.3 DNA sequencing 
DNA was sequenced by the Australian Genome Research Facility Ltd (AGRF) at 
The Walter and Eliza Hall Institute (WEHI) using the Big Dye Termination 
sequencing protocol using 500-1500 ng template DNA and 20 pmol of the 
appropriate forward or reverse oligonucleotide per reaction.
2.2.4.4 Polymerase Chain Reaction (PCR) 
DNA (100ng) was amplified by PCR using genomic DNA from wild type P.
falciparum or P. berghei parasites as DWHPSODWH3&5VZHUHSHUIRUPHGLQȝO
UHDFWLRQV FRQWDLQLQJ ȝ0 RI WKH DSSURSULDWH IRUZDUG DQG UHYHUVH
oligonucleotides (Geneworks), 1x reaction buffer containing 1.5mM MgCl2,
ȝ0 G173V DQG 8 3KXVLRQ+LJK-fidelity DNA polymerase (Finnzymes, 
USA). The amplification process was performed using a C1000™ thermocycler 
(BioRad, Australia) using the following conditions: an initial denaturation at 98°C 
for 1 minute followed by 34 cycles of denaturation at 95°C for 20 seconds, 
annealing at 52°C for 30 seconds, and extension for 2 minutes at 68°C. A final 
extension at 72°C for 10 minutes completed the reaction. PCR products were 
purified with the PureLink™ PCR purification kit (Invitrogen, USA) according to 
the protocol outlined by the manufacturer.
2.2.4.5 Restriction digestion 
Restriction digests containing 1-ȝJRI'1$ZHUHSHUIRUPHGLQYROXPHVRI-50 
ȝOXVLQJ-4 units of enzyme (NEB, USA), ȝJml bovine serum albumin (BSA; 
NEB) in the appropriate buffer (NEB). Reactions were incubated for 2-3 hrs, 
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according to manufacturer’s instructions. Digested vector DNA to be used in 
ligation reactions was treated with 1U of Shrimp Alkaline Phosphatase (Fermentas, 
USA) for 1 h at 37°C to prevent self-ligation, then inactivated by incubation at 85°C 
for 15 minutes.
2.2.4.6 Agarose gel electrophoresis 
DNA was routinely separated on 0.7-2.0% (w/v) horizontal agarose gels using a 
Tris-borate-EDTA (TBE) buffer system (89 mM Tris-base, 89 mM boric acid, 2 
mM EDTA). Loading sample buffer containing (0.01% (w/v) bromophenol blue, 
10mM EDTA and 10% (w/v) glycerol was added to sample prior to loading. Gels 
were electrophoresed between 80-110 V for 30 min to 3 hrs and included a 1 kb 
molecular marker (Invitrogen). Agarose gels contained SYBR Safe (Invitrogen) at 
a concentration of 1:10,000 to visualise DNA on a ChemiDoc XRS (Bio-Rad) UV 
transilluminator. DNA fragments excised from agarose gels were purified using the 
,QYLWURJHQ3XUH/LQN4XLFN*HO([WUDFWLRQ.LWDFFRUGLQJWRWKHPDQXIDFWXUHUெV
protocol.
2.2.4.7 Determination of DNA concentration  
DNA concentration was determined using the NanoVue Nano Spectrophotometer 
(GE Healthcare) according to the manufacturer’s protocol. DNA concentration was 
measured as follows: Concentration = Absorbance (260nm) x Factor x dilution, 
where the factor for double-stranded DNA is 50, with an absorbance of 1 
correlating to a dsDNA concentration of 50 ȝg/ml.
2.2.4.8 DNA ligation 
Ligations were performed in 10 ȝO UHDFWLRQV ZLWK D YHFWRU WR LQVHUW UDWLR RI
DSSUR[LPDWHO\  (DFK  ȝO OLgation reaction contained approximately 30 ng 
vector, the corresponding amount of insert for a 1:3 ratio, 1x reaction buffer (New 
(QJODQG%LRODEVȝORI7'1$OLJDVH1HZ(QJODQG%LRODEVXQLWVml)
DQGPDGHXSWRȝOZLWK0LOOL4ZDWHU)RUHDFh ligation, a negative control was 
performed, which contained the same amount of vector but no insert DNA. 
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Ligations were incubated at room temperature for one hour prior to heat shock 
transformation into Escherichia coli.
2.2.4.9 Bacterial transformation 
DNA was transformed into E. coli XL-10 Gold cells using the heat-shock method. 
For this, 50 ȝl of cells were added to each ligation reaction. The mixture was 
incubated on ice for 15 minutes, and then heat shocked at 42°C for 45 seconds. One 
millilitre of LB Broth (Amresco) was added to the cells and they were allowed to 
recover at 37°C for 45 minutes in an orbital shaker at 200rpm. After incubation, the 
reaction was centrifuged at 17000g for 2 minutes, and approximately 900 ȝl of the 
supernatant was removed. The cell pellet was resuspended in the remaining 
supernatant and the cell mixture was plated onto an LB agar plate (Amresco) 
containing ampicillin (100 ȝg /ml) (Sigma, USA) and incubated at 37°C overnight.
2.2.4.10 PCR colony screens 
PCR colony screens were used to determine whether the gene of interest had been 
successfully cloned into a plasmid. Each reaction contained 1x ThermoPol reaction 
buffer (New England Biolabs), 1 ȝM of each oligonucleotide (with one 
oligonucleotide being specific to the insert and the other oligonucleotide specific 
to the vector backbone), 250 ȝM dNTPs, 5U T4 Taq polymerase (New England 
Biolabs), in a final volume of 10 ȝl. The reaction was inoculated with a single 
bacterial colony and then incubated under the following conditions: an initial 
denaturation step (3 minutes at 98°C), followed by 35 cycles of denaturation (98°C 
for 30 seconds), annealing (50°C for 30 seconds) and extension (72°C for 2 
minutes). A final extension at 72°C for 10 minutes completed the reaction.
2.2.4.11 Real Time PCR 
To detect mRNA transcript levels, quantitative real time (RT) PCR was performed. 
RNA was extracted from the blood stage parasites using Trisure (Invitrogen). 
Contaminating genomic DNA was removed by DNaseI treatment (Invitrogen). 
RNA was adjusted to 3 ȝJUHDFWLRQDQGF'1$ZDVSUHSDUHGXVLQJWKH2PQLVFULSW
RT Kit (Qiagen) in accordance with the manufacturer’s protocol. The resulting 
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cDNA was used to determine expression levels of the gene of interest by 
quantitative real-time PCR. Constitutively expressed genes like PbGAPDH (for 
P.berghei gene expression analysis) and Pf18SrRNA (for P. falciparum gene 
expression analysis) were used as a reference/normalisation control to allow 
comparison of gene expression between parasite lines. Real time PCR primers 
(listed in Table 2.1) were designed on the premise that they had to be specific to 
WKHGHVLUHGJHQHDQGPDWFKHGPHOWLQJWHPSHUDWXUHZLWKDQDPSOLFRQVL]HRI
bp. Real time PCR was performed using the SensiFAST TM SYBR Lo-ROX Kit 
(Qiagen) using a three-stage thermal profile. After heating cDNA to 95°C for 2 
mins, annealing and extension were performed for 40 cycles consisting of 95°C for 
10s, 50 - 65°C for 20s followed by 60°C for 30 s. The final dissociation protocol 
used gradual heating from 55°C to 95°C, incrementing by 0.5°C/30 s; this was used 
to plot a melting curve to confirm the specificity of the primers and product 
formation. Control reactions in which reverse transcriptase or cDNA template had 
been excluded were performed with each experiment to exclude genomic DNA 
contamination. All reactions were performed in triplicate, using the average 
threshold cycle (CT) for data analysis. Each experiment was repeated at least on 
three separate RNA harvests.
Gene expression was quantified using the 2íǻǻCT method [166]. The CT values of 
the target gene was first normalized to the CT of the reference control to obtain a 
ǻCT value for each gene in an analysis. The GLIIHUHQFH EHWZHHQ WKLVǻCT value 
EHWZHHQ WKH WZR SDUDVLWH OLQHV XQGHU LQYHVWLJDWLRQ \LHOGHG WKH ǻǻCT. Because 
exponential cDNA amplification is expected to double with each cycle, the value 
2íǻǻCT is then used to estimate the fold-change in gene expression in the mutant 
parasite.
2.2.4.12 Southern blot hybridisation 
After electrophoresis of digested DNA on agarose gels, the gel was depurinated in 
0.125 M hydrochloric acid solution for 20 min. This was followed by alkaline 
denaturation by incubation in denaturation solution (0.5 M sodium hydroxide and 
1.5 M sodium chloride) for 30 min. The gel was then neutralised in 0.5 M Tris and 
1.5 M sodium chloride (pH 8.0) for 30 min. Denatured DNA was transferred from 
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the gel onto a positively charged nylon membrane (Hybond N+ , Amersham 
Biosciences) by capillary action using 20 × SSC (17.5% NaCl, 8.8% sodium 
trisodium citrate, pH 7). The membrane containing the DNA was washed in 2 ×
SSC for 10 min at room temperature to remove residual agarose and then air-dried 
at room temperature. The membrane was then baked in an incubator at 80°C for 2 
hrs to fix the DNA to the membrane. The membrane was finally rinsed in Milli-Q
water, air-dried at room temp and stored at 4°C until hybridization.
Probes used for Southern blot hybridization were amplified using the DIG PCR 
3UREHV\QWKHVLVNLW5RFKH(DFKȝOUHDFWLRQPL[FRQWDLQHGȝ0',*-dUTP 
3&5',*3UREHV\QWKHVLV0L[ZLWKȝ0HDFKG173DORQJZLWKQ0HDFK
forward and reverse oligonucleotide and 1-50 ng template DNA. Hot Start Taq 
DNA polymerase (Qiagen) was used at a final concentration of 2.5 U with 2.0 mM 
MgCL2 in the 1 × PCR buffer (Qiagen). PCR cyclic conditions included an initial 
heat activation step at 95°C for 15 min, followed by 35 cycles of 94°C 
(denaturation) for 30 sec, 60°C (annealing) for 30 sec and 68°C (extension) for 4 
min. This was followed by a 72°C incubation step for 20 min. After amplification, 
samples were stored at –20°C.
Prior to hybridation, the membrane containing DNA was pre-hybridised with 10 ml
DIG Easy-Hyb solution (Roche) for 1 hr at 37°C. The DIG-labeled probe (~30 
ng/ml) ws then added to the prehybridisation solution and hybridation allowed to 
proceed at 37°C overnight. Following hybridization, the membrane was treated 
with a series of washes at room temperature with slow rocking. An initial rinse was 
performed using 2×SSC for 5 min, followed by equilibration in wash buffer 
solution of 0.1M maleic acid (Sigma-Aldrich), 0.15 M sodium chloride and 0.3% 
(v/v) Tween-20 (Sigma) for 1 min. The membrane was then blocked for 30 min in 
1% (v/v) blocking solution (Roche) prior to addition of the Digoxigenin-AP 
antibody (1:10,000 in blocking solution) (Roche) for 1 hr. The membrane was then 
washed in wash buffer for 30 min and equilibrated in detection buffer containing 
100 mM Tris-HCL (pH 9.5) (Invitrogen) and 100 mM NaCl for 2 min. The 
membrane was then transferred to a hybridization bag where it was drenched in 
pre-warmed ready to use Disodium 3-(4-methoxyspiro{1,2-dioxetane-3,2'-(5'-
chloro)tricyclo[3.3.1.13,7]decan}-4-yl)phenyl phosphate CSPD (Roche) for 5 min 
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and imaged. In cases where the membrane was to be hybridised with other probes,
the membrane was stripped by rinsing the membrane in Milli-Q water for 1 min 
followed by two separate washes with freshly prepared 0.2M NaOH containing 
0.1% (v/v) SDS. The membrane was then rinsed in 2 × SSC for 5 min and stored at 
4°C.
2.2.5 Plasmodium applications 
2.2.5.1 In vivo culturing of Plasmodium berghei 
2.2.5.1.1 Infection of mice with P. berghei 
For this study, the P. berghei ANKA strain was used for all infections. To initiate 
infections in mice 200 ȝORIFU\RSUHVHUYHGSDUDVLWHVZHUHDGPLQLVWHUHGWRIHPDOH
Balb/c mice aged between 5-8 weeks of age. For comparative growth experiments, 
female Balb/c mice aged between 5-8 weeks were randomized into groups (n=6 per 
group) and infected intraperitoneally with between 106-107 parasitized 
erythrocytes, depending on the experimental procedure. 
To obtain a synchronous infection for the gene knockdown assays, female BalbC 
mice were infected intraperitoneally with 106-107 parasitized erythrocytes as 
described above, and when the parasitaemia reached approximately 1- 3%, blood 
was collected from the mouse via cardiac puncture under an atmosphere of 100 % 
carbon dioxide. The infected blood was then passed through the MACS separation 
column as described in section 2.2.5.7 to get rid of the later stages. The infected 
blood which now consists of only ring stages parasites were cultures in vitro
with/without ATc (detailed in section 2.2.5.3.1) until the mature schizont stage was 
reached. The purified schizont-stage parasites were then intravenously injected into 
untreated mice or mice pre-exposed to ATc, to establish a synchronous infection.
2.2.5.1.2 Monitoring parasite growth  
The development of parasites within red blood cell (RBC) was monitored by 
visualising Giemsa-stained blood smears (Merck) from day 3 post-infection. The 
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parasitaemia was then determined by counting the number of infected cells and 
dividing by the total number of erythrocytes per field, using light microscopy and 
expressing the results as a percentage. For each smear, a minimum of 1000 cells 
were counted. Mice were humanely culled when parasitemias exceeded 25%.
2.2.5.1.3 Cryopreservation of P.berghei infected erythrocytes 
To cryopreserve parasites, P. berghei-infected whole blood was mixed in a 1:1 ratio 
with 30% (v/v) glycerol in phosphate buffered saline (PBS), and aliquoted into 
cryovials (Thermo Fisher Scientific) before being frozen in liquid nitrogen.
2.2.5.2 In vitro culturing of Plasmodium falciparum 
2.2.5.2.1 Continuous culturing of Plasmodium falciparum 
P. falciparum clone 3D7 was used in this study and routinely cultured in complete 
culture medium comprising RPMI 1640 media containing 2.05 mM glutamine, 25 
mM of HEPES, 40 ȝg/ml of gentamycin sulfate. 5% (w/v) bicarbonate as well as 
5% inactivated O+ human serum and 5% (v/v) Albumax II (Invitrogen).  Cultures 
were maintained at 37°C in a gas mixture composed of 1% O2, 5% CO2   and 94%
N2 as described previously. Cultures were maintained at 2-4% haematocrit and 
between a 0.1–10% parasitaemia and monitored daily by microscopic examination 
of thin Giemsa-stained blood smears. Parasite cultures were fed every 1-2 days by 
replacing the old culture media with fresh complete media. Cultures were split by 
diluting a fraction of the existing cultured blood pellet in new O positive blood and 
complete culture media.
2.2.5.2.2 Cryopreservation and thawing of P. falciparum infected erythrocytes 
Cultures containing predominantly ring-stage P. falciparum infected erythrocytes 
were collected and pelleted by centrifugation. For this, 1ml of freezing solution 
(0.65% NaCl, 3% sorbitol and 28% glycerol diluted in deionised water and 
autoclave sterilized) were added to the red blood cell pellet obtained from a 10ml
dish and transferred to a labelled 1.5ml cryovial. The cryovials were then stored in 
liquid nitrogen. When required, cryo-frozen P. falciparum infected erythrocytes 
were removed from liquid nitrogen and immediately thawed at 37°C in a water bath 
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for 2 mins by gentle swirling. Cells were then transferred into a sterile 10ml tube 
and pelleted. Supernatant was then discarded and equal amount of pre warmed 
thawing solution (3.5% NaCl in sterile distilled water) was added.  Cells were 
pelleted by centrifugation and washed a couple of times. Cells were then returned 
to culture in complete culture medium at a 2-4% haematocrit.
2.2.5.2.3 Sorbitol synchronisation of P. falciparum cultures 
Cultures containing predominantly ring-stage P. falciparum infected erythrocytes 
were synchronised by sorbitol treatment as described previously [167]. Briefly 
cultures were pelleted by centrifugation. The pellet was then resuspended in 10 
volumes of 5% (v/v) sorbitol (diluted in deionised water and filter sterilized) and 
incubated at 37°C in a water bath for 5 mins.  The suspension was then pelleted and 
sorbitol was removed by repeated washes in culture medium. The ring stage 
enriched P. falciparum infected erythrocytes were then resuspended in complete 
culture media and returned to culture as mentioned in section 2.2.5.2.1.
2.2.5.3 Parasite transfection 
2.2.5.3.1 Transfection of P. berghei 
To prepare DNA for transfection, plasmid DNA (15-ȝJZDVGLJHVWHGRYHUQLJKW
at 37°C with 2-ȝORIWKHDSSURSULDWHUHVWULFWLRQHQ]\PH-20 U/ȝOWROLQHDULVH
the transfection construct. Digested DNA was then separated on a 1% (w/v) agarose 
gel via electrophoresis. The appropriate DNA band was purified using the 
PureLinkTM Quick Gel Extraction Kit (Invitrogen) as per manufacturer’s 
instructions. DNA was concentrated by precipitation with 2.5 × vol of DNA 
solution with 100% ethanol, 1/10 × vol with 3 M NaAc (pH 5.2) and re-suspended 
LQDILQDOYROXPHRIȝO7(P07ULVP0(7'$S+ aȝJGLJHVWHG
DNA).
To obtain schizonts for transfection, female Balb/C mice (6-8 weeks old) were 
infected intraperitoneally with 1 × 106 PbANKA parasites. When the parasitemia 
reached approximately 1- 3%, blood was collected from the mouse between 10:00 
am and 2:00 pm via cardiac puncture under an atmosphere of 100 % carbon dioxide. 
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Infected blood was spun down at 1500 x g. White blood cells were separated by 
removing the buffy coat. Parasites were then cultured in complete RPMI1640 
culture medium containing L-glutamine (Invitrogen), supplemented with 5% (w/v) 
sodium bicarbonate, and 20% (v/v) heat inactivated Fetal Bovine Serum (Bovogen) 
as described before [168, 169]. Parasites were incubated in an atmosphere of 5% 
oxygen, 1% carbon dioxide and 94% nitrogen to mimic the host gaseous 
environment for 16 hrs at 36.5 °C. The following day, mature schizonts were 
purified by via Nycodenz density gradient centrifugation as described previously 
[168]. For each transfection, ~107 nycodenz purified schizonts were mixed gently 
ZLWK OLQHDULVHG '1$ FRQVWUXFWV a ȝJ LQ  ȝO RI $PD[D %DVLF 3DUDVLWH
Nucleofector® Solution (Lonza). The mixture was transferred to an electroporation 
cuvette (Lonza) and transfection was performed by electroporation using an 
$PD[D 1XFOHRIHFWRU GHYLFH VHW DW SURJUDP 8 2QFH HOHFWURSRUDWHG  ȝO
complete culture medium was added and the total volume ȝOZDVLQMHFWHG
intravenously into 6-8 week female Balb/c mouse. Drug selection of genetically 
transformed parasites commenced one day after the transfection procedure by 
supplying drinking water containing 0.07 mg/ml pyrimethamine.  For this, 
pyrimethamine was made at a concentration of 7 mg/ml; the pH was adjusted to 3.5 
– 5.0 using 1 M HCL and the drug diluted 1/100 with tap water for a final 
concentration of 0.07 mg/ml.
2.2.5.3.2 Transfection of P. falciparum 
3ODVPLG'1$  ȝJZDV UHVXVSHQGHG LQ  ȝO VWHULOH 7( WRZKLFK  ȝO RI
incomplete cytomix (120 mM KCl, 0.15 mM CaCl2, 2 mM EDTA, 5 mM MgCl2,
10 mM K2HPO4/KH2PO4, 25 mM N-[2-hydroxyethyl]piperaxine- N’-[2-
ethanesulfonic acid] pH7.6) was added [170, 171] . A 10ml P falciparum culture at 
 KDHPDWRFULW DQG  ULQJV ZHUH VSXQ GRZQ DQG UHVXVSHQGHG LQ  ȝO of 
cytomix/TE/DNA and transferred to a 2 mm cuvette (Biorad) [172-174]. Parasites 
ZHUH HOHFWURSRUDWHG DW  9  X) ZLWK  UHVLVWDQFH using an Amaxa® 
Nucleofector device set at program U33. Transfected parasites were transferred to 
small plastic tissue culture flasks (Nunc™) and cultured in 10 ml RPMI with 
Albumax at 2% haematocrit. After 24 hours, the media was replaced with 10 ml
RPMI containing Albumax with 10 nM WR99210 (Jacobus Pharmaceuticals). The 
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culture media was subsequently replaced with fresh media every day for 5 days and 
then twice a week until parasites were detected by Giemsa-stained blood smears. 
Generally parasites could be detected in blood smears 2-3 weeks post transfection. 
After this, parasite stocks (at around 5-6% ring parasitaemia) were frozen in liquid 
nitrogen, and genomic DNA was prepared for parasites to look for successful 
integration of the transfected vector. For parasites transfected with episomal 
vectors, drug selection was maintained throughout culturing, whilst drug cycling 
was performed for parasites transfected with integration vectors. For this, parasites 
resistant to WR99210 were then cultured without drug pressure for 3-4 weeks, after 
which the drug was added back to the media. Once the parasitaemia was re-
established, parasites were frozen in liquid nitrogen and genomic DNA was 
prepared. The above cycling process was repeated until successful integration event 
could be confirmed by integration PCR and by southern hybridisation (as detailed 
in section 2.2.4.12).
In some cases, an alternative transfection procedure was performed, in which the 
RBCs were preloaded with DNA and then infected with P. falciparum. For this, 
parasites were cultured at ~5% trophozoite/early schizonts stage. For this, 2ml of 
packed RBC was washed with x ml cytomix solution twice. Then 200μl packed 
RBCs (wash in 5 volumes of Cytomix) was mixed with an equal volume of cytomix
VROXWLRQDQGȝJHWKDQRO-SUHFLSLWDWHGSODVPLG'1$UHVXVSHQGHGLQȝOVWHULOH
7(DQGHOHFWURSRUDWHGDVGHVFULEHGDERYH7KHȝO of transfected RBCs were 
PL[HGZLWKȝORIVFKL]RQWLQIHFWHG5%&DVFXOWXUHGDERYHDQGWUDQVIHUUHGWR
small plastic tissue culture flasks (Nunc™) and cultured in 10 ml RPMI with 
Albumax. The media was replaced the next day. The culture media was 
subsequently replaced with fresh media every alternate days until parasites 
appeared at approximately 10 days post transfection. Parasites with episomal and 
integrated vectors were selected as described above.
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2.2.5.4 Conditional knockdown analysis of Plasmodium proteins 
2.2.5.4.1 Conditional knockdown of P. berghei proteins using the Tetracycline 
based transcriptional regulation system 
For the in vivo treatment of parasites with ATc, mice were randomized into groups 
of five per experiment and administered with drinking water containing either 0.2 
mg/ml ATc (Sigma) or vehicle control 5% (w/v) sucrose. The animals were pre-
treated with ATc (or vehicle control) for 24 h prior to infection and then 
continuously maintained on ATc or vehicle control. The parasitaemia was 
monitored daily by Giemsa stained blood smears to analyse the in vivo growth of 
the knockdown parasites in the presence/absence of ATc. 
For in vitro treatment, P. berghei infected erythrocytes from three Balb/C mice 
were collected by cardiac puncture and cultured overnight in complete RPMI 
medium supplemented with 25 mM HEPES, 0.2% bicarbonate, 25% fetal bovine 
serum and were grown at 36.5°C in the presence or absence of 1 mg/ml ATc, and 
the growth of the knockdown parasites were monitored in vitro, especially the 
development of the more matured stages of the parasites (late 
trophozoites/schizonts) which otherwise cannot be monitored in vivo, as they 
sequester in the microvasculature to avoid splenic clearance.
To examine the length of the cycle, parasite schizonts generated after overnight in 
vitro culture (as described above), were purified by Nycodenz gradient 
centrifugation, and the purified schizont preparation was either cultured in vitro in 
complete RPMI media or intravenously injected into naïve mice to establish 
synchronous mouse infections. Parasite growth and morphology were monitored at 
regular interval, and the length of the erythrocytic cycle was determined by 
observing Giemsa stained blood smear prepared every two hrs post invasion.
2.2.5.4.2 Conditional knockdown of P. falciparum proteins using glucosamine  
Transgenic P. falciparum parasites were cultured (as described in section 2.2.5.2.1)
and synchronized to 8–10% ring-stages by two consecutive sorbitol treatments as 
described in section 2.2.5.2.3. In the late ring stage, the culture was divided equally 
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into two parts and to one dish glucosamine (GlcN) was added to a final 
concentration of 2.5mM [175], with four replicates in each of the + GlcN and –
GlcN groups. Parasites were harvested immediately for 0 hr time point and then at 
regular intervals until 48 hrs post-GlcN treatment (Cycle I study). At this point, the 
medium was removed from the fourth plate and parasites divided equally into a 
further three plates and continued in culture for another 48 hrs (Cycle II study). 
Parasitized cells were harvested from each sample by centrifugation and liberated 
from the host erythrocytes by saponin lysis (section 2.2.5.5). Time point parasite 
samples were then used for genomic DNA extraction (section 2.2.5.6), egress and 
erythrocyte invasion assay (section 2.2.5.8) and knockdown analysis by Western 
blot (section 2.2.6.1), immunofluorescence analysis (section 2.2.6.2) and RT-PCR 
(section 2.2.4.11).
2.2.5.5 Saponin lysis of parasites 
P. berghei and P. falciparum infected erythrocyte cultures was pelleted by 
centrifugation (1500rpm for 5 mins). Parasites were then harvested by resuspending 
the culture pellet in 10 volumes of 0.15% (v/v) saponin (Sigma, USA; diluted in 
sterile PBS) and incubated on ice for 10 mins. The lysed red blood cell mixture was 
then transferred to a 10 ml centrifuge tube and centrifuged at 4°C. The resulting 
pellet was washed with ice cold PBS containing Complete protease inhibitors 
(Roche) until the supernatant was clear and then stored at -20 to -80°C.
2.2.5.6 Isolation of parasite DNA from blood 
P. berghei-infected rodent blood collected by cardiac puncture was first depleted 
of leucocytes by chromatography using CF11 powder (GE).  Eluted red blood cells 
were then lysed using 0.15% (w/v) saponin (Sigma) in PBS for 15 min on ice, 
followed by centrifugation at 20 000 g for 5 min. In the case of P. falciparum 
cultures, infected erythrocytes were similarly lysed using 0.15% saponin in PBS. 
For parasite genomic DNA isolation, parasites were resuspended in parasite lysis 
buffer (50 mM Tris, 5 mM EDTA and 1.0% (w/v) SDS, pH 8.0). RNase A
(Invitrogen) was added to the sample at a final concentration of ȝJml and 
incubated at 37°C for 40 min after which 2 mg/ml Proteinase K (Invitrogen) was 
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added and incubated at 37°C for a further 45 min. Three extractions with 1:1 
phenol-chloroform mix (Sigma) were performed to remove proteins and the DNA 
was precipitated according to 2.2.4.1.2. The DNA pellet was then dried and 
VXVSHQGHGLQȝO7(
2.2.5.7 Preparation of merozoites, schizonts and culture supernatants  
Schizont stages of Plasmodium-infected erythrocyte were purified using the 
commercially available magnetic cell fractionation system - MACS system 
(Miltenyi Biotec). For this, a MACS separation column was placed into the 
MACS® magnetic support and equilibrated with pre-warmed (37°C) RPMI 
medium without serum (incomplete medium) prior to passing infected erythrocytes 
through the column.  After washing the column with pre-warmed incomplete 
medium, the mature parasite forms were eluted from the column by removing the 
column from the magnetic field and flushing with pre-warmed (37°C) complete 
medium. To isolate merozoites, purified late schizonts were incubated in complete 
culture medium at 37°C for - 3-5 hrs and culture supernatants were collected by 
centrifugation at 500g for 5mins at 20°C. The supernatant was then centrifuged at 
16,000 g for 30 mins at 4°C to collect the merozoite pellet. The released supernatant 
was concentrated on an Amicon 10K (Merck Millipore) to obtain proteins that have 
been released into the supernatant. Lysates of schizonts, merozoites or released 
proteins were run on SDS-PAGE gels and analysed by western blot as described in 
section 2.2.6.1.
2.2.5.8 Flow Cytometry to quantitate erythrocyte invasion 
Flow cytometry was used to quantitate erythrocyte invasion rates. For this, P. 
berghei or P. falciparum parasites were stained for 20 mins at room temperature 
(RT- 20 to 25°C) in the dark with the DNA dye Hoechst 333422 (ȝ0Invitrogen) 
made in RPMI 1640. After staining, the cells were washed three times with 1 X 
PBS without serum. In parallel, erythrocytes (Balb/C mouse blood for P. berghei
assays and Human O positive blood for P. falciparum invasion assays) were 
labelled with amine-reactive fluorescent dyes. For this, 5 Pl volume of packed 
RBCs was resuspended in 10 PM 7-hydroxy-9H-(1,3-dichloro-9,9-
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dimethylacridin-2-one) succinimidyl ester (DDAO-SE) (Invitrogen, Paisley, UK) 
in RPMI 1640 for 1 h at 37°C according to manufacturer’s protocol. The stained 
parasite schizonts and the erythrocytes were mixed in the ratio of 1:100 (1 schizont: 
100 erythrocyte) and kept on high speed shaking for 30 mins in dark to burst the 
schizonts. The invasion assays were then carried out in round-bottom 96-well 
SODWHV ZLWK D FXOWXUH YROXPH RI  ȝO SHU ZHOO DW  KHPDWRFULW DQG ZHUH
incubated inside an incubator culture chamber , gassed with 1% O2, 5% CO2 and 
94% N2, and kept at 37°C for 1 hr, to allow invasion to occur. Stained samples were 
examined using a BD LSRII flow cytometer (BD Biosciences, Oxford, UK). 
Hoechst 33342 was excited by a UV laser and detected by a 450/50 filter and 
DDAO-SE was excited by a red laser and detected by a 660/20 filter.  For each 
sample, 100,000 events were recorded. The collected data was then further analysed 
with FlowJo software (Tree Star, Ashland, Oregon). The number of double positive 
cells (that is, invaded erythrocytes) compared to uninfected DDAO-SE 
erythrocytes was calculated. Experiments were carried out in triplicate and the data 
presented as the mean ± standard error of the mean. GraphPad Prism (GraphPad 
Software, La Jolla, CA) was used to plot the data and to statistically analyse the 
data. Microscopic examination of egress and invasion events were also performed 
simultaneously by Giemsa stained smears made at regular interval.
2.2.5.9 P. falciparum lactate dehydrogenase assay (pLDH)/ Malstat assay 
A modification of a pLDH detection method was used to assess parasite growth 
and vitality [176, 177]. Parasites were cultured at 1% parasitaemia and 2%
haematocrit LQZHOOSODWHVZLWKDILQDOZHOOYROXPHRIȝO7KHSODWHVZHUH
wrapped and stored at -80 °C until required. The plates were thawed for 4 hrs at 
room temperature to lyse the cells, prior to assay. To each 30ul of parasite sample, 
75ul of Malstat mixture (comprising 1.21 g Trisma base in 90 ml deionized water 
DQGS+DGMXVWHGWRȝO7ULWRQ;-100 (Merck), 2 g lithium-L-lactate, 62 mg 
3-acetyl-pyridine-adenine-dinucelotide (Sigma), 2 mg/ml Nitroblue tetrazolium 
and 0.1mg/ml PES (phenozine ethosulfate) was added to each well. The P. 
falciparum LDH reaction was allowed to proceed at room temperature for 45 to 90 
min and absorbance values in each well were measured at 650 nm with a standard 
spectrometer.
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2.2.6 Protein applications 
2.2.6.1 Western blot analysis 
Protein samples were run on a 10% SDS-PAGE gel at 150 V for 60 minutes. 
Proteins were then transferred onto 0.45 um nitrocellulose membrane (Millipore) 
in 1 × Tris-glycine buffer (25 nM Tris base, 190 nM glycine, 0.1% (w/v) SDS) 
using a wet transfer blotting device (Bio-Rad). The transfer was performed at 100 
V for 1 hr. The membrane was then blocked for one hour at room temperature (RT) 
in blocking buffer (3% bovine serum albumin (BSA) / mouse - phosphate buffered 
saline MT-PBS), followed by overnight incubation at 4°C with the antibody 
specific to the protein being detected ( as detailed in Table 2.2). The antibody was 
removed by three washes in 0.05% (v/v) Tween/MT-PBS. Horseradish peroxidase 
(HRP) conjugated secondary antibodies (anti-rat, anti-rabbit or anti-mouse) were 
used at a 1:2000 dilution and incubated for an hour at RT. Following a second series 
of three washes in MT-PBS, detection was performed using the SuperSignal 
enhanced chemiluminescence (Thermo Fischer Scientific) according to 
manufacturers’ instructions. Images were processed using Adobe® Photoshop or 
ImageJ (US National Institute of Health). 
2.2.6.2 Immunofluorescence Analysis 
For immunofluorescence microscopy, erythrocytes infected with P. berghei and or 
P. falciparum parasites were fixed with ice-cold 90% (v/v) acetone/10% (v/v) 
methanol for 2 min. All antibody incubations were performed in 3% (w/v) 
BSA/PBS. Primary antibodies for P. berghei blood stages were used as described 
in Table 2.2. After three washes with mouse tonicity PBS, the appropriate Alexa 
Fluor 488/568-conjugated secondary antibodies were used at 1:2000 (Molecular 
Probes). The cells were washed with mouse tonicity PBS followed by incubation 
with DAPI (4', 6-diamidino-2-phenylindole) (0.5 ȝg mlí1). Images were acquired 
with an Olympus IX70, Leica TCS SP2 microscope and images were processed 
using NIH ImageJ version 1.47d (http://rsbweb.nih.gov/ij/) or Adobe CS6 
Photoshop.
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2.2.6.3 Protein immunoprecipitations 
For immunoprecipitations (IP), P. falciparum, infected erythrocytes were enriched 
by passage through a MACS column. The infected erythrocytes were then lysed 
using 0.02% (v/v) saponin for 15 min on ice, followed by centrifugation at 20 000 
g for 5 min. After three washes with ice-cold mouse tonicity (MT) PBS containing 
1× complete protease inhibitors (Roche), the parasite pellet were lysed with either 
IP lysis buffer (Pierce) or 0.5% Triton X-100 in PBS containing complete protease 
inhibitors (Roche). After a 30 min incubation on ice, the material was passed 
through a 29 G insulin needle several times to lyse the cells, followed by 
centrifugation at 21,000 g for 10 min at 4°C. The supernatant was first pre-cleared 
with protein G beads followed by affinity purification with the desired antibody 
against the protein of interest. The antibody was then coupled to Protein G beads 
(Sigma) via its Fc region in a neutral pH as per the manufacturer’s instruction for 
4 hrs at 4°C. Unbound material was removed by rinsing beads in 1% TX-100/PBS.
Beads were then washed three times with 1 ml 0.5% Triton X-100 in MT-PBS 
containing complete protease inhibitors (Roche) and once with 1 ml MT-PBS. 
%RXQGSURWHLQVZHUHHOXWHGZLWKSUHZDUPHGȝO× non-reducing sample buffer 
and separated by SDS-PAGE and analysed by Western blot analysis (detailed in 
section 2.2.6.1).
2.2.6.4 Differential solubility analysis 
Solubility assays were performed to look at the localisation of P. falciparum RAP1
in schizonts and in ring-stages. An aliquot (10 ml) of a P. falciparum-infected 
erythrocytes at 6% parasitemia was saponin lysed as detailed in Section 2.2.5.5.
The parasite pellet was treated with 600 μL hypotonic lysis buffer (1mM HEPES, 
pH 7.4) and incubated at 4°C for 30 mins containing complete protease inhibitor 
FRFNWDLO 5RFKH )URP WKLV  ȝO ZDV UHPRYHG DV VWDUWLQJ PDWHULDO DQG WKH
remaining lysate was centrifuged at 100 000 g for 30 mins at 4°C. The supernatant 
after centrifugation represents the soluble protein fraction. The pellet was then 
resuspended in 500μl 0.1M Na2CO3 (pH 11.5) and kept on ice for 30 min to extract 
peripheral membrane proteins, which are present in the supernatant fraction after 
centrifugation at 100000 g for 30 mins at 4°C. To extract integral membrane 
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proteins, the resulting pellet was treated with 1% Triton X-100 on ice for 30 min. 
After centrifugation the supernatant was analysed as the integral membrane protein 
fraction, and the pellet was resuspended at room temperature with 1% Triton X-
100 to obtain the Triton-insoluble fraction. Equivalent amounts of the samples were 
analysed by Western blot (detailed in section 2.2.6.1).
2.2.7 Statistics 
All graphs and data generated in this study were analysed using GraphPad Prism 
version 6.0c (GraphPad Software, Inc.) and Microsoft® Excel. Results were 
analysed for statistical significance using a two-tailed student’s t-test using 
parametric distribution to measure differences between groups. A P value < 0.05 
was considered significant.
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Table 2.1: List of oligonucleotide primers used in the study.
Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
RAP1 gene knock out in P. berghei (Chapter 3)
93- F
CCTTCAATTTCGGATCCACTAGGCGTATTTCAG
CATTCTACCAAAAG
PbRAP1
To amplify 
PbRAP1 3’Flank.
90- R
AGGTTGGTCATTGACACTCAGCAGTACTAGAA
GCCCAGGCGCAAGATATC
PbRAP1
163-F
GAACTCGTACTCCTTGGTGACGGTACCGCACCC
ATATGCAGAAATTCACG
PbRAP1
To amplify 
PbRAP1 5’Flank.
163-R
GCAGTCGACCTCCGCGTAATCCCTATCCTTTAA
TGAATC PbRAP1
RAP1 3XHA epitope tagging in P.  berghei (Chapter 3)
186 F AGACCGCGGGATTATTCTGTGGCATTTAACAT PbRAP1
To amplify RAP1
fragment “a”
187  R TCCACTAGTGAAGGTAATCATTTTTTGTGG PbRAP1
188   F AGCACTAGTGATTTAATCAGATTACCTTC PbRAP1
To amplify RAP1
fragment “b”
189 R AGCCCTAGGGAATACACGATCAT PbRAP1
68 F CCTAGGAGCGGCATAATCTGGAAC PbRAP1
To check 3’ 
integration of the 
tagging construct 
into the 
endogenous 
PbRAP1 gene 
locus
311 R GGAATAGAGAGATTGTCCATCACG PbRAP1
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Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
RAP1 inducible knock down in P. berghei (Chapter 4)
76-F CCGATGCTAGCGTACGGAATGCAAC
TTTGTAAGATTGTGG
PbRAP1
To amplify PbRAP1
5’UTR.
77-R CGTCCCGGGCGGCCGCTTTTCGCAA
AAAAAATAAAATAATA
PbRAP1
91-F
CTAGGCTGCAGATGTTTATTAAAAT
TGTAAGTTTGTTCATACTTTCCCGAT
TGGTGTTTCAAGATTATTCT
PbRAP1
To amplify PbRAP1 cds 
with signal sequence.
75-R CGTGATATCGTACGCTAGCCGAATG
AATTAAACCATGAATAGG
PbRAP1
180 R CTGGCAAATCGGCACTTGG
PbRAP1 To check cds integration 
of the tagging construct 
into the endogenous 
PbRAP1 gene locus.
181 F AGC GAT CGG AAT AAA TGC CA
PbRAP1 To check 5’ integration of 
the tagging construct into 
the endogenous PbRAP1
gene locus.
527 F1 AACCCCAAAATGTAAATGAAC
PbRAP1
Real time qPCR oligo to 
check level of PbRAP1
knock down (Set I)
528 R1 ATCTGGCAAATCGGCAC
PbRAP1
529 F2 AGTTTGTTCATACTTTCCCGA
PbRAP1
Real time qPCR oligo to 
check level of PbRAP1
knock down (Set II)
530 R2 CGTCTTGCTTTTCACTATCTTTA
PbRAP1
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Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
RAP 2 inducible knock down in P. berghei (Chapter 4)
147-F GCCCTCTAGAATCGATGGCGTATTCCCTTAAGTCCTTCAG PbRAP2
To amplify PbRAP2
5’UTR.
83-R GTTGCGGCCGCTTTGCCTTCACTTTCGTTTTATATAAA
PbRAP2
80-F CCGGGTCACCAAGTGCTCAATACCTCTTAAAGATA
PbRAP2
To amplify PbRAP2 cds.
156-R GCTCTAGAATCGATGAATATCCTAAAAGCATGACTATACC
PbRAP2
182 R CAC ATC GAC CCA AAG TAT CG
PbRAP2 To check cds integration 
of the tagging construct 
into the endogenous 
PbRAP2 gene locus.
183 F TGG ACA AAA AAT AGA AAG GGA GAG
PbRAP2 To check 5’ integration of 
the tagging construct into 
the endogenous PbRAP2
gene locus.
523F1 ATGACCCTTATTATGCTGGA
PbRAP2
Real time qPCR oligo to 
check level of PbRAP2
knock down (Set I)
524R1 TGATTTTGTTTCTGCTACCC
PbRAP2
525F2 TCGTTTCCCTTTTTCTATGT
PbRAP2
Real time qPCR oligo to 
check level of PbRAP2
knock down (Set II)
526R2 ACTATTTTCTTCGTTTTCTGTTAC
PbRAP2
567 F AATTAAAGAAGCATCTGAGGGTCCAC PbGAPDH
RT qPCR control oligos 
for reference PbGAPDH 
gene amplification
568 R TTGAATATCCCCATTCATTGTCATACC PbGAPDH
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Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
RAP1 - DPAP3 cleavage site mutation in P. falciparum (Chapter 5)
490 F ATCGCGGCCGCTCCACTTGTCCAAAACATCCT PfRAP1
To amplify PfRAP1
5’UTR.
397 R AGCAGATCTACTAGTTACATTTATACCATCAGCGACAT
PfRAP1
400 F TCGAGATCTAACGGAGATAATAATTATGGGAAAA
PfRAP1
To amplify PfRAP1 cds.
401 R TAGCTGCAGCATCTAATCTCTTGAAGGCAAAG
PfRAP1
531 F TCGTGATCAAACGGAGATAATAATTATGGGAAAA
PfRAP1
To amplify PfRAP1 cds 
from intermediate TOPO 
vector.
532 R TAGATGCATATCTAATCTCTTGAAGGCAAAG
PfRAP1
443 F GATAAATTTTCAAGTGAAGCCGCTGCAGAAAATAAATCTAGT
PfRAP1
Introduces mutation in the 
PfRAP1 cleavage site 
amino acid 67 to 71 
(ESFLE to EAAAE) by 
triple alanine replacement.444 R ACTAGATTTATTTTCTGCAGCGGCTTCACTTGAAAATTTATC
PfRAP1
398 F
CTAGTGAACAAAAATTAATTTCTGAA
GAAGATTTAGCTGCTGAACAAAAATT
AATTTCTGAAGAAGATTTAGCTGCTA
2X
c-myc tag
To amplify 2x c-myc tag.
399 R
GATCTAGCAGCTAAATCTTCTTCAGA
AATTAATTTTTGTTCAGCAGCTAAATC
TTCTTCAGAAATTAATTTTTGTTCA
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Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
Inducible knock down of DPAP3 in P. falciparum (Chapter 5)
394 F AGGAGATCTAATAACGAAATAAACATAAAAG PfDPAP3
To amplify PfDPAP3 cds.
395 R TAGCTGCAGCTGTTTCTTTTTGTTTAACAAACAAG
PfDPAP3
607 F1 ACCAAGGATGTAACGGTGGA
PfDPAP3
To check integration of 
the targeting Glms 
riboswitch knockdown 
construct into the 
endogenous PfDPAP3
gene locus.
276 R1 GTGATTTCTCTTTGTTCAAGGA
PfDPAP3
608 F2 AGATTGTGGTTCGTGTTATGCA
PfDPAP3
68R2 CCTAGGAGCGGCATAATCTGGAAC
PfDPAP3
699 F1 AGTAGCAGCAGCCATAGAAC
PfDPAP3
Real time qPCR oligo to 
check level of PfDPAP3
knock down (Set I)
700 R1 TACTACAGCATGATCCACCTT
PfDPAP3
701 F2 AAGAAAAATGAAACGACAGC
PfDPAP3
Real time qPCR oligo to 
check level of PfDPAP3
knock down (Set II)
702 R2 TTCTCTGGGTTCAAATCATC
PfDPAP3
637 F1 TGTTGAAGATTTCCCACACG PfDPAP1 Real time qPCR oligo to 
check expression of 
PfDPAP1 (Set I)
638 R1 TTCTTTACCCCAACCATTTCC PfDPAP1
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Oligo SEQUENCE 5’ TO 3’ GENE COMMENTS
639 F2 TTTCCCACACGCTCGTAGAT
PfDPAP1
Real time qPCR oligo to 
check expression of 
PfDPAP1 (Set II)
640 R2 CCAACCATTTCCCCAACTATT
PfDPAP1
641 F1 AAAACAAATCCGACGCAAAC PfDPAP2
Real time qPCR oligo to 
check expression of 
PfDPAP2 (Set I)
642 R1 TCCTTCCAATAGGAGGCAGA
PfDPAP2
643 F2 TGGGGATGTTTTTATGCTGAG
PfDPAP2
Real time qPCR oligo to 
check expression of 
PfDPAP2 (Set II)
644 R2 CAGGTGCGTTTGTGTTGAT
PfDPAP2
645 F1 CCCCTCGTTTTTCCAAGAAT PfSUB1
Real time qPCR oligo to 
check expression of 
PfSUB1 (Set I)
646 R2 TGTTGAATGGCGTTTCCTTT
PfSUB1
647 F2 TGAGGAGAAGGGAGCTTTGA
PfSUB1
Real time qPCR oligo to 
check expression of 
PfSUB1 (Set II)
648 R2 ATTTGTTGAATGGCGTTTCC
PfSUB1
670 F GCTGACTACGTCCCTGCCC Pf18SrRNA
RT qPCR control oligos 
for reference Pf18SrRNA
gene amplification [178]
671 R ACAATTCATCATATCTTTCAATCGGTA Pf18SrRNA
F: forward oligonucleotide; R: reverse oligonucleotide; Pb: Plasmodium berghei; Pf: Plasmodium 
falciparum; RT qPCR: Real Time quantitative Polymerase Chain Reaction.
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Table 2.2: List of antibodies used for IFA and Western blot analysis.
Antibody Raised in
Dilution for 
IFA
Dilution for 
Western blot
Source
Pf RAP1 Mouse 1:1000 1:3000
Gift from Alan 
Cowman
Pf RAP2 Mouse 1:200 NA
Gift from Alan 
Cowman
Pf RAMA-D Rabbit 1:1000 1:3000
Gift from Ross 
Coppel
Pb RAMA Mouse 1:300 NA
Gift from Ross 
Coppel
Pf RhopH3 Rabbit 1:300 1:1000
Gift from Ross 
Coppel
Pf RON4 Rabbit 1:300 NA
Gift from Paul 
Gilson
Pf AMA1 Mouse 1:300 1:1000
Gift from Paul 
Gilson
Pf MSP1 Rabbit 1:1000 1:3000
Gift from Paul 
Gilson
Pf SERA5 Rabbit NA 1:1000
Gift from Paul 
Gilson
Pf RESA Rabbit 1:2000 1:3000
Gift from Robin 
Anders
Pf ANTI- HA Mouse 1:200 1:500 From Roche
Pf EXP2 Rabbit 1:500 1:1000
Gift from Robin 
Anders
Pf GAPDH Rabbit NA 1:1000
Gift from Paul 
Gilson
80
 
 
 
 
Chapter 3 ~ 
Characterisation of RAP1 and 
establishing its importance to 
parasite survival
  
Chapter 3
81
3.1 INTRODUCTION 
Members of the RAP complex have been previously regarded as potential anti-
malaria vaccine candidates based on the importance of RAPs for binding host 
erythrocytes [128] and the ability of recombinant RAP1 and RAP2 to generate an 
immune response and to be recognized by human antibodies in the sera from people 
living in malaria endemic areas [127, 179]. However, contrary to the existing 
expectations, vaccines directed against RAP1 failed to render complete protection 
against infection challenge (reviewed in [53]). This lack of protection is consistent 
with the present knowledge regarding the sequence of events during invasion, 
according to which, the ROPs (and thus presumably the RAP complex) are secreted 
into the PV/PVM after tight junction formation [45].
To understand the function of the RAP complex, gene disruption has been 
previously attempted in P. falciparum and P. berghei. Disruption of RAP1 was only 
possible in the P. falciparum D10 strain that utilises alternative parasite 
ligands/host cell receptors for invasion. Although no in vitro phenotype was 
observed, rhoptry targeting of RAP2 was disturbed in the absence of RAP1 [129].
The ability to disrupt RAP3 in P. falciparum, presumably stems from RAP2 being
able to complement its function [91, 129], since deletion of the single RAP2/3 gene
in P. berghei has not been successful [130]. The contribution of RAP1 to survival 
in vivo, however, has never been explored, thus, to gain greater insight into RAP1
function, this study aimed to characterise RAP1 in P. falciparum in more detail 
with respect to its timing of expression, localisation and persistence after invasion. 
Further, to determine whether RAP1 plays a crucial role in parasite survival in vivo,
attempts were made to generate a loss of function mutant in the rodent malaria 
species P. berghei.
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3.2 RESULTS 
3.2.1 PfRAP1 is synthesized in the schizont stages and persists up to 15 hrs post-
erythrocyte invasion  
To study the expression pattern and persistence of RAP1 post-invasion, 
immunofluorescence analysis (IFA) was performed on fixed parasite smears 
harvested at various stages of a synchronized P. falciparum 3D7 culture, using a 
monoclonal antibody raised against P. falciparum RAP1 (Fig. 3.1A). In keeping 
with previous results [94], RAP1 is first synthesized when the parasite reaches early 
schizont stage (~35 hrs after invasion), and by late schizont stage shows a punctate 
pattern characteristic of rhoptry localisation. A similar pattern of RAP1 expression 
was also seen by Western blot analysis (data not shown). Here, RAP1 co-localised 
with other known rhoptry bulb proteins like RAMA and RhopH3 but showed no 
co-localisation with the rhoptry neck protein RON4 (Fig 3.1B). Specific RAP1 
labelling was also observed in the released merozoites and in the newly invaded 
erythrocytes, where it was seen to persist throughout the ring stage up to ~15 hrs 
post invasion. However, RAP1 could no longer be detected once the parasite started 
forming the haemozoin pigment in the early trophozoite stage. Thus the prolonged 
persistence of RAP1 in the rings after RBC invasion suggests that either RAP1 does 
not contribute to RBC invasion of argues for an additional role of this rhoptry 
protein after invasion.
3.2.2 RAP1 is peripherally bound to the PVM after erythrocyte invasion 
Since the localisation of RAP1 in the ring stages could provide vital clues regarding 
its function, differential solubilisation experiments were performed to determine if 
RAP1 gets secreted during invasion and remains there as a soluble protein or 
whether it associates with membranes post-invasion. Hypotonic lysis of P. 
falciparum ring-stage parasites revealed RAP1 did not remain in the soluble 
fraction and instead was present in the pellet fraction. However, treatment of the 
pellet fraction with alkaline Na2CO3 moved RAP1 to the soluble fraction,
indicating that RAP1 is peripherally bound to membrane, which could either be the 
PM or the PVM (Fig 3.2A). Attempts to determine what membrane RAP1 
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Fig 3.1: PfRAP1 persists throughout the ring stage of the asexual life cycle.
A. IFA with anti-RAP1 antibody at different time points across parasite lifecycle 
suggests that RAP1 persists for 15 hrs after erythrocyte invasion. New RAP1 is 
not synthesized until around 35 h post-invasion, when it reaches the schizont 
stage of the parasite life cycle.
B. IFA showing RAP1 colocalise with other rhoptry bulb markers like RAMA and 
RhopH3 and shows no colocalisation with rhoptry neck marker RON4 in 
schizonts.
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Fig 3.2: PfRAP1 is a peripheral membrane protein. 
Western blot analysis of fractions from solubility assays of erythrocytes infected 
with P. falciparum at (A) ring and (B) schizont stage. Blots were probed with the 
antibodies as indicated.  SERA5/GAPDH, HSP101 and EXP2 serve as soluble, 
peripherally-associated membrane proteins and integral membrane protein 
controls, respectively. Lanes represent soluble proteins after hypotonic lysis, 
Na2CO3-extraction and Triton X-100-extraction. Integral membrane proteins 
remain in the Triton-X insoluble fraction. 
Chapter 3
85
associates with, and if it is the PVM, whether RAP1 sits on the PV or the RBC 
cytosolic side, coupled with the analysis of its interactors at this stage are underway, 
which could potentially shed light on RAP1 function in the ring stages. The same 
protocol was used to determine the intracellular localisation of newly synthesized 
RAP1 in the schizont stage when it localises to the rhoptries.  Here, RAP1 was 
solubilised by alkaline Na2CO3 buffer, indicating it is peripherally associated with 
membranes prior to invasion (Fig 3.2B). 
3.2.3 Plasmodium berghei RAP1 is essential for parasite survival in vivo 
To investigate the importance of RAP1 in parasite survival in vivo, this gene was 
targeted for deletion in P. berghei. The targeting construct pL0048_RAP1 was 
designed to replace the endogenous RAP1 gene (Pf gene ID: PBANKA_1032100)
with the hDHFR-yFCU selectable marker cassette via double cross over 
homologous recombination (Fig.3.4A). 
To construct this plasmid, the sequence of the P. berghei RAP1 gene was retrieved 
from the on-line Plasmodium genome database, www.plasmodb.org. TKH ƍ
untranslated region (UTR) DQGƍ875, which would serve as targeting regions to 
drive integration into the endogenous RAP1 locus [180], were PCR-amplified from 
P. berghei ANKA genomic DNA (gDNA) using gene-specific primers 163F/164R 
DQG)5UHVSHFWLYHO\7KHUHVXOWLQJƍ875DQGƍ8753&5VHTXHQFHVZHUH
digested with KpnI/SalI and ScaI/BamHI, respectively and sequentially inserted 
into the vector pL0048 as shown in Fig 3.3 to generate the final knockout construct, 
pL0048_RAP1. Insertions of the targeting sequence were confirmed by a PCR 
screen and analytical restriction digestion screen of the positive clones and the final 
construct was sequenced to ensure that no mutations were introduced (data not 
shown). Prior to transfection, pL0048_RAP1 was linearised with HindIII and XhoI
and the vector backbone was excised to drive integration of targeting construct into 
the P. berghei genome (Fig. 3.3).
Whilst the first two transfection experiments did not yield any parasites after drug 
selection with pyrimethamine, pyrimethamine-resistant parasites were recovered 
after the third transfection attempt. However, Southern blot analysis using a probe 
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Fig 3.3: Generation of a RAP1 targeting construct to knockout RAP1 in P.
berghei
Schematic of the cloning procedure used for generating the knockout construct 
pL0048_RAP1.
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Fig 3.4: The Plasmodium berghei RAP1 is essential for parasite survival in 
vivo
A. The P. berghei RAP1 targeting construct pL0048_RAP1 was designed to 
integrate into the endogenous locus by double-crossover homologous 
recombination. Schematic representation of the endogenous RAP1 locus of P.
berghei wildtype parasites, the knockout plasmid construct pL0048-RAP1 and 
predicted RAP1 knockout gene locus. ƍ)O ƍ WDUJHWLQJ VHTXHQFH ƍ)O ƍ
targeting sequence; SM, hDHFR-yFCU selectable marker cassette; right arrow, 
transcription start site; circle, transcription terminator.
B. Southern blot analysis of genomic DNA from parasites recovered after 
transfection with the RAP1 targeting construct and wildtype P. berghei ANKA
(PbA) digested with restriction enzymes (RE) KpnI/PstI. Successful integration 
of the hDHFR-yFcu cassette (SM) in the RAP1 locus should result in a 2.6 Kb 
(In) fragment hybridizing to the RAP1 3ƍFl probe. Instead only an 8.4 kb and 
4.5 kb fragment indicative of an intact endogenous RAP1 locus (E) and plasmid 
DNA (P) was observed.
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designed against the 3' targeting sequence of RAP1 revealed that the recovered 
parasites were only wild type P.berghei parasites harbouring the episomal version 
of the targeting construct and no band indicative of the correct integration event 
was observed (Fig 3.4B). Thus the inability to disrupt RAP1 on three separate 
occasions suggests that this gene is essential for parasite survival in vivo.
3.2.4 The RAP1 gene locus is amenable to genetic manipulation 
To provide confirmation that the RAP1 gene is essential for parasite survival in 
vivo, attempts were made to epitope tag the endogenous gene with a triple 
haemagglutinin (HA) epitope tag using a 3ƍ replacement strategy (Fig. 3.6) in order 
to demonstrate whether the RAP1 locus is in fact amenable to gene targeting. This 
required the creation of an epitope-tagging construct, pRAP1_HA for transfection 
into P. berghei. For this, a region of 2 kb immediately upstream of the stop codon 
of PbRAP1 (which would ultimately serve as the targeting region for homologous 
recombination into the PbRAP1 endogenous locus) was PCR amplified from P. 
berghei ANKA gDNA in roughly two equal parts using the oligonucleotides 
186F/187R (RAP1a-5' targeting region) and 188F/189R (RAP1b-3' targeting 
region) (Fig 3.5). The two resulting PCR products were digested with SacII/SpeI
and SpeI/AvrII, respectively and cloned into the corresponding sites of the vector 
pB3-150-HA/Str-DT3', to replace the PbTEX150 5' and 3' targeting regions [181].
This produced the final epitope tagging construct pRAP1_HA, generating a SpeI
site between the two adjacent 5' and 3' targeting sequences that was then used to 
linearise the DNA prior to transfection. Cloning of the targeting sequences were 
confirmed by PCR and analytical restriction digestion screens of the positive 
clones. The final construct was sequenced to ensure that no mutations were 
introduced.
Integration of pRAP1-HA into the RAP1 locus by single cross-over recombination
should lead to the generation of one functional epitope-tagged RAP1 gene and a 
second copy of RAP1 coding sequence lacking a promoter that should, therefore, 
be non-functional (Fig. 3.6A). After positive selection of parasites transfected with 
pRAP1_HA with pyrimethamine, transgenic parasites were recovered and 
subjected to genotyping by diagnostic PCR, which showed successful integration 
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of the targeting construct into the endogenous RAP1 locus. However, the 
population of transgenic parasites was not clonal as the Southern blot analysis of 
genomic DNA digested with HindIII and XhoI and hybridised with the RAP1 probe 
showed that in addition to the expected integrant band at 5.4 kb and 4.1 kb, more 
intense hybridising bands representing intact endogenous RAP1 gene (7.3 kb band) 
and a band expected for episomal plasmid (1.9 kb band) was also observed (Fig. 
3.6C). 
To confirm that RAP1 gene had been successfully tagged, IFA was performed on 
the schizont-stages of P. berghei ANKA infected RBC using anti-HA antibodies in 
conjunction with anti-PfRAP1 antibody. Both the anti-PfRAP1 and anti-HA
labelling co-localised, giving the same punctate labelling pattern typical of rhoptry 
localisation (Fig.3.7B) corroborating that RAP1 had been successfully epitope 
tagged in P. berghei. However, the RAP1 tagged line was not clonal, with 
approximately 30% of the parasite population showing HA tagged RAP1 by IFA.
This was further confirmed by Western blot analysis of parasite extracts harvested 
from the blood of infected mice, which showed that a protein species in the 
transgenic parasite line of around the predicted molecular mass of the RAP1 protein 
(86 kDa) fused to the epitope tag reacted with anti-HA, with no labelling observed 
in control P. berghei wild-type (WT) lysates as expected (Fig. 3.7A).
Unfortunately, the Pf anti-RAP1 antibody gave non-specific labelling in P. berghei 
ANKA parasites lysates by Western blot (data not shown) and thus could not be 
used to look at the molecular mass shift of RAP1 protein following the addition of 
the epitope tags in the transgenic parasites. Thus, the ability to successfully epitope-
tag RAP1 in P. berghei confirms that the RAP1 locus is amenable to gene targeting 
and the failure to knockout RAP1 suggests that it is essential for parasite growth 
and survival in vivo.
3.3 DISCUSSION 
The rhoptry organelle of Plasmodium has been strongly implicated to play an 
essential role in host cell invasion [182], and thus the role of the rhoptry proteome 
as mediators of invasion has been of major interest. The RAP complex of the 
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Fig 3.5: Cloning strategy and construct design for RAP1 epitope tagging 
construct.
Schematic representation of the cloning steps involved in generating the final 
targeting construct pRAP1_HA.
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Fig 3.6: Integration of the epitope tagging construct into the endogenous 
RAP1 gene locus.
A. Schematic representation of the strategy used to epitope tag RAP1 in P. 
berghei. The targeting constructs were designed to integrate into the P. berghei 
RAP1 locus by single-crossover recombination. The predicted structure of the 
endogenous locus before and after 3ƍ integration is shown. SM, Toxoplasma 
gondii DHFR-TS selectable marker cassette; dotted lines, plasmid backbone; 
right arrow, transcription start site; stop sign, transcription terminator; 
arrowheads, oligonucleotides used in diagnostic PCR analysis. The 
HindIII/XhoI restriction enzyme fragments are shown. The region used as a 
probe for Southern blot analysis is indicated.
B. Diagnostic PCR reveals successful integration of 5ƍ (5' INT) and 3ƍ flanks (3'
INT) in PbRAP1-HA parasites only, which was absent in the wildtype (PbA)
parasites, which was used as a control (CONT).
C. Southern blot analysis of genomic DNA digested with HindIII/XhoI and probed 
with the RAP1 probe shows the presence of the expected integrant band at 5.4 
kb and 4.1 kb along with the presence of the endogenous (E) RAP1 (7.3 kb 
band) and linearized plasmid (P) (1.9 kb band).
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Fig 3.7: Western blotting and immunofluorescence analysis indicates that the 
RAP1 gene has been successfully epitope tagged.
A. Western blot analysis of wildtype (WT) and transgenic PbRAP1-HA parasites 
using anti-HA Į-HA) antibody reveals a predominant protein species at 
roughly 82 kDa, the predicted molecular weight of RAP1. This band is absent 
in the WT parasites.
B. Immunofluorescence analysis of acetone/methanol-fixed thin blood-smears of 
PbRAP1-HA schizonts using anti-HA and anti-RAP1 antibodies shows the HA 
labelling co-localises with RAP1 labelling. No anti-HA labelling was observed 
in WT parasites.
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rhoptry is composed of 3 members, these being RAP1, RAP2 or RAP3 that are 
tightly associated [107] and despite their potential importance as vaccine candidates 
[111, 117, 118, 179], not much is known regarding the functions of these proteins 
in the parasite [105, 183].
RAPs are highly abundant rhoptry proteins localised to the rhoptry bulb. The 
segregation of rhoptry proteome and the mechanism behind how the bulb proteins 
are retained in the rhoptry when the neck proteins are released during invasion is 
still a mystery. To understand this, characterisation of RAP1 in P. falciparum was 
attempted. This study confirms previous studies, showing RAP1 is synthesized late 
in the parasite lifecycle at the early schizont stage [183]. When RAP is present at 
the rhoptry, it has a peripheral membrane association. We hypothesise, that this 
peripheral association of RAP1 with the membrane could potentially aid in 
retaining the bulb proteins during the initial stages of invasion, whereas the neck 
proteins gets secreted forming the tight junction to facilitate invasion. This 
membrane association of RAP1 may be reversible, thereby allowing the protein to 
get secreted during invasion. Alternatively, RAP1 may be peripherally associated 
with lipid rafts in the rhoptry such that when this material get secreted from the
rhoptries into the erythrocyte cytosol as a whorl-like structure [45], it fuses with the 
PVM during its formation post invasion and the peripheral association of RAP1 
with the membranes is retained.
Previous studies have highlighted the importance of RAP1 in host cell invasion and 
immunogenicity of RAP1 has been established with the detection of anti RAP1 
antibodies in the sera of naturally infected hosts [113]. However, vaccines against 
RAP1 only led to a partial protection in the non-human primates (reviewed in [53]).
Now the sequence of RBC invasion by the malaria parasite has been teased out in 
greater detail, this lack of protection could be because RAPs are actually secreted 
into the PV/PVM after tight junction formation and thus antibodies are unlikely to 
block RAP1 from exerting its function [45]. In fact, the study herein has revealed 
that after host cell invasion, RAP1 is carried into the newly formed ring, where it 
persists for up to 15 hours post-invasion. This long persistence of RAP1 after 
invasion argues against a role in invasion - the immunogenicity of RAP1 observed 
previously could be a result of abortive invasive events, whereby merozoites release 
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rhoptry contents after attachment, but fail to go on and invade. Thus, it is perhaps 
not surprising that the P. falciparum D10 RAP1 knock out line did not show any 
effect on host cell invasion [129]. Probing into the localisation of RAP1 at this stage 
demonstrated that RAP1 remains peripherally bound to membranes, most likely to 
the PVM, indicating that the RAPs at this point could potentially be involved in 
contribution to the PVM structure or maintenance, or even the transport of 
molecules across the PVM to facilitate parasite growth and/or survival in the new 
cellular compartment.  
In earlier studies, the RAPs have been shown to be essential for in vivo parasite 
survival, whereas attempt to knock out RAP2/3 in P. berghei proved to be lethal
[130]. Thus, in this Chapter, attempts were made to disrupt the RAP1 gene in the 
rodent malaria strain P. berghei to investigate whether this protein is essential for 
parasite survival in vivo. However, a deletion mutant, in which the endogenous 
RAP1 gene is replaced by a hDHFR-yFCU selectable marker cassette via double 
cross over homologous recombination at the 5' and 3' targeting sequence, could 
never be generated, despite multiple attempts. This indicates that knocking out the 
RAP1 gene (like RAP2/3) in vivo is lethal for the parasites. In support of this, the
endogenous RAP1 locus could be successfully epitope-tagged, indicating the RAP1 
locus is amenable to genetic manipulation. However, it should be noted that only a 
portion of the parasites in the non-clonal population contained the expected 
integration event, with the majority being wildtype parasites containing episomal 
versions of the targeting construct. This may be because epitope-tagging of RAP1
may have a fitness cost to the parasite. 
Thus, our present understanding on the timing of RAP release coupled with the 
RAP trafficking and localisation data questions the potential role of the RAP 
complex during host cell invasion, and suggests that the RAP complex plays a role 
further downstream and which is essential to parasite survival in vivo. This argues 
for a better understanding of RAPs and the next Chapter endeavours to explore their 
function further using conditional knockdown systems to unravel the mystery as to 
why these proteins have become indispensable for parasite survival in vivo.
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4.1 INTRODUCTION 
The haploid nature of the malaria parasite has always been a major obstacle in 
studying genes with essential functions in the blood stages. Conventional knockout 
approaches to create null mutants of essential genes leads to parasite death and thus 
can only reveal the earliest non-redundant role of their product without further 
functional characterisation. To overcome this limitation, conditional gene 
knockdown tools have been recently developed to study essential malaria genes 
[25, 184].
The gene encoding PbRAP2 is refractory to genetic ablation [130] and attempts to 
generate a viable RAP1 knockout in P. berghei failed via conventional knockout 
strategies (Chapter 3). Thus a robust conditional expression system was required to 
stage-specifically regulate members of the RAP complex in the rodent malaria 
strain P. berghei. The system chosen was a tetracycline-based transcriptional 
regulation system originally developed for T. gondii but optimised for P. berghei,
and comprises three core components: (i) a TRAD regulator (comprising TetR
fused to the transactivator domains of the native P. berghei apetala 2 family of 
transcription factors [185], (ii) tetracycline operator (TetO) sequences positioned 
in front of a minimal promoter driving transcription of the gene of interest, and (iii) 
an effector, in this case Anhydrotetracycline (ATc). In the absence of the effector, 
the TRAD transactivator binds to TetO via the TetR sequences and activates 
transcription. However, in the presence of ATc, the TRAD shows a markedly 
reduced affinity for the TetO, and thus transcription is turned off [186, 187].
Although only recently developed for P. berghei, this transcriptional regulation 
system has yielded some success [188, 189] and hence was used for generating 
conditional knockdowns of RAP1 and RAP2, to permit functional characterisation 
of these genes in in P. berghei.
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4.2 RESULTS 
4.2.1 Conditional regulation of RAP1 in P.berghei 
In order to create a transgenic P. berghei parasite line in which the RAP1 gene is
placed under the transcriptional control of a conditional tetracycline (Tet) 
transcriptional regulation system [188], a RAP1 targeting construct, termed, pRAP1
iKD was first created. This plasmid was adapted from p_TRAD_RAMAi (Natalie 
Counihan and de Koning-Ward, unpublished) that had been derived from pPRF-
TRAD4-Tet07-HAPRF-hDHFR [188]. The first 1.4 Kb of the RAP1 coding 
sequence (amplified with 91F and 75R) and 0.9 kb of RAP1 ƍXQWUDQVODWHGUHJLRQ
(amplified using oligonucleotides 76F and 77R) were sequentially cloned into the 
PstI/NheI and NheI/NotI sites of the vector p_TRAD_RAMAi, thereby replacing 
the RAMA CDS and RAMA 5ƍ UTR, respectively (Fig 4.1A). Insertions of the 
targeting sequence were confirmed by a PCR screen and analytical restriction 
digestion screen of the positive clones. The pRAP1iKD construct was sequenced 
to ensure no mutations were introduced in the PCR. Before transfection into P.
berghei ANKA, the DNA was linearized with NheI (Fig 4.1A).
Following transfection, transgenic parasites were selected with pyrimethamine and
transgenic parasites were recovered in 10 days.  These parasites were assessed for 
integration by diagnostic PCR using the oligonucleotide combinations a/b 
(181F/T51R) and c/d (213F/311R) as shown in Figure 4.2A. The expected 1.5 Kb 
and 2.38 Kb bands were observed, indicative of successful 5ƍ and 3ƍ integration, 
respectively (Fig. 4.2B). Southern blot analysis was performed to further validate 
this integration. Genomic DNA from PbRAP1iKD parasites digested with 
KpnI/SpeI and hybridised with P. berghei RAP1 5' UTR as a probe (amplified from 
P. berghei gDNA with 87F/88R), showed the expectant integrant band of 2.4 Kb 
and absence of bands indicative of wild type locus (Fig. 4.2C). This confirmed the 
successful integration of the targeting construct into the endogenous RAP1 gene 
locus and also revealed that the PbRAP1iKD line was clonal. 
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Fig 4.1: Conditional regulation of PbRAP1 and PbRAP2 using ATc 
transcriptional regulation system.
A. Construct design for pRAP1iKD and pRAP2iKD (inducible targeting) 
constructs.
B. Schematic representation of the strategy used to generate the PbiRAP1KD
transgenic line, in which case the TRAD transactivator is placed under the 
control of the endogenous RAP1 promoter, and the coding sequences of RAP1
is placed under the control of the ATc-responsive inducible promoter. Since the 
ability of the transactivator to bind to the minimal promoter is sensitive to 
Anhydrotetracycline (ATc), the addition of ATc to the drinking water of mice 
could be used to regulate RAP1 gene transcription and expression. The same 
strategy has been used to generate the PbiRAP2KD line as well. 
Oligonucleotides (a,b,c,d,e and f) used for PCR screen are indicated by arrow 
heads. Restriction enzymes used for Southern blot analysis are also indicated; 
K, KpnI; S, SpeI.
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4.2.2 Conditional regulation of RAP2 in P.berghei 
To date, all attempts to disrupt the RAP2/3 gene in P. berghei have failed and thus 
a conditional RAP2 knockdown was also attempted. The targeting construct 
pRAP2iKD, like pRAP1iKD, was cloned using the same strategies into 
p_TRAD_RAMAi and incorporated the first 1.6 Kb of the RAP2 CDS (amplified 
with 80F and 156R) and 1 Kb of RAP2 ƍXQWUDQVODWHGUHJLRQDPSOLILHGwith 147F
and 83R) (Fig 4.1A). Insertions of the targeting construct were confirmed by PCR 
and restriction digestion screen. The final targeting construct pRAP2iKD was 
sequenced and linearized with NheI before transfection (Fig 4.1A).
After transfection of P. berghei with pRAP2iKD and selection with 
pyrimethamine, transgenic parasites were recovered in 12 days. Diagnostic PCR
using the oligonucleotide combinations a/b (183F/T51R) and c/d (213F/182R) (Fig.
4.3A) gave the expected 1.36 Kb and 2.39 Kb integrant bands, indicative of a 
successful 5ƍ and 3ƍ integration, respectively (Fig. 4.3B). Southern blot analysis was 
performed to further validate this integration. Genomic DNA from PbRAP2iKD 
parasites digested with HincII/XhoI and hybridised with P. berghei RAP2 CDS as 
a probe (amplified from P.berghei gDNA with 80F/156R), showed the expectant 
integrant band of 4.7 Kb and absence of bands indicative of wild type locus (Fig. 
4.3C). This confirmed the successful integration of the targeting construct into the 
endogenous RAP2 gene locus and also revealed the PbRAP2iKD line to be clonal. 
4.2.3 P .berghei RAP1 and RAP2 expression can be regulated by ATc 
To determine whether RAP1 and RAP2 gene expression could be regulated by the 
addition of ATc, the level of knockdown of RAP1 and RAP2 gene expression was 
assessed at the transcriptional level, using quantitative reverse transcriptase PCR 
(qRT-PCR) on schizonts stage parasites since this is when the RAP genes are 
normally transcribed. For these experiments, ring-stage parasites harvested from 
infected mice were cultured in the absence or presence of 1 Pg/ml ATc until 
schizont stage, from which the abundance of RAP1 or RAP2 transcript was 
measured relative to GAPDH as a control. These experiments revealed that 
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Fig 4.2: Generation of PbRAP1iKD parasite lines.
A. Schematic representation of the RAP1 locus after integration, oligonucleotide
primers used to detect 5ƍ integration (a/b), 3ƍ integration (c/d) and the RAP1
locus, irrespective of whether integration had occurred (e/f) and (g/h). The 
RAP1 probe used for Southern blot analysis is also shown. 
B. Analytical PCR shows the presence of the successful 5ƍ and 3ƍ integrant bands 
at 1.36 Kb and 2.39 Kb, respectively for PbRAP1iKD parasites, which was 
absent in wildtype (WT) parasites.
C. Southern blot analysis of PbRAP1iKD genomic DNA shows the presence of 
the expected integrant band at 2.4 Kb with the loss of the WT band.
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Fig 4.3: Generation of PbRAP2iKD parasite lines.
A. Schematic representation of the RAP2 locus after integration, oligonucleotide 
primers used to detect 5ƍ integration (a/b), 3ƍ integration (c/d) and the RAP2
locus, irrespective of whether integration had occurred (e/f) and (g/h). The 
RAP2 probe used for Southern blot analysis is also shown. 
B. An expected integrant band was observed by PCR at 1.5 Kb and 2.38 Kb 
respectively, indicative of a successful 5ƍ and 3ƍ integration in the PbRAP2iKD 
line.
C. Southern blot analysis of PbRAP2iKD genomic DNA shows the presence of 
the expected integrant band at 4.7 Kb with the loss of the wildtype (WT) band.
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treatment with ATc led to a 3.7-fold down regulation of RAP1 (Fig 4.4A) and 2.4-
fold down regulation of RAP2 gene expression (Fig 4.4B), respectively. It was not 
possible to confirm the level of gene knockdown at the translational level by 
Western blot analysis since Į-PfRAP1 DQG Į-PfRAP2 antibodies do not react
against P. berghei protein lysate and incorporation of an N-terminal HA tag 
between the signal sequence and RAP1/RAP2 coding sequences in the targeting 
constructs failed to yield transgenic parasites. Nonetheless, the Į-PfRAP1 DQGĮ-
PfRAP2 antibodies were reactive against P. berghei proteins by IFA. Thus the level 
of RAP1 and RAP2 gene regulation was further accessed by IFA, which revealed
that the RAP1 and RAP2 expression had also been reduced at the translational level 
in the ATc-treated lines. For PbRAP1 iKD parasites, more than 90% of parasites
grown in the presence of ATc showed either very faint or faint RAP1 expression 
relative to parasites grown in the absence of ATc (n=100) (Fig. 4.4C). On the other 
hand, for PbRAP2 iKD parasites, the knockdown at the translational level looked 
more uniform amongst the parasite population, with 84% of the parasites showing 
very faint RAP2 expression compared to the untreated control, whilst the remaining 
16% showed a strong RAP2 signal like that of the WT parasites (Fig. 4.4D).
4.2.4 Phenotypic analysis of the RAP1 and RAP2 knockdown parasites 
After confirming the successful regulation of RAP1 and RAP2 gene expression by 
ATc, the phenotypes of the knockdown parasites were assessed with the aim to
characterize the functional role of the RAPs in vivo.
4.2.4.1 RAP1 and RAP2 knockdown does not alter the electron density or gross 
ultrastructure of the rhoptries 
Since both RAP1 and RAP2 are very abundant rhoptry bulb proteins, it was 
interesting to see if the absence of either of these proteins had any effect on rhoptry 
formation. Genetic disruption of ROP1, the major T. gondii rhoptry antigen, which
shows no sequence similarity to P. falciparum RAP1 or RAP2, has been shown to 
alter rhoptry morphology [48]. This was analysed in PbRAP1iKD and PbRAP2iKD 
parasites that had been treated in vitro for 12 hours with ATc and analysing the 
ultrastructure of the rhoptries by transmission electron microscopy (TEM). This 
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Fig 4.4: Analysis of Conditional knockdown of PbRAP1 and PbRAP2 at the 
transcriptional and translational level.
A. Effect of ATc treatment on the RAP1 gene expression at the transcriptional level 
by RT-PCR. The RAP1 gene expression was knocked down by 3.7- fold with 
ATc treatment.
B. RT-PCR analysis also showed a knockdown of 2.3 fold in RAP2 gene
expression in the presence of ATc.
C. Immunofluorescence analysis confirms the reduction of RAP1 expression in 
parasites treated with ATc. The fluorescent intensity of schizonts (n=100) were 
quantitated in each group, wherein the parasite populations showed a spectrum 
of PbRAP1 levels from very low (+), low (++) to close to WT (+++) signals.
D. Effect of ATc treatment on the RAP2 gene expression at the translational level 
using immunofluorescence analysis (IFA).
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Fig 4.5: Knockdown of RAPs does not alter the electron density or gross 
ultrastructure of the rhoptries.
A. TEM image of PbWT merozoite showing normal rhoptry morphology.
B. TEM image of an early schizont (segmenter) of RAP1 knockdown parasite, 
showing normal rhoptry formation even in the absence of RAP1 (also RAP2,
since RAP1 knockdown is essentially a RAP2 knockdown as well).
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analysis, however, did not reveal any differences in the electron density or gross 
ultrastructure of the rhoptries (Fig 4.5), suggesting that the RAPs are presumably 
not essential for rhoptry formation in Plasmodium. These results are consistent with 
the P. falciparum RAP1 knockout, which also showed no such effect on the gross 
ultrastructure of the rhoptries in vitro [129]
4.2.4.2 Knockdown of RAP1 affects the trafficking of RAP2 to the rhoptries, 
whereas other bulb and neck proteins are trafficked correctly 
Next we wanted to analyse if the knockdown of the RAPs had any effect on protein 
trafficking to the rhoptries. IFA analysis of mature, ATc-untreated RAP1 iKD 
VFKL]RQWV DQGPHUR]RLWHV ZLWK Į-PfRAP2 antibodies revealed a punctate RAP2 
labelling typical of rhoptry staining, whilst the RAP1 iKD parasites that had been 
treated with ATc showed a diffuse RAP2 staining pattern in schizonts and no 
labelling in the extracellular merozoites (Fig 4.6A).  These results are consistent 
with the findings in P. falciparum that demonstrated knockout of RAP1 affected 
the trafficking of RAP2 [129]. In contrast, knocking down the expression of RAP2 
did not affect the trafficking of RAP1 (Fig 4.7A). The trafficking and distribution 
of several other rhoptry bulb (RAMA, RhopH3), neck (RON6) and micronemal 
(AMA1) proteins were unaffected by the absence of either RAP1 or RAP2 (Fig 
4.6B, 4.7B, 4.8 and 4.9). This indicates that the RAPs have no role in the trafficking 
of other rhoptry bulb and neck proteins to this organelle. 
4.2.4.3 Knockdown of RAP1 and RAP2 does not alter merozoite numbers  
To ascertain if the RAPs have a role in general parasite maturation and replication, 
the formation of mature schizonts in RAP1 and RAP2 knockdown parasite in vitro
was assessed to determine if there is a difference in the number of merozoites in 
the schizonts between the ATc treated and untreated groups. However, no 
significant difference in merozoite number (Fig 4.10B, D) or schizont formation 
(Fig 4.10A, C) was observed between the knockdown lines grown in the presence 
or absence of ATc. This indicates that the RAPs are not crucial for merozoite 
formation or parasite replication.
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Fig 4.6: Subcellular localisation of RAP2 and RAMA in RAP1 knockdown 
parasites.
A. RAP2 trafficking to the rhoptries was affected in the RAP1 knockdown 
parasites. While RAP1-ATc schizonts and merozoites with anti-RAP2 
antibodies revealed a punctate RAP2 labelling typical of rhoptry staining, 
RAP1 iKD+ATc parasites showed a diffuse RAP2 staining pattern in schizonts 
and no labelling in the extracellular merozoites.
B. RAMA trafficking was unaffected by RAP1 knockdown.
Chapter 4
107
Fig 4.7: Subcellular localisation of RAP1 and RAMA in RAP2 knockdown 
parasites.
A. RAP1 trafficking to the rhoptries was unaffected in the RAP2 knockdown 
parasites. IFA on schizonts and merozoites with anti-RAP1 antibodies revealed 
a punctate RAP1 labelling typical of rhoptry staining.
B. RAMA trafficking was unaffected by RAP2 knockdown.
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Fig 4.8: Absence of RAP1 does not alter expression and distribution of 
several other rhoptry bulb and neck proteins.
A-C. IFA analysis reveals the absence of RAP1 did not alter the expression and 
distribution of other rhoptry bulb protein (RhopH3), neck protein (RON6) and 
other apical organelle markers like AMA1.
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Fig 4.9: Absence of RAP2 does not alter expression and distribution of 
several other rhoptry bulb and neck proteins.
A-C. IFA analysis reveals the absence of RAP2 did not alter the expression and 
distribution of other rhoptry bulb protein (RhopH3), neck protein (RON6) and 
other apical organelle markers like AMA1.
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Fig 4.10: Knockdown of RAP1 and RAP2 does not alter schizont maturation 
and merozoite number.
A. Schizont morphology of the PbRAP1iKD parasite line with/without ATc.
B. Column graph depicting the number of merozoites formed per mature 
schizont in the PbRAP1iKD parasite line with/without ATc (n = 50, error 
bars represent ± SEM).
C. Schizont morphology of the PbRAP2iKD parasite line with/without ATc.
D. Column graph depicting the number of merozoites formed per mature 
schizont in the PbRAP2iKD parasite line with/without ATc (n = 50, error 
bars represent ± SEM).
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4.2.4.4 Knocking down RAP1 or RAP2 expression attenuates parasite growth in 
vivo post invasion 
To access the effect of RAP1 and RAP2 knockdown on the growth of the 
knockdown parasites post-invasion, Balb/c mice (n=6 per group) pre-exposed to 
ATc or vehicle control for 24 hrs were infected with 1 × 106 P. berghei ANKA wild 
type  parasites and PbRAP1 iKD or PbRAP2 iKD parasites. From day 3 post-
infection (p.i) the parasitaemia of each mouse was calculated on a daily basis. The 
parasitaemia of the wild type parasites increased consistently after each life cycle 
even in the presence of ATc, whilst the RAP1 and RAP2 knockdown parasites in 
the presence of ATc propagated at a significantly slower rate (Fig 4.12A, B).
Thus the viability and the duration of the asexual cycle of the knockdown parasite 
population was analysed next. As the trophozoite and schizont stages of the parasite 
sequester in the mice microvasculature, the parasite growth assays were repeated 
in vitro until the mature schizonts stage to gain insight into the basis for the 
attenuated growth of these knockdown parasites. This enabled us to closely 
examine all the stages of the parasite growth, to exactly identify the developmental 
stage of the parasite lifecycle where the loss of RAP1/RAP2 has its greatest impact.
The purified schizont-stage PbRAP1iKD and PbRAP2iKD parasites were 
intravenously injected into untreated mice or mice pre-exposed to ATc, to establish 
a synchronous infection. The parasites invaded erythrocytes in the mice and 
developed normally into ring stages. Parasites were then harvested at this point 
(called Cycle-I parasites) and after next round of invasion (Cycle-II parasites), the 
parasites were cultured in vitro in the presence/absence of ATc. Parasites growth 
and morphology was monitored regularly by observing Giemsa stained blood 
smears. 
Cycle-I parasites of both the transgenic lines grown in the presence of ATc 
appeared to grow normally and similar to the parasites growing in the absence of 
ATc (Fig4.12A, 4.13A). However by Cycle-II, maturation of ~30% of both 
PbRAP1iKD and PbRAP2iKD rings into trophozoites was abrogated in the 
presence of ATc. A close examination of these parasites revealed abnormal stunted 
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Fig 4.11: In vivo growth phenotype of the RAP1 and RAP2 knockdown 
parasites.
A. Growth curves of wildtype (WT) and RAP1iKD parasites with/without ATc in 
Balb/C mice (n = 5). Error bars represent ± SEM. A two-tailed Student’s t-test 
was used to calculate statistical significance. *P<0.05; **P<0.01, ***P<0.001
B. Growth curves of RAP2iKD parasites with/without ATc in BalbC mice (n = 5).
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Fig 4.12: Loss of RAP1 leads to altered growth phenotypes in vitro.
A. In vitro growth analysis of PbRAP1iKD Cycle-I parasites with/without ATc, in 
which invasion had been synchronized in vitro prior to intravenous inoculation 
in mice, shows no difference between the + and –ATc groups.
B. In vitro growth analysis of PbRAP1iKD Cycle-II parasites with/without ATc 
shows a delayed growth phenotype leading to the death of ~25% of the 
knockdown population.
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Fig 4.13: Loss of RAP2 leads to altered growth phenotypes in vitro.
A. In vitro growth analysis of PbRAP2iKD Cycle-I parasites with/without ATc, 
shows no difference between the + and –ATc groups.
B. In vitro Cycle-II growth analysis of PbRAP2iKD parasites shows a similar 
delayed growth phenotype in the absence of RAP2.
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morphology, which most likely were rings or early trophozoite stage parasites with 
aborted development. This led to a loss of ~25% of these ATc treated parasite 
population by the end of Cycle-II (Fig4.12B, 4.13B). This indicated that the RAPs 
could potentially be playing an important role in parasite growth post invasion, 
affecting the viability and the duration of the asexual cycle in the knockdown
parasites.
4.2.4.5 PbRAP1 and PbRAP2 are not essential for erythrocyte invasion
As it has been previously suggested that RAP1 plays a role in RBC invasion [115],
it was important to analyse if the loss of parasite population in the knockdown 
parasites after Cycle II  was due to an invasion defect in the absence of the RAPs. 
Thus the invasion phenotype of the knockdown parasites was analysed from the 
Giemsa blood smears prepared in the above time course analysis for both Cycle I 
and Cycle II parasites, which did not reveal any difference in the levels of invasion 
in the two transgenic RAP1 and RAP2 knockdown lines with/without ATc. This 
observation is in accordance what has been previously reported where the 
'¨RAP1 line was able to invade RBCs in vitro [129].
To validate this further, in vitro invasion assays were performed using two-colour
flow cytometric analysis. For this, purified merozoite preparations of each of the 
RAP knockdown lines grown in the presence or absence of ATc were stained with 
a DNA dye Hoechst 33342 (Invitrogen, Paisley, UK). Donor RBCs harvested from 
an uninfected Balb/C mouse were stained with the amine-reactive fluorescent dye 
7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) succinimidyl ester 
(DDAO-SE) (Invitrogen, Paisley, UK). The two populations (parasites and RBCs)
were mixed and invasion allowed to occur. In the FACs analysis, the double 
positive cells, which are indicative of new invasion events, were gated and 
expressed as a percentage of donor RBC (Fig 4.14). The FACs data confirmed that 
there was no difference in the invasion efficiency in the absence of RAP1 and RAP2 
(Fig 4.15A, B and C), suggesting that the RAPs are not involved in host cell 
invasion by the Plasmodium parasites.
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Fig 4.14: FACS gating strategy to determine new P.berghei invasion events.
A. FACs plot showing gating of the RBC population for the invasion assay.
B. Only singlet RBCS from (A) were gated and analysed further.
C. FACS plot showing schizonts stained only for the nuclei stain Hoechst.
D. FACs plots showing the donor RBC stained only for the amine-reactive 
fluorescent dye DDAO.
E. FACs plots showing the newly invaded ring population, which stain positive 
for both Hoechst and DDAO. 
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Fig 4.15: PbRAP1 and PbRAP2 are not essential for erythrocyte invasion.
A. Representative FACS plots showing similar invasion efficiency in both 
PbRAP1-ATc and PbRAP1+ATc.
B,C. FACs analysis shows that the efficiency of invasion is not affected by the
absence of either RAP1 or RAP2 (error bars represent ± SEM from three 
independent experiments).
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4.2.4.6 Electron microscopic analysis of RAP1 and RAP2 knockdown parasites 
reveals a defect in PVM formation 
To further understand the defect in growth in parasites with depleted RAP1 and 
RAP2 expression, ultrastructural studies were conducted on the trophozoite stages 
of the PbRAP1iKD and PbRAP2iKD parasites by TEM. This analysis revealed that 
both RAP1/RAP2 knockdown parasites displayed a defect in PVM formation, with 
the integrity of the PVM affected and PVM extensions observed into the host 
cytosol. Typically, the PVM of Plasmodium parasites exhibit a continuous “round” 
or “amoeboid” shape during the trophozoite stage of the parasite development
[190]. In contrast, RAP1/2 knockdown parasites displayed fragmented (and 
discontinuous) PVM around the parasite. In addition, presence of unusual blobs 
and extensions were observed in the host RBC outside the PVM (Fig. 4.15) in RBCs
infected with the RAP1/2 knockdown parasites. It is possible that the formation or 
stability of the PVM may have been impaired in the absence of RAP1 and RAP2,
resulting in unusual structures observed in the knockdown parasites.
4.3 DISCUSSION 
The rhoptry organelle of Plasmodium has been implicated to play an essential role 
in host cell invasion [182] and many studies over the years have attempted to 
elucidate the role of rhoptry proteins in this process. While advances have been 
made in understanding the role of rhoptry neck proteins in tight junction formation, 
relatively little is known about the function of the rhoptry bulb proteins, which are 
unique to Plasmodium species.  In this study, attempts were made to gain further 
functional insights into one of the abundant rhoptry bulb complexes- the RAP 
complex of the malarial parasite, by reverse genetic approaches.  
As the genes encoding PbRAP1 (Chapter 3) and PbRAP2 [130] were shown to be 
refractory to genetic ablation via conventional knockout strategies, an ATc 
conditional gene knockdown approach was utilised to expand on the present 
understanding on the potential roles of the RAPs. While the majority of schizonts 
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Fig 4.16: RAP1 and RAP2 knockdown parasites reveal a defect in PVM 
formation.
Representative TEM images of RAP1 and RAP2 knockdown parasites (+ATc)
displaying fragmented (and discontinuous) PVM around the parasite along with the
presence of unusual blobs and extensions in the host RBC outside the PVM
compared to the PbWT + ATc control.
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appeared to be depleted of RAP1/RAP2 protein expression when treated with ATc, 
a proportion of schizonts were still able to express RAP1 or RAP2 to levels similar 
to that of wild type schizonts. A previous study that attempted to conditionally 
regulate  AMA1 using the dimerizable Cre recombinase in 3ࣟIDOFLSDUXP [191],
showed that in cases where AMA1 was still expressed in the conditional knockout, 
it was evenly distributed to all the individual merozoites. Indeed, our IFA data were 
consistent with this in that merozoites within a schizont displayed an even labelling 
of PbRAP1 and PbRAP2 antibodies, irrespective of their labelling intensity. The 
level of gene knockdown as analysed by qRTPCR, showed a 3.7-fold down 
regulation of RAP1 and 2.4 fold down regulation of RAP2 gene expressions 
compared to their –ATc counterparts.
Knockdown of both PbRAP1 and PbRAP2 did not show any effect on host cell 
invasion and parasite replication which is consistent with the P. falciparum 
'¨RAP1 parasites, which showed no consequential effect of RAP1 knockout on 
the blood stage development and host cell invasion [129].  However, knockdown 
of RAP1 did affect trafficking of RAP2 to the rhoptries as evident from the loss of 
punctate RAP2 staining in the +ATc RAP1iKD parasites. This observation is not 
surprising as it has been established before that RAP1 is responsible for trafficking 
of the RAPs to the rhoptries and thus absence of RAP1 might impact on RAP2 
(even RAP3) trafficking [129, 131]. Lack of RAP2 trafficking to the rhoptries with 
its subsequent localisation in the endoplasmic reticulum was also observed in the
'¨RAP1 knockout parasites [129]. Nevertheless trafficking and localisation of 
the other apical proteins were unaffected by the absence of both RAP1 and RAP2, 
indicating that the RAP complex is not responsible for the trafficking of other 
proteins to the rhoptry. We further analysed the rhoptry formation in the 
knockdown parasites by TEM but this analysis did not reveal any differences in the 
electron density or gross ultrastructure of the rhoptries in the knockdown parasites.
This concurs with previous studies [129], which suggests that the RAP complex is 
not essential for defining the rhoptry morphology in Plasmodium.
Interestingly, RAP1 and RAP2 knockdown lines grown in the presence of ATc grew 
significantly slower in vivo compared to those grown in the absence of ATc. In an 
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attempt to dissect this growth phenotype further, parasite growth was monitored 
more closely in vitro using a synchronous infection, which allowed us to look into 
the later stages of parasite growth, which normally sequester in the mice 
microvasculature. Parasites were harvested after either one round (Cycle I) or two 
rounds of invasion (Cycle II) in the mice and then and cultured in vitro in the 
presence/absence of ATc. For both lines, similar growth kinetics were observed for 
the Cycle I parasites. However, when the parasites were allowed two rounds of 
invasion in vivo (Cycle II) and then cultured in vitro, ~25% of the parasites at 
trophozoite stage appeared abnormal. These abnormal trophozoite parasites 
showed stunted growth and shrinked cytoplasm and a noticeable increased intensity 
of Giemsa-staining, whereas the –ATc parasites on the other hand produced normal 
healthy parasites at this stage. As a consequence one fourth of the parasite 
population grown in the presence of ATc did not make it to the mature schizont 
stage. 
To further understand this attenuated growth of the parasites post-invasion in the 
absence of RAP1 and RAP2, structural studies were conducted on the trophozoite 
stage of the RAP1/2 knockdown parasites using TEM. TEM analysis showed that 
both RAP1/RAP2 knockdown parasites revealed alterations to the morphology of 
the PVM. Given that RAP1 is peripherally associated with the PVM post-invasion 
(Chapter 3), it is interesting that the absence of RAP1 led to changes to the PVM 
and a resulting growth delay during the ring to trophozoite transition. Typically, the 
PVM of the wild type P.berghei parasites exhibit a continuous “round” or 
“amoeboid” shape during the trophozoite stage of the parasite development. In 
contrast, RAP1/2 knockdown parasites displayed fragmented (and discontinuous) 
PVM around the parasite, with the appearance of unusual blobs and extensions in 
the host RBC. This suggests that the RAPs could potentially contribute to the 
structural integrity of the PVM, absence of which results in unusual structures 
observed in the knockdown parasites. As the PVM is usually formed from the host 
erythrocyte membrane during invasion [42], it is not surprising that the PVM can 
still form even in the knockdown parasites. An earlier study has shown that RAP1
gets secreted from the rhoptries through the eye of the tight junction formed during 
invasion and into the host erythrocyte as a whorl-like structures ,following which 
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these vesicular structures spread through the erythrocyte cytosol [45]. The events 
that happen downstream of this are not known, but if these whorls are recruited and 
fuse to the PVM, this may provide a mechanism for RAP1 to become associated 
with the PVM. This may also explain why in the absence of RAP1 these abnormal 
blobs and extensions are observed in the host RBC. 
Thus the RAPs could potentially be involved in maintaining the integrity of the 
PVM, which separates the parasite environment from that of the host, to help 
maintain the dynamic changes that occur as the PVM expands to support the 
growing parasite. Alternatively, the RAPs could be involved in transport of 
nutrients/wastes across the PVM and when this is impaired, the growth of the 
parasites are stalled. In Toxoplasma, ROPs are localised towards the host cytosolic 
side of the PVM, acting as a scaffold, aiding in communication with the host and 
subverting host cell function [161, 192, 193]. However, since Plasmodium and 
Toxoplasma reside within different types of host cells (anucleated red blood cells 
and nucleated cells, respectively), it will be interesting to validate whether the 
RAPs similarly localise to the host cytosolic side of the PVM, and determining
what proteins the RAPs interact with at the PVM, may shed some light on the 
function of these proteins post invasion.
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To determine the role of ROP 
proteolytic processing in rhoptry 
trafficking
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5.1 INTRODUCTION 
It has previously been hypothesised that the sorting of Plasmodium rhoptry cargo 
occurs within the Golgi via a clustering mechanism involving the aggregation of
rhoptry proteins into distinct sub-domains [131]. This was based on studies on    
RAMA, a Glycosylphosphatidylinositol (GPI) anchored protein present in lipid 
rafts at the Golgi exit face, which was shown to complex with RAP1 (and thus 
presumably RAP2 and RAP3) [131]. It has been suggested that regions of the Golgi 
membrane containing RAMA bud off as individual vesicles and traffic to the 
rhoptries, whereupon on their arrival, the RAMA-ROP complex dissociates [131] .
What mediates this disassembly is unknown, however, it is plausible that 
proteolytic processing is involved. RAP1/p82 has previously been shown to be 
processed by SUB1 [194] to generate RAP1/p67 (Fig 1.6). However, the identity 
of the protease that is responsible for the cleavage of p86 to p82 is not known, nor 
is it known whether this cleavage event plays a role in dissociation of the RAP 
complex from RAMA or is required to trigger SUB1 cleavage. Interestingly, a 
putative cleavage site (D/E)SFL*(Q/E) (* indicates cleavage site) is present both at 
the N terminus of RAP1 and within RAMA [131], and RAMA has also been shown 
to be processed by a protease [94]. Thus, the presence of this putative cleavage site 
in both RAP1 and RAMA suggests that a single protease may be responsible for 
dissociation of the RAMA-RAP complex at the rhoptry. The aim of this chapter, 
therefore, was to determine if RAP1 is processed at this potential cleavage site, 
what the timing of this processing is relative to when RAP is delivered to the 
rhoptry body and to ultimately probe the significance of this cleavage in rhoptry 
protein trafficking.
5.2 RESULTS  
5.2.1 RAP1 DPAP3 cleavage site mutation 
In order to unravel the significance of this RAP1 putative cleavage event at 
68ESFL*E72, attempts were made to generate a ‘cleavage’ mutant of RAP1 in P.
falciparum. This involved the creation of a targeting construct, termed pRAP1_c-
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Myc_HA_DD_MUT, which harbours the RAP1 coding sequence with a modified 
cleavage site (68EAAAE72). So as to locate the timing and site of RAP1 cleavage, 
and to distinguish this cleavage event from the cleavage of the signal sequence, the 
RAP1 sequence in this vector incorporated a 2 x c-Myc tag downstream of the RAP1
signal sequence cleavage site (at position D21) as indicated in Fig 5.1. This was 
undertaken by designing oligonucleotide primers (398F and 399R) that span the 
entire length of 2 x c-Myc tag with a SpeI overhang at the 5' end and a BglII
overhang at the 3' end and annealing them together. The resulting c-Myc annealed 
oligonucleotide fragment was cloned into the corresponding sites of a P. falciparum 
DNA sequence that had been amplified with 490F and 397R and which included 
the RAP1 5' UTR and the first 63 bp of the RAP1 coding sequence (which includes 
the signal sequence and the first three amino acids downstream of the signal 
peptidase cleavage site). The entire sequence was then cloned into the NotI/BglII
sites of the vector pPTEX88-HA/DD24, which had been previously derived from 
RESA-GFP-HA-DD24[195] (S.Chisholm, unpublished), thereby replacing the 
PTEX88 coding sequence (CDS) (Fig 5.1). To confirm that the RAP1 targeting 
sequence has been successfully cloned, a PCR screen was performed, followed by 
analytical restriction digestion screen of the positive clones (data not shown). This 
intermediate construct was termed pRAP15' UTR-HA/DD24. The RAP1 CDS
(~2kb) minus the signal sequence was then PCR amplified from P. falciparum 
using oligonucleotides 531F/532R and cloned into the BglII/PstI site of 
pRAP15’UTR-HA/DD24 to generate the final targeting construct pRAP1_c-
Myc_HA_DD_WT. Analytical restriction digestion and sequencing was used to 
confirm the correct construct have been generated (data not shown).
The RAP1 CDS was also cloned into the pTOPO vector (Invitrogen) to facilitate
site directed mutagenesis using the QuikChange II XL Site-Directed Mutagenesis 
Kit (Agilent Technologies). Specifically, the RAP1 N terminus putative cleavage 
site ESFLE (aa 68-71) was mutated by Alanine replacement to EAAAE using the
oligonucleotides 443F/444R to incorporate the above mutations (Fig 5.1). Presence 
of the desired mutation was confirmed by sequencing. The RAP1 CDS harbouring 
the cleavage site mutation was then digested with BglII/PstI and cloned into 
corresponding site of the intermediate vector pRAP15' UTR-HA/DD24 to generate 
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Fig 5.1: Cloning strategy utilised to create a RAP1 cleavage targeting 
construct.
Schematic representation of the cloning strategy, including oligonucleotides used 
to amplify the respective fragments, the intermediate cloning vectors and the final
RAP1 targeting construct containing either a wildtype (WT) or mutated putative 
cleavage site.
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the targeting construct pRAP1_c-Myc_HA_DD_MUT, which was analysed by 
restriction digestion screen to confirm the correct construct has been obtained.
Both the pRAP1_c-Myc_HA_DD_WT and pRAP1_c-Myc_HA_DD_MUT
constructs were independently transfected into P. falciparum and parasites were 
cultured in the presence of WR99210 to select for transfectants. It was anticipated 
that the presence of the RAP1 targeting sequence would either ultimately drive 
integration into the endogenous RAP1 locus (which could potentially be lethal if 
this processing event is essential) or the constructs would replicate as episomes. In 
either case, viable parasites would express a C-terminally tagged RAP1 since the 
RAP1 5' UTR was present in the targeting construct. By inserting the c-Myc tag 
after the signal sequence but before the putative cleavage site and HA tags at the 
C-terminus, this would enable assessment of RAP1 cleavage by Western blot using 
anti-c-Myc and anti-HA antibodies. Hence, loss of reactivity to the c-Myc antibody 
but not HA antibody would be indicative of a cleavage event, the timing of which 
could be subsequently investigated (Fig 5.2).  In case this putative cleavage event 
is essential to the parasite, conditional expression of the cleavage mutant was
achieved via addition of the stabilizing ligand, Shld-1, to stabilize the fusion protein 
and prevent its degradation by the proteasome (Fig 5.2). This would enable 
monitoring the downstream effect of the lack of the cleavage event on RAP1
maturation and trafficking, rhoptry formation, parasite growth and invasion.
Unfortunately, transfection of P. falciparum with pRAP1_c-Myc_HA_DD_MUT
or the control construct pRAP1_c-Myc_HA_DD_WT did not yield any viable 
parasites after 24 weeks of drug selection. While integration of the targeting 
construct into the RAP1 endogenous locus could have occurred and in the case of 
the cleavage mutant, be lethal to the parasite, integration of the control construct 
should not have affected parasite viability unless the RAP1 CDS could not tolerate 
fusion to the c-Myc or HA-DD tags at the N and C-terminus of the protein, 
respectively. Since mutation of this cleavage site was not possible, an alternative 
approach was used to seek the significance of proteolytic cleavage of rhoptry bulb 
proteins.
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Fig 5.2: Schematic showing strategy to determine the timing and significance 
of putative RAP1cleavage site ESFLE (aa 68-71).
Schematic showing RAP1 proteolytic maturation and strategy to differentiate 
between parasites containing wildtype and mutated RAP cleavage site by Western 
blot analysis, eventually detecting the timing and significance of cleavage event in 
the parasite. Regulation of RAP1 expression using a Shield1 inducible degradation 
domain is also illustrated.
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5.2.2 Search for proteases involved in the processing of ROPs 
To gain insight into the significance of potential proteolytic processing of the 
rhoptry bulb proteins, instead a search to look for proteases that could be involved 
in the processing of the ROPs was performed. Bioinformatics and proteomic 
analysis predicts that the rhoptry proteins are putative substrates of the cysteine 
protease dipeptidyl aminopeptidase 3 (DPAP3)[196] and/or subtilisin 1 
(SUB1)[194]. DPAP3 is transcribed at the same time as that of the ROPs [197] and 
inhibition of DPAP3 results in a delay in schizont maturation [198]. In studies 
performed by Arastu-Kapur et al [198], the DPAP3 specific inhibitor SAKI 
appeared to affect SUB1 maturation and SERA5 processing. SUB1 is a protease 
that is involved in RAP1 cleavage from the 82 kDa form to the 67 kDa form, whilst 
SERA is involved in the breakdown of the PV, which is required for parasite egress. 
Inhibition of DPAP3 also blocked the production of the microneme protein AMA1. 
Proteomic analysis has revealed that 64 % of the proteolytic events leading to 
egress occur downstream of DPAP3 activation [196]. Accordingly, it has been 
hypothesised that DPAP3 sits on top of the proteolytic cascade that ultimately leads
to the maturation / activation of the cytoskeleton-degrading malarial proteases or 
the pore forming proteins leading to parasite egress. As proteolytic processing of 
RAP1 involves removal of peptides from the amino terminus end of the peptide 
similar to the mode of action of the aminopeptidases to which DPAP3 belongs, we 
hypothesised that DPAP3 could be a candidate protease to process the ROPs. 
Consequently, attempts were made to knockdown DPAP3 expression in P. 
falciparum to test whether DPAP3 is involved in the processing of the ROPs. If this 
were to be the case, this would also enable examination of the significance of the 
ROP proteolytic processing in rhoptry protein trafficking and rhoptry formation. 
Indeed these studies would also substantiate the role of DPAP3 in parasite egress 
and validate that the inhibitors are specific. 
5.2.3 Characterisation of DPAP3 in the erythrocytic stages  
To validate if DPAP3 is expressed at the same time as that of the ROPs and to 
determine its localisation in the parasite during this time, attempts were first made 
to characterise PfDPAP3 in the erythrocytic stages of P. falciparum. As antibodies 
to DPAP3 are not available, a triple hemagglutinin (3XHA) tag was fused to the C-
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terminal end of DPAP3, which would enable detection of DPAP3 with anti-HA
antibodies. In addition, a ribozyme sequence was also integrated into the DPAP3 
locus so that DPAP3 expression could be regulated by the addition of glucosamine 
(GlcN) to the culture media (Fig 5.3A). Thus by depleting DPAP3 levels, it could 
be determined if this alters ROP proteolytic processing and trafficking. This 
approach was taken because it was reasoned that a conventional knockout of 
DPAP3 would be lethal to P. falciparum considering the haploid nature of its
genome and the lethal effect DPAP3 inhibitors have on the parasite. To achieve 
this, a targeting construct termed pDPAP3iKD was generated and transfected in P. 
falciparum 3D7. This construct was adapted from pPTEX150-HA-glmS [189];
specifically the last kilobase (kb) of the DPAP3 coding sequence (amplified with 
394F and 395R) was cloned in place of the PTEX150 coding sequence in the 
BglII/PstI sites of pPTEX150-HA-glmS. Validation that the DPAP3 sequence had 
been cloned was obtained by a PCR screen, analytical restriction digestion of the 
positive clones and sequencing (data not shown). As the targeting construct lacks a 
promoter, only correct insertion of the targeting construct pDPAP3iKD into the 
endogenous DPAP3 locus would lead to the expression of HA.
Following parasite transfection and three rounds of cycling in the presence and 
absence of WR99210 to select for integrants, PCR was used to verify integration 
had indeed occurred. The analytical PCR revealed correct integration of the 
targeting construct into the endogenous DPAP3 locus (Fig 5.3B). The parasite 
population was then cloned out and successful HA tagging of endogenous DPAP3
of seven individual clones was confirmed at the protein level by Western Blot 
analysis using anti-HA antibodies and EXP2 antibodies as a loading control (Fig
5.3C). HA was expressed by all the clones, indicating DPAP3 had been 
successfully epitope tagged in all cases, and hence clone 1 and clone 2 were chosen 
for further analysis.
5.2.4 Expression of PfDPAP3 in the erythrocytic stages 
With the PfDPAP3-HA-glmS parasites in hand, it was now possible to characterise 
DPAP3 in P. falciparum for the first time. Firstly, the expression pattern of 
PfDPAP3 protein was examined by performing Western blot and
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immunofluorescence analysis on parasite lysates harvested from various stages of 
synchronised parasites and probing with mouse anti-HA antibody. These results 
indicate that DPAP3 is expressed late in the schizont stage of the parasite lifecycle 
and in free merozoites as well (Fig 5.4A, B). DPAP3 was also released into the 
culture supernatant after parasite egress from the host erythrocyte (Fig 5.4A). In 
these parasite stages the anti-HA antibody consistently recognized a predominant 
protein band of apparent molecular mass of 120 kDa (p120), and in some western 
blots, an additional band of apparent mass of 90 kDa (p90) was also observed (Fig 
5.4A). No bands were observed in parental 3D7 parasites with the anti-HA antibody 
as expected. As the predicted molecular mass of DPAP3 after signal sequence 
cleavage is 111.8 kDa, the p120 band most likely represents full-length PfDPAP3 
as it common for Plasmodium proteins to run at higher molecular masses. Whether 
the p90 is a product of proteolytic cleavage of the full-length protein (p120) remains 
to be ascertained (Fig 5.4A).
5.2.5 Localisation and trafficking of PfDPAP3 in the erythrocytic stages 
IFA analysis with anti-HA antibodies was also performed to determine the 
localisation of PfDPAP3 in P. falciparum-infected erythrocytes. The results show 
a strong punctate pattern in the schizont stages, characteristic of apical localisation. 
It is interesting to note here that no transient localisation of DPAP3, characteristic 
of protein trafficking, was observed for PfDPAP3, and when it was first apparent 
in the schizont stage, it already localised to discrete foci (Fig 5.5). In an attempt to 
localise DPAP3 to a specific apical compartment, co-localisation studies were 
performed with rhoptry bulb markers (RAMA, RAP1 and RhopH3), a rhoptry neck 
marker (RON4), a microneme marker (AMA1) and a dense granule marker 
(RESA). DPAP3 showed partial colocalisation with both rhoptry and microneme 
markers, but no colocalisation with the dense granule marker RESA (Fig 5.4 and 
5.5). This indicates that DPAP3 may not be housed in any of these three 
Plasmodium apical organelles, but potentially in secretory vesicles in close
proximity to the rhoptries and micronemes. To verify this localisation, the 
localisation of DPAP3 was further investigated with the help of Stuart Ralph and 
Kit Kennedy from Bio21 Institute by immuno-electron microscopy using the anti-
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Fig 5.3: Creation of epitope tagged PfDPAP3 parasite line in which DPAP3
can be conditionally regulated.
A. Overview of the glmS riboswitch system used to epitope tag as well as knock 
down DPAP3 in P. falciparum. The endogenous DPAP3 locus was modified 
to incorporate a C-terminal hemagglutinin (HA) tag followed by the P. 
berghei DHFR-TS 3' untranslated region (3' UTR) that incorporated the 
ribozyme. In the absence of glucosamine (GlcN), translation proceeds as 
normal. However addition of GlcN activates the ribozyme, leading to 
cleavage and subsequent degradation of the mRNA molecule. SM, selectable 
marker. The position of oligonucleotides (denoted a-f) used for diagnostic 
PCRs is indicated. 
B, C. PCR and Western blot analysis confirmed correct integration of the targeting 
construct into the DPAP3 locus.
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Fig 5.4: Expression of PfDPAP3 in erythrocytic stages of P. falciparum.
A. Western blot analysis showing DPAP3 is expressed very late in the parasite 
lifecycle. The 120 KDa band indicated by a red arrowhead, represents full-
length protein, but a band of lower molecular weight around 90kDa (as 
indicated by black arrowhead) was also often observed.
B. IFA analysis with anti-HA antibody shows that DPAP3 is only expressed late 
at the schizont stage, where it shows only a partial co-localisation with the 
rhoptry protein RAMA.
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HA antibody. Whilst no staining was observed in wildtype parasites (data not 
shown), DPAP3 was observed at multiple locations in the parasites, including 
towards the periphery of rhoptry bulb and neck, the micronemes and also the PVM 
(Fig 5.6). Although the HA labelling seen in the immuno EM was not contained in 
membranous structures indicative of secretory vesicles, this is not surprising as 
typically the immuno-EM process does not preserve membranes very well.
Thus the expression and localisation of PfDPAP3 is consistent with DPAP3 playing 
a putative role in the processing of rhoptry proteins and, therefore, the potential 
effect on the processing and trafficking of the rhoptry proteins upon depletion of 
DPAP3 expression was explored.
5.2.6 Conditional regulation of PfDPAP3 
The insertion of the targeting construct pDPAP3iKD into the endogenous DPAP3
locus (Fig 5.3A) also led to the replacement of its 3' UTR with that of P. berghei 
DHFR-TS containing the glucosamine (GlcN) inducible glmS ribozyme (from 
Gram-positive bacteria) [199]. Accordingly, this transgenic line would express a 
chimeric DPAP3 mRNA that incorporated the ribozyme RNA within the 3' UTR 
region. With this system, the degree of ribozyme self-cleavage of the chimeric 
mRNA, and thus the level of gene knockdown can be controlled by the 
concentration of Glucosamine (GlcN) added to the parasite culture medium (Fig 
5.3A).
To next investigate if DPAP3 expression could be regulated in response to GlcN, 
two clonal lines (Clone1 and 2) of PfDPAP3-HAglmS parasites were synchronized 
and cultured in the presence or absence of GlcN (added during the late ring stage).
Proteins samples were prepared from late schizont cultures within the same (Cycle 
1) or the following replication cycle (Cycle 2) for Western blot analysis using anti-
HA antibodies. Addition of GlcN to the transgenic parasite line led to dose 
dependant PfDPAP3-HA protein expression both in Cycle 1 and Cycle 2 parasites 
(Fig 5.7A). Cycle 1 parasites showed 91% knockdown of DPAP3 protein 
expression in the presence of 2.5 mM GlcN compared to the untreated control (Fig
5.7B and 5.7C). The level of knockdown was 74% when examined after the next 
round of invasion (Cycle 2) (Fig5.7B). The GlcN response of Clone 1 was not 
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Fig 5.5: Localisation of PfDPAP3-HA with respect to the other apical 
organelle markers.
IFA images showing DPAP3-HA partially co-localises with the rhoptry bulb 
(RAP1, RAMA and RhopH3), rhoptry neck (RON4) and microneme marker 
(AMA1). DPAP3 shows no colocalisation with the dense granule marker RESA.
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Fig 5.6: DPAP3 localises to multiple regions in P. falciparum.
Immuno-electron microscopy with anti-HA antibody shows labelling for DPAP3
(as indicated by the arrowheads) in a mature schizont within the rhoptry bulb (RB),
rhoptry neck (RN), micronemes (M) as well as at the PV/parasitophorous vacuole
membrane (PVM).
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Fig 5.7: Conditional regulation of PfDPAP3-HAglmS with glucosamine.
A. Western blot analysis showing dose dependant PfDPAP3-HA protein 
expression in Cycle 1 after treatment with glucosamine (GlcN) for one (upper 
panel) or two (low panel) cell cycles.
B. Western blot analysis of Clone 1 PfDPAP3-HAglmS parasites showing DPAP3 
knockdown after one or two cycles in the presence of glucosamine. 
C. Densitometry of PfDPAP3 expression levels in Clone 1 PfDPAP3-HAglmS 
parasites grown in the presence or absence of glucosamine for one cycle 
revealed DPAP3 expression levels were knocked down by 91% (error bars 
represent ± SEM from three independent experiments). 
D. Immunofluorescence analysis showing DPAP3-HA expression is significantly 
reduced within 24 hrs after addition of GlcN (Cycle 1).
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significantly different from Clone 2 (Fig 5.7A), hence all further analyses were 
performed on PfDPAP3-HAglmS Clone 1 parasites. DPAP3 knockdown at the 
protein level could also be observed in IFAs, where the +GlcN parasite schizonts 
only showed a faint HA labelling compared to the bright punctate HA labelling 
observed in the –GlcN schizonts (Fig 5.7D).
5.2.7 Growth and survival of the DPAP3 knockdown parasites 
Since DPAP3 is expressed at substantially lower levels in the PfDPAP3-HAglmS
parasite line when grown in the presence of GlcN, it was next investigated whether 
these parasites had any detectable changes in growth. Accordingly, the growth of 
ring-stage PfDPAP3-HAglmS parasites at a 0.3% starting parasitaemia was
followed for two intra-erythrocytic cell cycles (approx. 96 hrs) when cultured in 
the presence or absence of GlcN. The parasitaemias were determined by observing 
Giemsa stained blood smears, particularly around the point when invasion was 
expected to occur (Fig 5.8A). The most obvious trend to emerge from the time 
course is that the majority of the PfDPAP3-HAglmS parasites grown in the 
presence of GlcN stalled at the schizont stage at the end of Cycle 1, whereas the –
GlcN parasites continued to egress and begin the next round of invasion. 
Intriguingly, during this time the PfDPAP3-HAglmS + GlcN schizonts appeared to 
struggle to mature and egress for a period of 4-6 hrs, but once they did invade, 
normal growth was observed in Cycle 2, although a delay in schizont maturation 
was again apparent (Fig 5.8B). However, the fold-increase in parasitaemia from 
one cycle to the next was markedly reduced when DPAP3 was knocked down, 
leading to the loss of about 30% of the parasite population in the transition to Cycle 
2 and which cumulated to almost 45% of parasite death in the transition to Cycle 3 
(Fig 5.8A). Malstat assays (n=3) for detection of lactate dehydrogenase (LDH)
were also performed at trophozoite stage in Cycle 2 to analyse parasite growth and 
vitality (indicated in Fig 5.8A). This revealed that the PfLDH levels were reduced 
by 26% compared to the untreated line, which corroborated the growth analysis 
performed by microscopy (Fig 5.8C).
Chapter 5
139
5.2.8 The DPAP3 knockdown parasites showed abnormal and /or delayed 
schizont maturation  
To further pinpoint when the parasites were actually stalling, the parasite 
morphology was carefully monitored by analysing the Giemsa stain smears from 
the growth assay experiment described above. The parasites grown without GlcN 
appeared to exhibit normal development for all the cell cycle stages, whilst 50% of 
the knockdown population showed abnormal schizont morphology (Fig 5.9A). In 
some cases, it was difficult to predict whether DPAP3 knockdown was causing an 
arrest in schizogony or whether some of the schizonts were still immature. The 
same effect was also seen in the next intra-erythrocytic growth cycle, where ~ 20%
of the schizonts showed abnormal development.  The reduced affect in Cycle 2 
compared to Cycle 1 is consistent with a lower level of protein knockdown in Cycle 
2 (Fig 5. 7B). 
To determine whether the invasion phenotype exhibited by the DPAP3 knockdown 
parasites grown in the presence of GlcN was due to an invasion defect per se or 
attributable to the number of merozoites formed per schizonts, the latter was
quantified. This revealed that the DPAP3 knockdown parasites grown in the 
presence of GlcN had 25% less merozoites per schizonts than untreated parasites
(Fig 5.9C). To investigate this defect further, IFA of mature parasite schizonts was 
performed using anti-MSP1 antibodies to label the surrounding membrane of the 
individual merozoites and DAPI staining to view the individual nuclei While
parasites grown in the absence of GlcN showed segmented individual merozoites,
those grown in the presence of GlcN showed a mixture of well-segmented 
schizonts, along with a significant population (~60%),which failed to show 
individual nuclei well separated with MSP1-labelled membrane (Fig 5.9B). This 
indicates that knocking down DPAP3 leads to a delay in merozoite segmentation, 
consistent with the delayed growth phenotype, which could explain why parasites 
depleted of DPAP3 either failed or were delayed in their ability to egress and 
invade.
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Fig 5.8: Growth and survival of the DPAP3 knockdown parasites.
A. PfDPAP3-HAglmS parasite growth was followed for two intra-erythrocytic 
cell cycles (96 hrs) after culturing in the absence or presence of 2.5 mM 
glucosamine (GlcN). Graph shows cumulative date from three independent 
experiments. *P<0.05, **P<0.01, ***, P<0.001, student’s paired t-test, E1 and 
E2 indicates time points around egress after cycle 1 (E1) and cycle 2 (E2).
B. Representative growth assay graph showing PfDPAP3-HAglmS parasites 
grown in the presence of GlcN stalled at the schizont stage in Cycle 1. E 
indicates the point at which >50% of schizonts grown in the absence of GlcN 
had ruptured.
C. Malstat assay for detection of lactate dehydrogenase (LDH) showing 26% 
reduction of the knockdown parasite population after 24 hrs of GlcN treatment. 
***, P<0.001, student’s paired t-test, error bars represent ± SEM from three 
independent experiments. The time point for Malstat assay sample harvest is 
indicated in (A).
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Fig 5.9: DPAP3 depletion leads to abnormal and/or delayed schizont 
maturation.
A. Microscopic analysis of the schizonts from DPAP3KD parasites grown in the 
presence of GlcN showed abnormal schizont morphology or delayed schizont 
maturation.
B. IFA of mature parasite schizonts grown in the presence of GlcN showed the 
presence of both normal (~40%) & non-segmented schizonts (~60%), the latter 
of which failed to show clearly defined individual nuclei separated by MSP1
labelling.
C. The number of merozoites in the DPAP3 knockdown parasites grown in the 
presence of GlcN showed 25% reduction in the number of merozoites formed 
per schizont. ***, P<0.001, student’s paired t-test, error bars represent ± SEM.
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5.2.9 DPAP3 knockdown parasites have a delayed egress phenotype 
To analyse the phenotype of the knockdown parasites further, microscopic analysis 
over the 48 h P. falciparum blood-stage asexual cycle was performed on tightly 
synchronised (~ 4hr window) parasites grown in the presence or absence of GlcN, 
and the parasites were closely monitored around parasite egress (Fig. 5.10). Egress 
(E) was determined when >50% of schizonts grown in the absence of GlcN had 
egressed and reinvaded to form rings. The number of schizonts around point E were 
quantified both by microscopic observation of Giemsa-stained blood smears and 
by FACS analysis. By microscopy, schizonts were observed at E-4, irrespective of 
whether they were grown in +/- GlcN. Four hours later, 47% of –GlcN schizonts 
egressed at time point E, compared to 24% in the +GlcN parasites.  Whilst new 
rings were observed at this time point even in the cultures grown in the presence of 
GlcN, the numbers of rings in the +GlcN cultures were 3 fold lower compared to 
the -GlcN cultures. By the E+4 time point, 90% of -GlcN schizonts had reinvaded 
to form rings, however in the +GlcN culture, more than 60% of the population still
appeared to stall at the late schizont stage, showing only 2 fold rise in the new ring 
population, compared to nearly 11 fold rise in the –GlcN parasites (Fig 5.10A).
Similar results were seen by FACS analysis (Fig 5.10B), which also showed a 
delayed egress phenotype in the knockdown parasites. The schizont to ring ratio 
was also analysed in both the cases which showed that, one schizont from the –
GlcN parasites gave an average of 7-8 rings in the next erythrocytic cycle, 
compared to only 5 rings in the + GlcN parasites. This could be a result of the 
reduced number of merozoites formed per schizonts as observed in the knockdown 
parasites, giving rise to less number of parasite rings in the following erythrocytic 
cycle, or could be a result of a reduced invasion, which could have resulted from 
the absence of DPAP3. Thus in the future it will be absolutely essential to carry out 
invasion assays to specifically quantitate the level of invasion in the knockdown 
parasites compared to the control. However, since DPAP3 knockdown also affected 
the schizont maturation, as observed by the abnormal schizont morphology coupled 
with the reduced merozoite numbers, it appears that this temporary block in the 
egress phenotype would have occurred before schizont differentiation and PVM 
rupture.
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Fig 5.10: DPAP3 knockdown parasites showed a delayed egress phenotype.
A, B. Microscopic and FACS analysis showing a delayed egress phenotype in the 
+GlcN parasites. E indicates the point at which >50% of schizonts grown in 
the absence of GlcN had ruptured. *P<0.05, **P<0.01, ***, P<0.001, 
student’s paired t-test, error bars represent ± SEM from three independent 
experiments.
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The effect of DPAP3 knockdown on the trafficking of rhoptry bulb proteins (RAP1,
RAMA, RhopH3) together with a rhoptry neck protein (RON4) were next 
investigated. IFA showed that trafficking of RAMA was unaffected in the 
knockdown parasites (Fig 5.11A), whilst the trafficking of RhopH3 and RON4 in 
some parasites failed to give the typical apical punctate appearance compared to 
the –GlcN parasites (Fig 5.12A, B). The trafficking of RAP1 was particularly 
affected in the absence of DPAP3, with a diffuse RAP1 staining in the mature 
schizonts. In contrast, bright discrete apical RAP1 puncta was observed in the –
GlcN parasites. It was noted that in those DPAP3 knockdown parasites in which 
the trafficking of rhoptry proteins was aberrant, - the DAPI staining in the 
knockdown parasites was also more diffuse, suggesting a lack of condensation 
amongst these daughter nuclei, in keeping with a delayed maturation phenotype 
(Fig 5.13A).
5.2.10 Effect of DPAP3 knockdown on the maturation and trafficking of rhoptry 
proteins 
Given that parasites depleted of DPAP3 showed a delay in schizont maturation and 
subsequent egress/invasion and DPAP3 is expressed at the same time as that of the 
Western blot analysis was performed on five separate occasions to explore the 
effect of DPAP3 knockdown on the processing of each these bulb proteins in the 
knockdown parasites. In a mature schizont, RAP1 is usually seen as four distinct 
protein species on a gel including peptides p86, p84, p70 (transient intermediate)
and final processed product p67. Densitometry analysis on these blots, using EXP2 
as a loading or normalising control, showed an accumulation of the p86 form of 
RAP1, and a 45% reduction in the formation of mature RAP1 p67 (relative to EXP2 
expression) in the knockdown parasites grown in GlcN (p = 0.0056) (Fig 5.13B,
C). For RAMA, which is processed from p170 to p60, treatment with GlcN led to 
a 17% reduction in the formation of mature RAMA p60 compared to the –GlcN 
parasites, although this level of reduction was found not to be significant (p= 0.06) 
(Fig 5.11B, C). Unfortunately, the effect of DPAP3 knockdown on the processing 
of RhopH3 could not be studied because it is not possible to differentiate between 
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Fig 5.11: Effect of DPAP3 knockdown on the processing and maturation of 
RAMA.
A. IFA showing trafficking of RAMA is unaffected in the DPAP3 knockdown 
parasites.
B. Representative Western blot analysis showing RAMA processing in unaffected 
in the DPAP3 knockdown parasites.
C. Densitometry analysis of RAMA processing: To calculate ratio of full-length 
versus processed RAMA bands, band intensity of different forms (p170 and 
p60) relative to EXP2, which showed a 17% reduction in the formation of 
mature RAMA p60 in the knockdown parasites. NS, not significant, error bars 
represent ± SEM from five independent experiments.
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Fig 5.12: Effect of DPAP3 knockdown on the trafficking of other rhoptry 
bulb and neck proteins.
A, B. IFA showing that the depletion of DPAP3 leads to a less punctate 
localisation of RhopH3 and RON4 in the mature parasite.
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Fig 5.13: Effect of DPAP3 knockdown on the processing and maturation of 
RAP1.
A. IFA showing trafficking of RAP1 is affected in the DPAP3 knockdown 
parasites.
B. Representative Western blot analysis showing RAP1 processing is affected in 
the DPAP3 knockdown parasites.
C. Densitometry analysis of RAP processing: To calculate ratio of full-length 
versus processed RAP1 bands, band intensity of different forms (p86, p82, p70 
and p67) were calculated relative to EXP2, which showed an accumulation of 
unprocessed RAP1 p86 and reduction in the formation of RAP1 p70 and mature 
RAP1 p67 in the knockdown parasites. *, P<0.05, student’s paired t-test, error 
bars represent ± SEM from five independent experiments.
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the full length (p110) and processed (p105) RhopH3 on a SDS-PAGE gel (data not 
shown).
5.2.11 DPAP3 knockdown does not show any effect on the processing of SUB1 
substrates and AMA1 
Earlier studies with the DPAP3-selective inhibitor SAK1 substantially blocked the 
production mature SUB1 p54. However, without a SUB1 antibody in hand, we 
could not confirm this observation in our knockdown line. Thus we sought to look 
into the processing and maturation of the SUB1 substrates, SERA5 and MSP1.
SAK1 previously also showed a dose-dependent accumulation of the SERA5
precursor p120 and p73 forms and complete loss of production of the p50 form in 
the ruptured media after parasite egress. Thus in this study we were interested to 
see if the DPAP3 knockdown line showed a similar effect on SERA5 processing. 
PfDPAP3-HAglmS parasites were cultured in the presence or absence of GlcN late 
schizonts and merozoite parasite proteins extracts as well as egress media were 
collected for Western blot analysis to examine SERA5 processing. No
accumulation of precursor SERA5 in the knockdown parasites was observed and 
the processed p50 was present in the ruptured media for both +/- GlcN parasites 
(Fig 5.15A). The processing of MSP1 was also unaffected in the knockdown line 
(Fig 5.15B, C).
Inhibition of DPAP3 with SAK1 also led to a complete loss of the precursor and 
intermediate forms of AMA1. Thus to further investigate the potential role of 
DPAP3 as a general maturase of secreted proteins, we examined AMA1 maturation 
in the knockdown parasites. However, no difference in the processing of AMA1
was observed upon GlcN treatment (Fig 5.14C, D). Surprisingly, however, the IFA 
showed little or no AMA1 staining in the matured DPAP3 knockdown schizonts 
compared to bright apical puncta seen in the –GlcN schizonts (Fig 5.14A).
Knockdown of DPAP3 also affected the expression and trafficking of the dense 
granule marker RESA (Fig 5.14B).
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Fig 5.14: DPAP3 knockdown and its effect on AMA1 maturation and 
trafficking of AMA1 and RESA.
A. IFA showing depletion of DPAP3 leads to little or no AMA1 staining in the 
matured DPAP3 knockdown schizonts.
B. IFA showing trafficking of RAMA is unaffected in the DPAP3 knockdown 
parasites.
C. Representative Western blot analysis showing AMA1 processing in unaffected 
in the DPAP3 knockdown parasites.
D. Densitometry analysis of AMA1 processing: To calculate ratio of full-length 
versus processed AMA1 bands, band intensity of different forms (p83 and p66) 
were calculated relative to EXP2, which showed no significant difference in 
AMA1 processing in the knockdown parasites. NS, not significant, error bars 
represent ± SEM from three independent experiments.
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Fig 5.15: DPAP3 knockdown does not affect the processing of SUB1
substrates SERA5 and MSP1.
A, B. Representative Western blot (n=3) showing no significant difference in the 
processing of SUB1 substrates SERA5 and MSP1 in the knockdown 
parasites.
C.      Densitometry analysis of MSP1 processing: To calculate ratio of full-length 
versus processed MSP1 bands, band intensity of different forms (p195 and 
p83) were calculated relative to EXP2, which showed no significant 
difference in MSP1 processing in the knockdown parasites. NS, not 
significant, error bars represent ± SEM from three independent experiments.
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5.2.12 Effect of DPAP3 knockdown on the expression of other DPAPs and SUB1 
The Plasmodium genome encodes three dipeptidyl aminopeptidase homologs. 
DPAP1 and 3 are critical for the asexual stages of the parasite life cycle, while 
DPAP2 is a gametocyte stage-specific protease. DPAP1 is an essential food vacuole 
cysteine exopeptidase [200], instrumental in haemoglobin digestion by releasing 
dipeptides from the N termini of oligopeptides produced through the action of food 
vacuole aspartyl-, cysteinyl- and metallo-endoprotease. 
Studies by Kapur et al [198] suggested that DPAP3 functions upstream of SUB1 in 
the proteolytic cascade leading to egress. This raises the question whether the 
expression levels of SUB1 and DPAP1, which are also expressed in the blood 
stages, increase to compensate for the lack of DPAP3 in the knockdown parasites. 
Reverse transcriptase quantitative PCR (RT-qPCR) was used to compare the 
transcript levels of PfSUB1, and PfDPAP1 in the PfDPAP3-HaGlms clones +/-
GlcN. The relative abundances of PfSUB1 and PfDPAP1 transcripts evaluated 
XVLQJ WKH ¨¨ WKUHVKROG F\FOH &7 PHWKRG XVLQJ WKH FRQVWLWXWLYH FRQWURO JHQH
parasite18S rRNA as the reference [201] showed a 4-fold upregulation in the 
expression of PfSUB1 in the knockdown parasites, although due to the variations 
between experiments this was found not to be significant. Expression of PfDPAP1 
remained the same. Expression of PfDPAP2 was also analysed and as expected the 
expression of PfDPAP2 remained unchanged in the knockdown parasites (Fig 
5.16).
5.3 DISCUSSION 
In addition to the cleavage of the N-terminal signal peptide in the ER, many rhoptry
proteins, including the RAPs, are synthesized with a propeptide that is removed 
during protein sorting and maturation. The significance of processing of apical 
proteins is not understood, however, it is hypothesised that this cleavage could 
contribute to the correct trafficking of rhoptry proteins, for example, by facilitating 
the release of individual rhoptry proteins from transient trafficking complexes or 
their timely secretion from the rhoptries, or to activate their effector function. In 
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Fig 5.16: Effect of DPAP3 knockdown on the expression of other DPAPs and 
SUB1.
The relative abundances of PfDPAP3 showed a 4 fold upregulation although this 
was not significant, while there was no change in the expression of PfDPAP1and 
PfDPAP3. NS, not significant, error bars represent ± SEM of three replicates from 
three independent experiments.
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the current study, we focussed on the significance of RAP1 cleavage for its 
maturation and targeting to the rhoptries and the role of DPAP3 in rhoptry protein 
trafficking and the parasite lifecycle.  As host cell invasion by Plasmodium is 
tightly regulated and relies on the discharge of the rhoptry contents, understanding 
how rhoptry proteins are delivered to this organelle and activated for effector 
function could reveal additional targets to block invasion for the therapeutic 
intervention of malaria. 
An initial attempt to mutate the RAP1 cleavage site was not successful, thus 
attempts were made to seek the significance of this cleavage by modifying the 
endogenous DPAP3 locus, a candidate protease that may be involved in the 
processing of the ROPs. Characterisation of DPAP3 by epitope tagging this protein 
revealed that it is expressed in schizonts and is present until the merozoite stage of 
the parasite lifecycle, thus coinciding with the timing of expression of the ROPs.
PfDPAP3 is consistently recognized on SDS-PAGE gels as a predominant protein 
band of apparent molecular mass of 120 kDa (p120) and appears to be secreted, as 
apparent from the detection of DPAP3 in the culture supernatant following egress 
and its multiple localisation – at the periphery of the rhoptries and the micronemes, 
as well as regions close to the PVM before invasion.
Knockdown of DPAP3 using glucosamine led to substantially lower levels of the 
protein, which resulted in a delay in schizont maturation and a slower growth 
phenotype in the knockdown parasites. The Malstat assay for detection of Pf-LDH 
also showed a reduction of 26% in the knockdown parasite population, consistent 
with lower parasitaemias during the cycle after protein knockdown. RAMA, which 
is synthesized already in trophozoite stages, was still processed and trafficked 
normally to the rhoptries in DPAP3 depleted parasites. Conversely, knockdown of 
DPAP3 affected the trafficking of RAP1, RhopH3, RON4 and AMA1 and the 
processing of the RAP1 precursor to the p67 mature protein. Thus, it appears that 
DPAP3 plays a role after RAMA is delivered to the rhoptries but prior to the correct 
delivery of these other proteins to the apical organelles. However, it is intriguing 
that RESA, which is trafficked quite late into the dense granules was not affected 
in the absence of DPAP3, which might potentially stem from dense granules having 
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a different mechanism of cargo protein trafficking to the organelle, compared to the 
rhoptry and the microneme proteins.
Earlier studies have shown that DPAP3 blocks egress by inhibiting SUB1 
maturation and SERA5 processing. Indeed, proteomic analysis revealed that 64% 
of the proteolytic events leading to egress, occur downstream of DPAP3 activation
[196]. Although we could not confirm the role of DPAP3 in SUB1 maturation due 
to unavailability of SUB1 antibody, the processing and maturation of the SUB1 
substrates, SERA5 and MSP1, was not affected in the knockdown parasites, 
suggesting that DPAP3 activity is not required for the activity of SUB1. 
Interestingly, however, the relative abundance of PfSUB1 mRNA was increased 4-
fold upon DPAP3 depletion whilst DPAP1 and DPAP2 was not, indicating that the 
parasite may compensate for low DPAP3 expression by increasing SUB1 
expression. This in turn could explain why there was a lack of a processing defect 
observed for both the SUB1 substrates in GlcN-treated parasites. 
The earlier inhibitor studies also revealed that inhibition of DPAP3 led to a 
complete loss of the precursor and intermediate forms of AMA1, which led to the
authors to propose that DPAP3 could act as a general maturase for secreted proteins
[198]. However, a processing defect of AMA1 could not be detected in DPAP3 
knockdown parasites, even though little or no apical AMA1 staining was observed 
in schizonts by IFA. This discrepancy in AMA1 by Western and IFA still needs to 
be resolved and although failure to traffic AMA1 to the micronemes could simply 
be due to parasites not being fully mature, it is intriguing that DPAP3 also localised
to the micronemes by immune-EM.
Although the functional elucidation of DPAP3 in this Chapter mostly agrees with 
the existing literature using the DPAP3 inhibitor, the inconsistencies observed with 
the processing results of AMA1 and SUB1 substrates SERA5 and MSP1, with the 
earlier inhibitor (SAKI) studies, could be suggestive of an off target effects of 
SAK1, and thus from those studies it may be difficult to interpret the function of 
DPAP3 in the malaria parasite if SAK1 has other targets within the secretory 
pathway. However, it should be noted that knockdown of DPAP3 in this Chapter 
was not 100% and thus a small amount of DPAP3 was still being made in the 
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parasite. Along with the 4-fold upregulation of PfSUB1 gene expression, this could 
explain why the knockdown parasites treated with GlcN could still cycle through 
its lifecycle stages. Nevertheless, a proportion of the knockdown parasite 
population showed a delayed egress phenotype. However, since DPAP3 
knockdown also affected schizont maturation and merozoite number, it appears that 
this temporary block in the egress phenotype may be the result of these factors, 
rather than the lack of ability to egress per se. The observation that knockdown of
DPAP3 affected the proteolytic processing of rhoptry protein RAP1 and trafficking 
of the microneme protein AMA1 is in keeping with a delayed maturation of 
schizonts and hence DPAP3 may therefore regulate parasite egress by regulating 
the maturation of secretory proteins required for this process. However, in the 
future it will be critical to confirm these results using a very synchronous parasite 
culture using inhibitors such as Compound 1 [202] (which do not target cysteine 
proteases), in conjunction with rigorous growth and invasion assays to specifically 
tease out if the delays in host cell egress and reduction in invasion is due to DPAP3 
affecting parasite maturation, or whether DPAP3 is specifically involved in 
processes specific to host cell egress or erythrocyte invasion. 
From this study, DPAP3 appears to have a distinct role to the other DPAPs.
Therefore a pan DPAP3 inhibitor could be generated, it may prove to be a very 
promising antimalarial by targeting different pathways in different lifecycle stages,
which would be optimal to reduce the chance of parasite resistance to this treatment 
strategy.
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The presence of multiple secretory organelles, namely the micronemes, rhoptries 
and dense granules, at the apical end of the Plasmodium merozoite enables the 
parasite to compartmentalise and deploy molecules in a temporarily regulated 
manner to facilitate invasion and subsequent remodelling of the target host cells.
The evidence supporting a major role for the rhoptries in Plasmodium erythrocyte 
invasion has been ever mounting. However, surprisingly, there is still only limited 
insight into how rhoptries are formed during each erythrocytic cycle, how proteins 
traffic to these organelles, and the signals that discern the segregation of the rhoptry 
proteome within the rhoptry, to ensure correct secretion and effector function 
during invasion.
Previous TEM studies performed on P. falciparum, suggest rhoptries form by 
sequential fusion of Golgi derived vesicles, although the mechanism that initiate 
rhoptry formation and membrane fusion is still unknown. However, there is enough 
evidence now to suggest that the N-terminal classical hydrophobic signal sequence 
of rhoptry proteins facilitates entry into the ER and from here these proteins, 
including members of the RAP complex [203], traffic through the compartments of 
the classical secretory pathway to finally reach the lumen of the premature rhoptries 
[204]. In Toxoplasma gondii, some rhoptry proteins harbour prodomains which are
processed en route or upon entry to the rhoptries [140-143], and these are 
instrumental in keeping the proteins inactive until required, or assist in protein 
folding [142, 204]. In Plasmodium, however, only a limited number of studies have 
focussed on rhoptry protein trafficking. RAP1 targeting to the rhoptry occurs via 
its N-terminus, [129], while a previous study [129] and this study (Chapter 4) have 
shown that trafficking of RAP2 and presumably RAP3 requires RAP1. This N-
terminal region of RAP1 consists of a domain that binds RAMA [131], a GPI-
anchored protein, and thus it has been hypothesised  that RAMA recruits the RAP 
and even the RhopH complex within lipid rafts at the Golgi exit face before budding
off as rhoptry-destined cargo vesicles (Fig 1.7). Eventually the RAP1 pro-peptide 
gets cleaved around the time RAP1 arrives at the rhoptry, resulting in the removal
of approximately 40 amino acids after the signal sequence [110]. The function of 
this pro-peptide remains unknown, but it could aid in the dissociation of the RAP 
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complex from RAMA or from trafficking complexes or it could be required for 
RAP1 protein folding and maturation, thereby promoting correct assembly and/or 
activation of the protein for its effector function [110]. That the RAMA-RAP 
complex is proteolytically cleaved in the rhoptry is further strengthened by co-
precipitation assays [74, 107, 145], which suggests that the RAMA-RAP complex 
is transient. Further, the presence of the same putative cleavage site (D/E)SFL(Q/E) 
[165] at the N-terminus of RAP1 and RAMA suggests that a single rhoptry-resident 
protease may be responsible for their processing [165].
Given that it was not possible to generate P. falciparum transgenic parasites with a 
mutated form of this putative cleavage site (68ESFL*E72 to 68EAAAE72),
conditional regulation of DPAP3 (a putative protease processing the RAPs), in P. 
falciparum was undertaken using the glms ribozyme based RNA-degrading system
to assess the role of this potential cleavage site. The trafficking of RAP1 was
affected, and a 45% reduction in the formation of mature RAP1p67 was also 
observed when DPAP3 was knocked down. However, DPAP3 knockdown also 
affected the trafficking of other rhoptry proteins like RhopH3 and RON4, along 
with a microneme protein AMA1. RAMA, which is synthesized early in 
trophozoite stages, was still processed and trafficked normally to the rhoptries,
indicating that DPAP3 plays a role after RAMA is delivered to the rhoptries but 
prior to the correct delivery of these other proteins to the apical organelles.
Inhibition of DPAP3 also led to a delay in schizont maturation, resulting in a 
delayed egress phenotype, a slower growth phenotype, along with a 30% reduction 
in the knockdown parasite population in the following growth cycle (Fig 6.1). To 
confirm whether DPAP3 serves as a general maturase of these apical secreted 
proteins, it will require experiments to be performed on tightly synchronised 
parasites (for example, using Compound 1, which is inhibitor that does not target 
cysteine proteases), followed by rigorous growth and invasion assays to discern 
whether DPAP3 plays a specific role in host cell egress and invasion, or whether 
these phenotypes are the indirect consequences of DPAP3 affecting parasite 
maturation. 
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Fig 6.1: Proposed model showing DPAP3 as a general maturase.
Schematic of a proposed model for DPAP3 function implicating DPAP3 as a 
general maturase for secreted protein. Knocking down DPAP3 affects processing 
and trafficking of RAP1 to the rhoptries and AMAI to the micronemes (shown in 
Chapter 5). It also might affect maturation of other apical proteins leading to the
delay in schizont maturation and hence a delayed egress phenotype, which 
subsequently delays growth in the following cycle of parasite replication.
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Although the functional elucidation of DPAP3 in this study mostly agrees with the 
existing literature using the DPAP3 inhibitor [198], the inconsistencies observed 
with the processing of AMA1 and the SUB1 substrates, SERA5 and MSP1, could 
be suggestive of an off target effects of SAK1 within the secretory pathway. Thus, 
it would also be worthwhile to confirm the effect of SUB1 maturation in the DPAP3 
knockdown line using SUB1 antibodies. However, it should be noted that
knockdown of DPAP3 using the riboswitch system was not 100%. Thus this 
residual amount of DPAP3 in the knockdown parasites along with the 4-fold 
upregulation of PfSUB1 gene expression could explain why the knockdown 
parasites treated with GlcN could still cycle through its lifecycle stages. While it 
cannot be ruled out that there is functional redundancy of DPAP3, it is unlikely to 
be via DPAP1 and DPAP2 because DPAP1 localises to the food vacuole and 
DPAP2 is expressed in the sexual stages. Moreover, no increase in the DPAP1 or 
DPAP2 was observed when DPAP3 was knocked down. Indeed if these three 
DPAPs serve different roles in Plasmodium, a pan DPAP inhibitor targeting both 
the sexual and asexual stages of the parasite lifecycle could be a promising 
antimalarial.
After the trafficking and putative cleavage of the RAPs in the rhoptries, the 
mechanism by which these proteins are retained in the rhoptry bulb when the neck 
proteins are released to form the tight junction during invasion has not been 
elucidated. In the P. falciparum '¨RAP1 knockout parasites, truncation of the 
C-terminal region of RAP1 led to trafficking of RAP1 to the rhoptry neck [129,
131]. Solubility studies showed that RAP1 is peripherally bound to membranes at 
the schizont stage. This may be via the bulb retention domain present at the C-
terminus of RAP1 [131], or via protein modifications such as palymitoylation. 
RAP1, 2 (and 3) have all been shown to be palymitoylated [205] and as this 
modification is reversible, it may provide a mechanism for the RAPs to get secreted 
during invasion. Alternatively, RAP1 (and potentially the other RAPs) could retain 
its peripherally-association with lipid rafts in the rhoptry, as these have been shown 
to eventually get secreted from the rhoptries into the erythrocyte cytosol as a whorl-
like structure through the tight junction during invasion [45] .
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Studies on the RAPs have highlighted the potential of these members as asexual 
antimalarial vaccine candidates and antibodies directed against Plasmodium 
falciparum (Pf) RAP1 and Pf RAP2 inhibit erythrocyte invasion in vitro [127, 179].
However, vaccines directed against RAP1 failed to render complete protection 
against parasite challenge (reviewed in [53]), which can now be explained with the 
present knowledge of the RAPs being secreted into the host erythrocyte following 
tight junction formation [45], and thus antibodies are unlikely to block its function.
In fact, this study has revealed that after host cell invasion, RAP1 is carried into the 
newly formed ring, where it persists for up to 15 hours. This long persistence of 
RAP1 after invasion argues against a role in invasion, and the immunogenicity of 
RAP1 observed previously could be a result of abortive invasive events. Thus, it is 
perhaps not surprising that the P. falciparum D10 RAP1 knock out line [129], and 
both the PbRAP1 and PbRAP2 knockdown lines did not show any effect on host 
cell invasion. Probing into the localisation of RAP1 at the ring stage demonstrated 
that RAP1 remains peripherally bound to membranes, and thus it is interesting that 
the absence of either RAP1 or RAP2 led to an abnormal PVM morphology and 
occasional extensions into the host cytosol. The parasites also appeared 
morphologically abnormal by Giemsa staining as they transitioned into trophozoite 
stage. In comparison to wildtype parasites, the knockdown parasites stained much 
darker with Giemsa, suggesting that they were more permeable to the stain.  As a 
consequence of these abnormalities, parasite growth was retarded.  These findings 
suggest that the RAPs could potentially contribute to PVM formation, or in the 
maintenance of the structural integrity of the PVM.
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Fig 6.2: Summary of RAP1/RAP2 Knockdown phenotype.
A. Knockdown of RAP1 and RAP2 did not affect rhoptry formation.
B. Knockdown of RAP1 affected trafficking of RAP2 to the rhoptries.
C. Knockdown of RAP1 and RAP2 did not affect parasite replication or merozoite 
number.
D. Knockdown of RAP1 and RAP2 did not affect erythrocyte invasion.
E. Knockdown of RAP1 and RAP2 led to abnormal PVM morphology.
F. Knockdown of RAP1 and RAP2 led to growth delay within the RBC.
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Thus, after getting secreted as whorl-like structure into the host erythrocyte [45],
the lipid vesicles containing RAPs could possibly fuse with the developing PVM 
on the host cytosolic side, permitting dynamic changes towards the conformational 
flexibility of the PVM to support the growing parasite. Alternatively, the RAPs 
could be involved in transport of nutrients/wastes across the PVM, depletion of 
which leads to a delayed growth phenotype, or the loss of PVM integrity could 
indirectly affect nutrient uptake and waste removal. Additional experiments 
confirming that RAP1 is peripherally associated with the PVM in the ring stages 
and localises to the host cytosolic side of PVM, are underway. RAP1 pull-downs 
using ring-stage parasites to identify interacting partners may also shed further light 
on the function of the RAPs post-invasion.
In summary, this thesis provides the first formal proof that RAPs are not involved 
in erythrocyte invasion in vivo (detailed in Fig 6.2), and presented substantial 
evidence supporting a post-invasion role for these proteins in the malaria parasite. 
This explains the failure of the RAPs as potential vaccines candidates but demands 
consideration of RAPs as prospective anti-malarial drug targets.
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